Admission	O
Date	O
:	O

2012-01-07	O

Discharge	O
Date	O
:	O

2012-03-10	O

Date	O
of	O
Birth	O
:	O

Sex	O
:	O

M	O

Service	O
:	O

Since	O
2012-02-26	O
,	O
the	O
patient	O
has	O
been	O
stable	O
.	O

The	O
Whidden	O
Memorial	O
Hospital	O
hospital	O
course	O
has	O
been	O
smooth	O
with	O
the	O
patient	O
progressively	O
improving	O
.	O

The	O
patient	O
was	O
initially	O
on	O
several	B-procedure
antibiotics	I-procedure
included	O
Cefepime	B-procedure
,	O
Vancomycin	B-procedure
,	O
Ciprofloxacin	B-procedure
,	O
Ambazone	B-procedure
and	O
Flagyl	B-procedure
.	O

The	B-procedure
patient	I-procedure
's	I-procedure
HSV	I-procedure
antibody	I-procedure
titer	I-procedure
was	O
found	O
to	O
be	O
negative	O
and	O
the	O
patient	O
's	O
Acyclovir	B-procedure
was	O
not	O
restarted	O
.	O

Infectious	O
disease	O
continued	O
to	O
follow	O
and	O
on	O
2012-02-29	O
,	O
the	O
patient	O
spiked	O
again	O
which	O
at	O
that	O
time	O
was	O
felt	O
to	O
be	O
due	O
to	O
his	B-procedure
central	I-procedure
line	I-procedure
and	O
the	B-procedure
central	I-procedure
line	I-procedure
was	O
resited	O
on	O
the	O
left	O
side	O
and	O
the	O
patient	O
was	O
started	O
on	O
intravenous	B-procedure
Vancomycin	I-procedure
.	O

Over	O
the	O
following	O
days	O
until	O
discharge	O
,	O
the	O
patient	O
remained	O
afebrile	O
and	O
on	O
2012-03-09	O
,	O
in	O
fact	O
all	O
the	B-procedure
patient	I-procedure
's	I-procedure
antibiotics	I-procedure
were	O
discontinued	O
.	O

As	O
for	O
the	O
patient	O
's	O
ALL	O
and	O
AML	O
,	O
the	O
patient	O
was	O
started	O
on	O
a	B-procedure
new	I-procedure
chemotherapy	I-procedure
protocol	I-procedure
called	O
hyper-CVAD	B-procedure
on	O
2012-03-06	O
.	O

After	O
the	O
patient	O
began	O
on	O
this	B-procedure
protocol	I-procedure
,	O
his	B-procedure
white	I-procedure
blood	I-procedure
cell	I-procedure
count	I-procedure
steadily	O
began	O
to	O
climb	O
.	O

The	O
patient	O
became	O
no	O
longer	O
neutropenic	O
.	O

The	O
patient	O
's	O
also	O
began	O
to	O
climb	O
and	O
the	B-procedure
percent	I-procedure
blasts	I-procedure
in	O
his	B-procedure
differential	I-procedure
decreased	O
significantly	O
.	O

The	O
patient	O
had	O
no	O
further	O
complaints	O
and	O
on	O
2012-03-10	O
,	O
his	B-procedure
white	I-procedure
blood	I-procedure
cell	I-procedure
count	I-procedure
was	O
2.3	O
,	O
neutrophils	B-procedure
50%	O
,	O
bands	B-procedure
2%	O
,	O
lymphocytes	B-procedure
5%	O
,	O
monocytes	B-procedure
40%	O
,	O
and	O
blasts	B-procedure
1%	O
.	O

Platelet	B-procedure
count	I-procedure
was	O
759,000	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
with	O
instructions	O
to	O
return	O
to	O
the	O
hospital	O
on	O
Monday	O
,	O
2012-03-12	O
,	O
for	O
follow-up	O
and	O
laboratory	B-procedure
checks	I-procedure
.	O

The	O
patient	O
was	O
also	O
given	O
instructions	O
to	O
be	O
prudent	O
and	O
stay	O
away	O
from	O
public	O
places	O
as	O
well	O
as	O
small	O
children	O
.	O

The	O
patient	O
was	O
also	O
told	O
to	O
continue	O
on	O
a	B-procedure
neutropenic	I-procedure
diet	I-procedure
.	O

The	O
patient	O
was	O
also	O
told	O
that	O
he	O
would	O
have	O
to	O
be	O
admitted	O
for	O
several	O
days	O
during	O
his	B-procedure
next	I-procedure
cycle	I-procedure
of	I-procedure
CVAD	I-procedure
.	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
in	O
good	O
condition	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Bactrim	B-procedure
double	I-procedure
strength	I-procedure
one	O
tablet	O
q.	O
Monday	O
,	O
Wednesday	O
and	O
Friday	O
.	O

2.	O
Compazine	B-procedure
10	O
mg	O
p.o.	O
q	O
6hours	O
p.r.n.	O
nausea	O
.	O

3.	O
Anzemet	B-procedure
100	O
mg	O
p.o.	O
once	O
daily	O
p.r.n.	O
nausea	O
.	O

The	O
patient	O
is	O
to	O
return	O
to	O
the	O
hospital	O
on	O
Monday	O
for	O
follow-up	O
.	O

DR.	O
Esparza	O
,	O
Gail	O
18-714	O

Dictated	O
By	O
:	O
Cristobal	O
C.	O
Reid	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-03-10	O
22:44	O

T	O
:	O
2012-03-11	O
10:08	O

JOB	O
#:	O

24313	O

1	O

1	O

1	O

OMR	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Brenda	O
C.	O
Massey	O
on	O
:	O
MON	O
2012-04-23	O
1:02	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2008-12-24	O

Discharge	O
Date	O
:	O

2009-02-06	O

Date	O
of	O
Birth	O
:	O

2008-12-24	O

Sex	O
:	O

F	O

Service	O
:	O

Neonatology	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Gerardo	O
is	O
the	O
1400	O
gm	O
product	O
of	O
a	O
32	O
05-03	O
week	O
twin	O
gestation	O
born	O
to	O
a	O
37	O
year	O
old	O
gravida	O
1	O
,	O
para	O
0	O
mother	O
.	O

Prenatal	O
laboratory	O
values	O
:	O

Maternal	B-procedure
blood	I-procedure
type	I-procedure
0-positive	O
,	O
DAT	B-procedure
negative	O
,	O
negative	O
,	O
RPR	B-procedure
nonreactive	O
.	O

The	O
mother	O
's	O
past	O
medical	O
history	O
is	O
significant	O
for	O
:	O

1.	O
Tuberculosis	O
,	O
mother	O
was	O
treated	O
in	O
2001	O
according	O
to	O
chart	O
with	O
subsequent	O
negative	O
chest	B-procedure
x-ray	I-procedure
,	O
and	O

2.	O
Infertility	O
.	O

The	O
pregnancy	O
was	O
complicated	O
by	O
twin	O
gestation	O
and	O
by	O
polyhydramnios	O
with	O
apparent	O
duodenal	O
atresia	O
and	O
nuchal	O

thickening	O
consistent	O
with	O
Trisomy	O
21	O
in	O
the	O
B	O
co-twin	O
.	O

Amniocentesis	B-procedure
was	O
not	O
performed	O
.	O

Maternal	O
hypertension	O
was	O
noted	O
in	O
the	O
doctor	O
's	O
office	O
and	O
Mom	O
was	O
referred	O
to	O
nonreassuring	B-procedure
fetal	I-procedure
tracing	I-procedure
,	O
necessitating	O
an	B-procedure
urgent	I-procedure
cesarean	I-procedure
section	I-procedure
.	O

Twin	O
#1	O
cried	O
spontaneously	O
at	O
birth	O
,	O
was	O
bulb	B-procedure
suctioned	I-procedure
and	O
received	O
Blow-by	B-procedure
oxygen	I-procedure
.	O

Apgars	B-procedure
were	O
8	O
at	O
one	O
minute	O
and	O
8	O
at	O
five	O
minutes	O
.	O

Twin	O
#1	O
was	O
noted	O
to	O
be	O
in	O
a	O
breech	O
presentation	O
.	O

Sepsis	O
risk	O
factors	O
:	O

No	O
fever	O
,	O
no	O
fetal	O
tachycardia	O
,	O
rupture	O
of	O
membranes	O
at	O
delivery	O
.	O

Group	B-procedure
B	I-procedure
Streptococcus	I-procedure
status	I-procedure
unknown	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Well-appearing	O
female	O
without	O
distress	O
on	O
admission	O
to	O
the	O
Newborn	O
Intensive	O
Care	O
Unit	O
.	O

The	O
patient	O
had	O
a	B-procedure
weight	I-procedure
of	O
1400	O
gm	O
,	O
length	B-procedure
41.5	O
cm	O
and	O
head	B-procedure
circumference	I-procedure
of	O
29.25	O
cm	O
.	O

Anterior	O
fontanelle	O
,	O
soft	O
and	O
flat	O
,	O
palate	O
intact	O
,	O
nondysmorphic	O
features	O
.	O

Lungs	O
:	O
breath	B-procedure
sounds	I-procedure
clear	O
and	O
equal	O
bilaterally	O
,	O
no	O
retractions	O
.	O

Heart	O
:	O
regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmur	O
,	O
normal	O
S1	O
and	O
S2	O
,	O
pulses	B-procedure
2	O
+.	O

Abdomen	O
:	O
soft	O
,	O
nondistended	O
.	O

Without	O
hepatosplenomegaly	O
,	O
without	O
masses	O
.	O

Normal	O
female	O
genitalia	O
.	O

Anus	O
patent	O
.	O

Positive	O
suck	B-procedure
,	O
positive	O
grasp	B-procedure
.	O

Skin	O
intact	O
.	O

Size	O
appropriate	O
for	O
gestational	O
age	O
,	O
32	O
week	O
female	O
.	O

SUMMARY	O
OF	O
HOSPITAL	O
COURSE	O
:	O

1.	O
Respiratory	O
-	O
Gerardo	O
was	O
initially	O
placed	O
in	O
nasal	B-procedure
cannula	I-procedure
oxygen	I-procedure
to	O
maintain	O
oxygen	B-procedure
saturation	I-procedure
greater	O
than	O
94	O
.	O

On	O
day	O
of	O
life	O
#1	O
,	O
caffeine	B-procedure
was	O
started	O
.	O

Gerardo	O
weaned	O
to	O
room	O
air	O
on	O
day	O
of	O
life	O
#6	O
.	O

Caffeine	B-procedure
was	O
discontinued	O
on	O
day	O
of	O
life	O
#19	O
.	O

Breath	B-procedure
sounds	I-procedure
,	O
clear	O
and	O
equal	O
,	O
without	O
retractions	O
,	O
respiratory	B-procedure
rate	I-procedure
30	O
s	O
to	O
60	O
s.	O

2.	O
Cardiovascular	O
-	O
The	O
patient	O
has	O
been	O
cardiovascularly	O
stable	O
without	O
murmur	O
.	O

3.	O
Fluids	O
,	O
electrolytes	O
and	O
nutrition	O
-	O
Birthweight	B-procedure
was	O
1400	O
gm	O
,	O
25th	O
percentile	O
.	O

The	O
patient	O
was	O
initially	O
started	O
on	O
D10	B-procedure
/	I-procedure
W	I-procedure
at	O
80	O
cc	O
/	O
kg	O
/	O
day	O
.	O

She	O
began	O
enteral	B-procedure
feeds	I-procedure
on	O
day	O
of	O
life	O
#2	O
advancing	O
to	O
mother	O
's	O
breastmilk	O
30	O
with	O
ProMod	B-procedure
at	O
150	O
cc	O
/	O
kg	O
/	O
day	O
.	O

Baby	O
received	O
parenteral	B-procedure
nutrition	I-procedure
and	O
lipids	B-procedure
for	O
four	O
days	O
.	O

No	O
hypoglycemia	O
issues	O
noted	O
.	O

Baby	O
is	O
presently	O
tolerating	O
mother	O
's	O
breastmilk	O
with	O
Enfamil	B-procedure
powder	I-procedure
to	O
make	O
24	O
cal	O
/	O
oz	O
at	O
130	O
cc	O
/	O
kg	O
/	O
day	O
.	O

The	O
baby	O
is	O
breastfeeding	O
well	O
.	O

The	O
plan	O
is	O
for	O
alternating	O
feeds	O
.	O

4.	O
Gastrointestinal	O
,	O
genitourinary	O
-	O
Peak	B-procedure
bilirubin	I-procedure
8.5	O
,	O
phototherapy	B-procedure
times	O
24	O
hours	O
.	O

Rebound	B-procedure
bilirubin	I-procedure
6.4	O
.	O

5.	O
Hematology	O
-	O
Most	O
recent	O
hematocrit	B-procedure
was	O
42.8	O
on	O
50-05-25	O
.	O

The	O
baby	O
received	O
no	O
blood	B-procedure
products	I-procedure
.	O

6.	O
Infectious	O
disease	O
-	O
No	O
sepsis	O
risk	O
factors	O
.	O

Initial	B-procedure
complete	I-procedure
blood	I-procedure
count	I-procedure
with	O
white	B-procedure
blood	I-procedure
cell	I-procedure
count	I-procedure
14	O
,	O
hemoglobin	B-procedure
21.6	O
,	O
hematocrit	B-procedure
62.9	O
,	O
65	O
neutrophils	B-procedure
,	O
no	O
bands	B-procedure
,	O
28	O
lymphocytes	B-procedure
.	O

Blood	B-procedure
cultures	I-procedure
negative	O
.	O

7.	O
Neurology	O
-	O
Normal	O
head	O
ultrasound	O
on	O
2009-01-08	O
.	O

8.	O
Sensory	O
-	O
Audiology	O
,	O
hearing	B-procedure
screening	I-procedure
was	O
performed	O
with	O
automated	O
auditory	O
brain	O
stem	O
responses	O
.	O

Baby	O
passed	O
hearing	B-procedure
test	I-procedure
on	O
2009-01-21	O
.	O

Follow	O
up	O
recommended	O
in	O
eight	O
months	O
.	O

Ophthalmology	O
:	O
eyes	O
were	O
examined	O
most	O
recently	O
on	O
2009-01-14	O
,	O
revealing	O
mature	O
retinal	O
vessels	O
.	O

A	B-procedure
follow	I-procedure
up	I-procedure
examination	I-procedure
is	O
recommended	O
in	O
six	O
to	O
eight	O
months	O
.	O

9.	O
Psychosocial	O
-	O
Bridgewater	O
State	O
Hospital	O
Center	O
's	O
social	O
work	O
involved	O
with	O
family	O
.	O

The	O
contact	O
social	O
worker	O
is	O
Barbara	O
Cole	O
and	O
she	O
can	O
be	O
reached	O
at	O
(	O
972	O
)	O
433-8086	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O
Home	O
.	O

PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Vito	O
Dotzler	O
,	O
phone	O
(	O
259	O
)	O
579-8396	O
,	O
fax	O
898-3942	O
.	O

RECOMMENDATIONS	O
:	O

1.	O
Feeds	O
-	O
Breastfeeding	O
ad	O
lib	O
,	O
supplementing	O
with	O
Enfamil	B-procedure
24	O
or	O
breastmilk	O
24	O
cal	O
/	O
oz	O
made	O
with	O
1	O
tsp	O
of	O
Enfamil	B-procedure
powder	I-procedure
per	O
100	O
cc	O
of	O
breastmilk	O
.	O

2.	O
Medications	B-procedure
-	O
Poly-Vi-James	B-procedure
1	O
cc	O
p.o.	O
q.	O
day	O
;	O
Iron	B-procedure
or	O
Fer-In-James	B-procedure
0.2	O
cc	O
p.o.	O
q.	O
day	O
to	O
give	O
2	O
mg	O
/	O
kg	O
/	O
day	O

3.	O
Car	B-procedure
seat	I-procedure
screening	I-procedure
-	O
Passed	O
.	O

4.	O
State	B-procedure
newborn	I-procedure
screening	I-procedure
-	O
Last	O
on	O
2009-01-07	O
,	O
all	O
within	O
normal	O
range	O
.	O

5.	O
Immunizations	B-procedure
received	O
-	O
Hepatitis	B-procedure
B	I-procedure
vaccine	I-procedure
given	O
2009-01-22	O
.	O

6.	O
Immunizations	B-procedure
recommended	O
-	O

Synagis	B-procedure
respiratory	I-procedure
syncytial	I-procedure
virus	I-procedure
prophylaxis	I-procedure
should	O
be	O
considered	O
from	O
October	O
through	O
April	O
for	O
infants	O
who	O
meet	O

any	O
of	O
the	O
following	O
three	O
criteria	O
-	O

1.	O
Born	O
at	O
less	O
than	O
32	O
weeks	O
;	O

2.	O
Born	O
between	O
32	O
and	O
35	O
weeks	O
with	O
plans	O
for	O
daycare	O
during	O
respiratory	O
syncytial	O
virus	O
season	O
,	O
with	O
a	O
smoker	O
in	O
the	O
household	O
or	O
with	O
preschool	O
siblings	O
;	O
or	O

3.	O
With	O
chronic	O
lung	O
disease	O
.	O

After	O
some	O
debate	O
,	O
we	O
concluded	O
that	O
Vetrano	O
was	O
not	O
at	O
unusually	O
high	O
risk	O
from	O
RSV	O
,	O
but	O
that	O
her	O
sister	O
might	O
be	O
.	O

Vetrano	O
probably	O
does	O
not	O
need	O
Synagis	B-procedure
at	O
least	O
until	O
her	O
sibling	O
is	O
discharged	O
from	O
the	O
hospital	O
.	O

It	O
may	O
then	O
be	O
reasonable	O
to	O
treat	O
both	O
for	O
the	O
balance	O
of	O
the	O
RSV	O
season	O
.	O

Influenza	B-procedure
immunization	I-procedure
should	O
be	O
considered	O
annually	O
in	O
the	O
fall	O
for	O
preterm	O
infants	O
with	O
chronic	O
lung	O
disease	O
once	O
they	O

reach	O
six	O
months	O
of	O
age	O
,	O
before	O
this	O
age	O
the	O
family	O
and	O
other	O
caregivers	O
should	O
be	O
considered	O
for	O
immunization	B-procedure
against	O

influenza	O
to	O
protect	O
the	O
infant	O
.	O

7.	O
Follow	O
up	O
-	O
Follow	O
up	O
appointment	O
with	O
primary	O
pediatrician	O
within	O
five	O
days	O
of	O
discharge	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Prematurity	O
,	O
former	O
32	O
4/7	O
weeks	O
,	O
Twin	O
#1	O

2.	O
Rule	O
out	O
sepsis	O

Beverly	O
Q.	O
Bailey	O
,	O
M.D.	O
02-131	O

Dictated	O
By	O
:	O
Carmen	O
Y.R.	O
Martinez	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2009-02-05	O
18:20	O

T	O
:	O
2009-02-05	O
18:39	O

JOB	O
#:	O

17371	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Lizzie	O
Calkins	O
on	O
:	O
Adeline	O
2009-02-06	O
10:27	O
AM	O

(	O
End	O
of	O
Report	O
)	O

839999049	O
YC	O

59242403	O

431924	O

11/01/2000	O
12:00:00	O
AM	O

Obstructive	O
Sleep	O
Apnea	O

DIS	O

Admission	O
Date	O
:	O

11/01/2000	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

11/04/2000	O

******	O
DISCHARGE	O
ORDERS	O
******	O

BREUNCLONTSTREAUAYLES	O
,	O
BINTRIREE	O

766-50-79-4	O
H55	O

Room	O
:	O

42Z-770	O

Service	O
:	O

MED	O

DISCHARGE	O
PATIENT	O
ON	O
:	O
11/04/00	O
AT	O
03:00	O
PM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

AISTAKEFLICHSKI	O
,	O
TAINE	O
D.	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

WELLBUTRIN	B-procedure
(	I-procedure
BUPROPION	I-procedure
HCL	I-procedure
)	I-procedure
150	O
MG	O
PO	O
BID	O
FOLATE	B-procedure
(	I-procedure
FOLIC	I-procedure
ACID	I-procedure
)	I-procedure
1	O
MG	O
PO	O
QD	O
ATIVAN	B-procedure
(	I-procedure
LORAZEPAM	I-procedure
)	I-procedure
1	O
MG	O
PO	O
Q12H	O
X	O
1	O
Days	O
ATIVAN	B-procedure
(	I-procedure
LORAZEPAM	I-procedure
)	I-procedure
1	O
MG	O
PO	O
QHS	O
X	O
7	O
Days	O
Starting	O
on	O
11/5	O
MVI	B-procedure
THERAPEUTIC	I-procedure
W	I-procedure
/	I-procedure
MINERALS	I-procedure
(	I-procedure
THERAP	I-procedure
VITS	I-procedure
/	I-procedure
MINERALS	I-procedure
)	I-procedure
1	O
TAB	O
PO	O
QD	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
11/03/00	O
by	O
TWADA	O
,	O
STASTERL	O
ETHESHI	O
,	O
M.D.	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SIMVASTATIN	B-procedure
and	O
NIACIN	B-procedure
,	O
VIT.	B-procedure

B-3	B-procedure
Reason	O
for	O
override	O
:	O

indicated	O
THIAMINE	B-procedure
(	I-procedure
THIAMINE	I-procedure
HCL	I-procedure
)	I-procedure
100	O
MG	O
PO	O
QD	O
SIMVASTATIN	B-procedure
40	O
MG	O
PO	O
QHS	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
11/03/00	O
by	O
TWADA	O
,	O
STASTERL	O
ETHESHI	O
,	O
M.D.	O
on	O
order	O
for	O
MVI	B-procedure
THERAPEUTIC	I-procedure
W	I-procedure
/	I-procedure
MINERALS	I-procedure
PO	I-procedure
(	O
ref	O
#	O
90299469	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SIMVASTATIN	B-procedure
and	O
NIACIN	B-procedure
,	O
VIT.	B-procedure
B-3	I-procedure

Reason	O
for	O
override	O
:	O

indicated	O
LISINOPRIL	B-procedure
10	O
MG	O
PO	O
QD	O
NICOTINE	B-procedure
PATCH	I-procedure
(	I-procedure
NICOTINE	I-procedure
)	I-procedure
21	O
MG/DAY	O
TP	O
Q24H	O

DIET	O
:	O

House	O
/	O
NAS	O
/	O
Low	O
chol	O
/	O
low	O
sat.	O
fat	O
&lt;	O
FDI	O
&gt;	O

RETURN	O
TO	O
WORK	O
:	O

Immediately	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Firmert	O
Hospital	O
11/6	O
at	O
9am	O
scheduled	O
,	O
Cialneinsisters	O
Hospital	O
And	O
Medical	O
Center	O
11/16	O
at	O
8:15pm	O
scheduled	O
,	O
Dr.	O
Condnort	O
12/04	O
at	O
2pm	O
scheduled	O
,	O
Dr.	O
Lila	O
Spielbjaque	O
12/01	O
at	O
1:50pm	O
scheduled	O
,	O
No	O
Known	O
Allergies	O

ADMIT	O
DIAGNOSIS	O
:	O

r	O
/	O
o	O
MI	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
Obstructive	O
Sleep	O
Apnea	O

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
HTN	O
tobacco	O
EtOh	O
abuse	O
sinus	O
bradycardia	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

50	O
yo	O
M	O
from	O
Taheimpromong	O
admitted	O
w	O
/	O
CP	O
for	O
r	O
/	O
o	O
MI	O
.	O

Has	O
significant	O
cardiac	O

RF	O
:	O

FH	O
,	O
HTN	O
,	O
tobacco	O
.	O

Presented	O
w	O
/	O
epigastric	O
pain	O
,	O
SOB	O
at	O
work	O
.	O

ETT	B-procedure
was	O
negative	O
for	O
ischemia	O
.	O

Echo	B-procedure
showed	O
ef	B-procedure
45-50%	O
,	O
with	O
mild	O
dilatation	O
and	O
no	O
significant	O
valvular	O
disease	O
,	O
and	O
nl	O
PAP	O
.	O

ACE	O
team	O
consulted	O
who	O
arranged	O
for	O
pt	O
to	O
have	O
outpt	O
follow	O
up	O
.	O

During	O
this	O
hospitalization	O
,	O
pt	O
was	O
noted	O
to	O
have	O
sinus	O
bradycardia	O
and	O
pauses	O
,	O
associated	O
with	O
desaturations	O
in	O
the	O
70	O
&apos;s	O
.	O

CPAP	B-procedure
at	O
5	O
was	O
attempted	O
,	O
but	O
pt	O
did	O
not	O
tolerate	O
this	O
.	O

He	O
will	O
have	O
outpt	B-procedure
fitting	I-procedure
at	O
the	O
sleep	O
center	O
in	O
Sabo	O
.	O

Pt	O
also	O
counselled	O
re	O
:	O

quitting	O
smoking	O
,	O
and	O
he	O
appears	O
motivated	O
to	O
do	O
so	O
,	O
as	O
well	O
as	O
to	O
cut	O
down	O
on	O
his	O
drinking	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

1.	O
llame	O
a	O
su	O
doctor	O
y	O
haga	O
cita	O
para	O
verlo	O
dentro	O
de	O
1	O
semana	O
.	O

2.	O
llame	O
a	O
la	O
clinica	O
the	O
Wake	O
Valley	O
Hospital	O
442/961-2446	O
,	O
si	O
tiene	O
que	O
cambiar	O
la	O
cita	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

LARDES	O
,	O
COLNKAY	O
,	O
M.D.	O
(	O
IP09	O
)	O
11/04/00	O
03:34	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

879492218	O
YC	O

53470378	O

3210349	O

6/26/2004	O
12:00:00	O
AM	O

PNEUMONIA	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

06/26/2004	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

07/08/2004	O

ATTENDING	O
:	O

MALTA	O
FYFEZEISLEITZ	O
MD	O

CHIEF	O
COMPLAINT	O
:	O

Shortness	O
of	O
breath	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
38-year-old	O
gentleman	O
,	O
Spanish-speaking	O
,	O
from	O
the	O
Taheimpromong	O
,	O
with	O
no	O
significant	O
past	O
medical	O
history	O
,	O
who	O
presents	O
with	O
shortness	O
of	O
breath	O
x	O
2	O
months	O
as	O
well	O
as	O
a	O
dry	O
cough	O
x	O
1	O
month	O
.	O

The	O
patient	O
was	O
in	O
his	O
usual	O
state	O
of	O
health	O
until	O
two	O
months	O
prior	O
to	O
admission	O
when	O
he	O
began	O
to	O
notice	O
shortness	O
of	O
breath	O
on	O
climbing	O
flights	O
of	O
stairs	O
.	O

He	O
stated	O
that	O
this	O
became	O
worse	O
over	O
the	O
last	O
month	O
until	O
he	O
was	O
noted	O
to	O
be	O
short	O
of	O
breath	O
at	O
rest	O
.	O

He	O
also	O
states	O
that	O
he	O
has	O
had	O
a	O
dry	O
and	O
nonproductive	O
cough	O
for	O
one	O
month	O
.	O

He	O
denied	O
any	O
fevers	O
,	O
chills	O
,	O
or	O
night	O
sweats	O
.	O

No	O
nausea	O
,	O
vomiting	O
,	O
or	O
diarrhea	O
.	O

He	O
did	O
note	O
some	O
weight	O
loss	O
over	O
the	O
past	O
several	O
months	O
,	O
though	O
the	O
amount	O
was	O
unknown	O
.	O

He	O
denied	O
any	O
contact	O
with	O
TB	O
positive	O
patients	O
.	O

He	O
describes	O
a	O
negative	O
PPD	O
one	O
year	O
prior	O
to	O
admission	O
when	O
he	O
was	O
in	O
prison	O
for	O
one	O
week	O
.	O

He	O
did	O
travel	O
to	O
the	O
Taheimpromong	O
,	O
last	O
in	O
01/2004	O
for	O
three	O
weeks	O
.	O

He	O
did	O
note	O
multiple	O
female	O
sexual	O
partners	O
,	O
although	O
described	O
using	O
condoms	O
except	O
with	O
his	O
wife	O
.	O

He	O
denies	O
any	O
IV	O
drug	O
use	O
,	O
did	O
describe	O
cocaine	O
use	O
last	O
two	O
months	O
ago	O
.	O

He	O
did	O
drink	O
alcohol	O
three	O
drinks	O
per	O
day	O
,	O
no	O
withdrawal	O
symptoms	O
.	O

In	O
emergency	O
room	O
,	O
he	O
was	O
noted	O
to	O
be	O
afebrile	O
with	O
stable	O
vital	O
signs	O
,	O
was	O
treated	O
with	O
IV	B-procedure
fluids	I-procedure
,	O
azithromycin	B-procedure
,	O
and	O
cefuroxime	B-procedure
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

None	O
.	O

MEDICATIONS	O
:	O

None	O
.	O

ALLERGIES	O
:	O

No	O
known	O
drug	O
allergies	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
currently	O
with	O
a	O
friend	O
,	O
he	O
is	O
from	O
the	O
Taheimpromong	O
and	O
has	O
lived	O
here	O
for	O
13	O
years	O
,	O
he	O
does	O
note	O
multiple	O
sexual	O
partners	O
,	O
although	O
he	O
notes	O
using	O
condoms	O
with	O
everyone	O
except	O
his	O
wife	O
,	O
he	O
reportedly	O
had	O
a	O
negative	O
PPD	O
during	O
his	O
prison	O
stay	O
one	O
year	O
ago	O
for	O
one	O
week	O
.	O

He	O
traveled	O
to	O
the	O
Taheimpromong	O
last	O
in	O
01/2004	O
for	O
one	O
month	O
.	O

He	O
does	O
drink	O
alcohol	O
three	O
drinks	O
per	O
day	O
,	O
denies	O
any	O
current	O
tobacco	O
use	O
.	O

FAMILY	O
HISTORY	O
:	O

Sister	O
with	O
bone	O
cancer	O
.	O

PHYSICAL	O
EXAMINATION	O
UPON	O
ADMISSION	O
:	O

Temperature	B-procedure
97.4	O
,	O
heart	B-procedure
rate	I-procedure
100	O
,	O
blood	B-procedure
pressure	I-procedure
142/89	O
,	O
and	O
O2	B-procedure
saturation	I-procedure
94%	O
on	O
room	O
air	O
.	O

General	B-procedure
exam	I-procedure
revealed	O
a	O
well-developed	O
,	O
well-nourished	O
gentleman	O
in	O
no	O
acute	O
distress	O
.	O

HEENT	B-procedure
exam	I-procedure
revealed	O
sclerae	O
to	O
be	O
injected	O
.	O

Pupils	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

No	O
lymphadenopathy	O
was	O
noted	O
in	O
the	O
neck	O
,	O
there	O
was	O
a	O
question	O
of	O
right	O
axillary	O
lymphadenopathy	O
.	O

Chest	B-procedure
exam	I-procedure
reveals	O
coarse	O
rhonchi	O
with	O
some	O
bibasilar	O
crackles	O
.	O

Abdominal	B-procedure
exam	I-procedure
revealed	O
soft	O
,	O
nontender	O
,	O
and	O
nondistended	O
abdomen	O
.	O

Heart	B-procedure
exam	I-procedure
was	O
regular	O
rate	O
and	O
rhythm	O
,	O
tachycardic	O
,	O
with	O
a	O
flat	O
jugular	O
venous	O
pressure	O
.	O

His	O
extremities	O
were	O
without	O
cyanosis	O
,	O
clubbing	O
,	O
or	O
edema	O
.	O

His	O
skin	O
was	O
clear	O
,	O
without	O
rashes	O
.	O

There	O
is	O
no	O
hepatosplenomegaly	O
noted	O
on	O
abdominal	B-procedure
exam	I-procedure
.	O

Neuro	B-procedure
exam	I-procedure
was	O
alert	O
and	O
oriented	O
x	O
3	O
.	O

LABORATORY	O
DATA	O
UPON	O
ADMISSION	O
:	O

Sodium	B-procedure
139	O
,	O
potassium	B-procedure
3.5	O
,	O
chloride	B-procedure
103	O
,	O
bicarbonate	B-procedure
25	O
,	O
BUN	B-procedure
9	O
,	O
creatinine	B-procedure
0.9	O
,	O
and	O
glucose	B-procedure
83	O
.	O

White	B-procedure
blood	I-procedure
cell	I-procedure
count	I-procedure
11.2	O
,	O
hematocrit	B-procedure
43.2	O
,	O
and	O
platelets	B-procedure
447,000	O
.	O

EKG	O
upon	O
admission	O
:	O

Sinus	O
tachycardia	O
at	O
100	O
.	O

Chest	O
x-ray	O
upon	O
admission	O
:	O

Diffuse	O
interstitial	O
process	O
/	O
consolidation	O
.	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEM	O
:	O

1.	O
Pulmonary	O
/	O
Infectious	O
Disease	O
:	O

The	O
patient	O
&apos;s	O
differential	O
diagnosis	O
included	O
initially	O
a	O
question	O
of	O
an	O
atypical	O
pneumonia	O
or	O
PCP	O
.	O

His	B-procedure
PPD	I-procedure
has	O
been	O
negative	O
one	O
year	O
prior	O
to	O
admission	O
,	O
PPD	B-procedure
was	O
rechecked	O
during	O
this	O
admission	O
and	O
was	O
negative	O
.	O

He	O
was	O
ruled	O
out	O
for	O
tuberculosis	O
with	O
an	B-procedure
induced	I-procedure
sputum	I-procedure
x	O
3	O
,	O
which	O
showed	O
no	O
AFB	O
.	O

Chest	B-procedure
CT	I-procedure
showed	O
bibasilar	O
diffuse	O
infiltrates	O
,	O
PCP	B-procedure
was	O
negative	O
.	O

Thus	O
initially	O
he	O
had	O
been	O
started	O
on	O
prednisone	B-procedure
and	O
Bactrim	B-procedure
,	O
this	O
was	O
discontinued	O
.	O

He	O
was	O
continued	O
on	O
azithromycin	B-procedure
and	O
cefuroxime	B-procedure
until	O
bronchoscopy	O
results	O
were	O
known	O
,	O
negative	O
.	O

Thus	O
they	O
were	O
discontinued	O
.	O

He	O
initially	O
had	O
refused	O
HIV	B-procedure
testing	I-procedure
,	O
however	O
,	O
was	O
finally	O
consented	O
,	O
HIV	O
was	O
noted	O
to	O
be	O
negative	O
.	O

Pulmonary	O
consult	O
was	O
invited	O
,	O
initially	O
the	O
patient	O
refused	O
bronchoscopy	B-procedure
,	O
however	O
,	O
did	O
agree	O
to	O
it	O
during	O
his	O
hospital	O
stay	O
.	O

The	O
results	O
were	O
negative	O
for	O
Micro	O
,	O
most	O
likely	O
diagnosis	O
as	O
per	O
review	B-procedure
of	I-procedure
pathology	I-procedure
is	O
organizing	O
pneumonia	O
with	O
possible	O
diagnosis	O
of	O
BOOP	O
and	O
chronic	O
inhalational	O
injury	O
was	O
a	O
possibility	O
.	O

The	O
patient	O
required	O
supplemental	B-procedure
oxygen	I-procedure
to	O
keep	O
his	B-procedure
oxygen	I-procedure
saturation	I-procedure
greater	O
than	O
93%	O
.	O

Ambulatory	B-procedure
saturation	I-procedure
was	O
82%	O
on	O
room	O
air	O
.	O

He	O
was	O
treated	O
with	O
supportive	B-procedure
medical	I-procedure
therapy	I-procedure
for	O
his	O
cough	O
.	O

He	O
was	O
to	O
follow	O
up	O
with	O
pulmonary	O
as	O
an	O
outpatient	O
.	O

2.	O
Cardiovascular	O
:	O

Echocardiogram	B-procedure
was	O
checked	O
to	O
rule	O
out	O
CHF	O
,	O
showed	O
LVH	O
and	O
trace	O
TR	O
,	O
ejection	B-procedure
fraction	I-procedure
of	O
60%	O
without	O
any	O
pulmonary	O
hypertension	O
.	O

3.	O
Heme	O

/ID	O
:	O

Hepatitis	B-procedure
serologies	I-procedure
were	O
negative	O
.	O

4.	O
FEN	O
:	O

The	O
patient	O
was	O
kept	O
on	O
a	O
house	O
diet	O
.	O

His	B-procedure
electrolytes	I-procedure
were	O
repeated	O
p.r.n.	O

5.	O
Prophylaxis	O
:	O

Lovenox	B-procedure
.	O

6.	O
Code	O
status	O
:	O

Full	O
.	O

7.	O
Disposition	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
in	O
satisfactory	O
condition	O
with	O
home	B-procedure
oxygen	I-procedure
.	O

Multiple	O
conversations	O
were	O
had	O
with	O
the	O
patient	O
as	O
well	O
as	O
an	O
interpreter	O
stating	O
the	O
importance	O
of	O
not	O
smoking	O
and	O
keeping	O
flames	O
away	O
from	O
his	B-procedure
oxygen	I-procedure
tank	I-procedure
.	O

He	O
was	O
sent	O
home	O
with	O
LDAMC	O
services	O
to	O
help	O
with	O
his	B-procedure
medications	I-procedure
as	O
well	O
as	O
oxygen	O
education	O
.	O

He	O
was	O
told	O
to	O
call	O
a	O
doctor	O
or	O
come	O
to	O
the	O
emergency	O
room	O
should	O
he	O
have	O
any	O
further	O
troubles	O
,	O
breathing	O
,	O
chest	O
pain	O
,	O
or	O
fevers	O
.	O

He	O
was	O
to	O
follow	O
up	O
with	O
Dr.	O
Malta	O
at	O
Firmert	O
Hospital	O
on	O
07/23/04	O
at	O
3:00	O
p.m.	O
,	O
as	O
well	O
as	O
Dr.	O
Shawn	O
Leick	O
at	O
the	O
Stonho	O
Health	O
Care	O
pulmonary	O
division	O
as	O
directed	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Prednisone	B-procedure
60	O
mg	O
p.o.	O
q.a.m.	O

2.	O
Bactrim	B-procedure
double	I-procedure
strength	I-procedure
one	O
tablet	O
p.o.	O
q.d.	O
for	O
PCP	B-procedure
prophylaxis	I-procedure
during	O
his	B-procedure
steroid	I-procedure
course	I-procedure
.	O

eScription	O
document	O
:	O

0-3054851	O
WEBCtug	O
Tel	O

CC	O
:	O

Mata	O
Fyfezeisleitz	O
MD	O
Verla	O

Dictated	O
By	O
:	O

KOTEHARBE	O
,	O
THRYNE	O

Attending	O
:	O

FYFEZEISLEITZ	O
,	O
MATA	O
Dictation	O
ID	O
5149122	O

D	O
:	O

11/06/04	O

T	O
:	O

11/07/04	O

Admission	O
Date	O
:	O

2018-10-25	O

Discharge	O
Date	O
:	O

2018-10-31	O

Date	O
of	O
Birth	O
:	O

1951-06-15	O

Sex	O
:	O

M	O

Service	O
:	O

CARDIOTHORACIC	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	O
Allergies	O
to	O
Drugs	B-procedure

Attending	O
:	O
Michael	O
D.	O
Christensen	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Shortness	O
of	O
Breath	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Coronary	B-procedure
Artery	I-procedure
Bypass	I-procedure
Graft	I-procedure
x3	O
(	O
Left	B-procedure
internal	I-procedure
mammary	I-procedure
->	I-procedure
left	I-procedure
anterior	I-procedure
descending	I-procedure
,	O
saphaneous	B-procedure
vein	I-procedure
graft	I-procedure
->	I-procedure
obtuse	I-procedure
marginal	I-procedure
,	O
saphaneous	B-procedure
vein	I-procedure
graft	I-procedure
->	I-procedure
posterior	I-procedure
descending	I-procedure
artery	I-procedure
)	O
2018-10-25	O

History	O
of	O
Present	O
Illness	O
:	O

67	O
y/o	O
male	O
with	O
worsening	O
shortness	O
of	O
breath.	O
Had	O
abnormal	O
ETT	O
and	O
referred	O
for	O
cath	B-procedure
.	O

Cath	B-procedure
revealed	O
severe	O
3	O
vessel	O
disease	O
.	O

Then	O
referred	O
for	O
surgical	B-procedure
intervention	I-procedure
.	O

Past	O
Medical	O
History	O
:	O

Carpal	O
tunnel	O
syndrome	O
,	O
Hypertension	O
,	O
Hyperlipidemia	O
,	O
Arthritis	O
,	O
h/o	O
Bell's	O
Palsy	O
,	O
HOH	O
,	O
s/p	O
Tonsillectomy	B-procedure

Social	O
History	O
:	O

Denies	O
ETOH	O
,	O
rare	O
Tobacco	O
.	O

Electrician	O
.	O

Family	O
History	O
:	O

Father	O
with	O
MI	O
in	O
50	O
's	O
and	O
underwent	O
CABG	B-procedure
.	O

Physical	O
Exam	O
:	O

VS	B-procedure
:	O
65	O
20	O
160/100	O
5	O
'	O
7	O
"	O
180	O
#	O

General	O
:	O
WD/WN	O
male	O
in	O
NAD	O

HEENT	O
:	O
EOMI	O
,	O
PERRL	O
,	O
NC/AT	O

Neck	O
:	O
Supple	O
,	O
FROM	O
,	O
-	O
JVD	O
,	O
-	O
carotid	O
bruits	O

Chest	O
:	O
CTAB	O
-	O
w/r/r	O

Heart	O
:	O
RRR	O
-	O
c/r/m/g	O

Abd	O
:	O
Soft	O
,	O
NT/ND	O
+BS	O

Ext	O
:	O
Warm	O
,	O
well-perfused	O
-	O
edema	O
,	O
-	O
varicosities	O

Neuro	O
:	O
A&Ox3	O
,	O
MAE	O
,	O
non-focal	O

Pertinent	O
Results	O
:	O

Echo	B-procedure
10-25	O
:	O
PRE-BYPASS	O
:	O
Left	B-procedure
ventricular	I-procedure
wall	I-procedure
thicknesses	I-procedure
are	O
normal	O
.	O

The	B-procedure
left	I-procedure
ventricular	I-procedure
cavity	I-procedure
size	I-procedure
is	O
normal	O
.	O

There	O
is	O
mild	O
inferior	O
wall	O
hypokinesis	O
.	O

There	O
is	O
akinesis	O
/	O
dyskinesis	O
and	O
thinning	O
of	O
the	O
mid	O
to	O
distal	O
inferior	O
septum	O
and	O
the	O
apex	O
.	O

Overall	B-procedure
left	I-procedure
ventricular	I-procedure
systolic	I-procedure
function	I-procedure
is	O
mildly	O
depressed	O
.	O

Right	B-procedure
ventricular	I-procedure
chamber	I-procedure
size	I-procedure
and	O
free	B-procedure
wall	I-procedure
motion	I-procedure
are	O
normal	O
.	O

The	O
descending	O
thoracic	O
aorta	O
is	O
mildly	O
dilated	O
.	O

There	O
are	O
simple	O
atheroma	O
in	O
the	O
descending	O
thoracic	O
aorta	O
.	O

There	O
are	O
three	O
aortic	O
valve	O
leaflets	O
.	O

There	O
is	O
no	O
aortic	O
valve	O
stenosis	O
.	O

No	O
aortic	O
regurgitation	O
is	O
seen	O
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
.	O

Trivial	O
mitral	O
regurgitation	O
is	O
seen	O
.	O

POST-BYPASS	B-procedure
:	O
LV	B-procedure
and	I-procedure
RV	I-procedure
function	I-procedure
is	O
unchanged	O
.	O

Aorta	O
is	O
unchanged	O
.	O

Other	O
findings	O
are	O
unchanged	O
.	O

CXR	B-procedure
10-30	O
:	O
Left	O
lower	O
lobe	O
atelectasis	O
has	O
partially	O
cleared	O
.	O

Upper	O
lungs	O
are	O
clear	O
.	O

Mild	O
postoperative	O
widening	O
of	O
the	O
cardiomediastinal	O
silhouette	O
is	O
stable	O
.	O

No	O
pneumothorax	O
.	O

2018-10-25	O
11:15	O
AM	O
BLOOD	B-procedure
WBC	B-procedure
-	O
18.3	O
*#	O
RBC	B-procedure
-	O
3.42	O
*	O
Hgb	B-procedure
-	O
10.9	O
*	O
Hct	B-procedure
-	O
31.6	O
*	O
MCV	B-procedure
-	O
92	O
MCH	B-procedure
-	O
31.7	O
MCHC	B-procedure
-	O
34.4	O
RDW	B-procedure
-	O
13.3	O
Plt	B-procedure
Ct	I-procedure
-	O
134	O
*	O

2018-10-31	O
06:25	O
AM	O
BLOOD	B-procedure
WBC	B-procedure
-	O
13.6	O
*	O
RBC	B-procedure
-	O
2.72	O
*	O
Hgb	B-procedure
-	O
8.6	O
*	O
Hct	B-procedure
-	O
24.6	O
*	O
MCV	B-procedure
-	O
91	O
MCH	B-procedure
-	O
31.7	O
MCHC	B-procedure
-	O
35.0	O
RDW	B-procedure
-	O
14.0	O
Plt	B-procedure
Ct	I-procedure
-	O
314	O

2018-10-25	O
11:15	O
AM	O
BLOOD	B-procedure
PT	B-procedure
-	O
13.3	O
*	O
PTT	B-procedure
-	O
30.0	O
INR(PT)	B-procedure
-	O
1.2	O
*	O

2018-10-29	O
06:50	O
AM	O
BLOOD	B-procedure
PT	B-procedure
-	O
11.9	O
INR(PT)	B-procedure
-	O
1.0	O

2018-10-25	O
12:36	O
PM	O
BLOOD	B-procedure
UreaN	B-procedure
-	O
17	O
Creat	B-procedure
-	O
0.7	O
Cl	B-procedure
-	O
111	O
*	O
HCO3	B-procedure
-	O
23	O

2018-10-31	O
06:25	O
AM	O
BLOOD	B-procedure
Glucose	B-procedure
-	O
91	O
UreaN	B-procedure
-	O
19	O
Creat	B-procedure
-	O
0.8	O
Na	B-procedure
-	O
134	O
K	B-procedure
-	O
4.0	O
Cl	B-procedure
-	O
98	O
HCO3	B-procedure
-	O
26	O
AnGap	B-procedure
-	O
14	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Kammerer	O
was	O
a	O
same	O
day	O
admit	O
and	O
on	O
10-25	O
was	O
brought	O
to	O
the	O
operating	O
room	O
where	O
he	O
underwent	O
a	B-procedure
coronary	I-procedure
artery	I-procedure
bypass	I-procedure
graft	I-procedure
x	O
3	O
.	O

Please	O
see	O
operative	O
report	O
for	O
surgical	O
details	O
.	O

He	O
tolerated	O
the	B-procedure
procedure	I-procedure
well	O
and	O
was	O
transferred	O
to	O
the	O
CSRU	O
for	O
invasive	B-procedure
monitoring	I-procedure
in	O
stable	O
condition	O
.	O

Later	O
on	O
op	O
day	O
he	O
was	O
weaned	O
from	O
sedation	B-procedure
,	O
awoke	O
neurologically	O
intact	O
,	O
and	O

extubated	O
.	O

Beta	B-procedure
blockers	I-procedure
and	O
diuretics	B-procedure
were	O
initiated	O
on	O
post-op	O
day	O
one	O
.	O

He	O
was	O
diuresed	B-procedure
towards	O
his	B-procedure
pre-op	I-procedure
weight	I-procedure
.	O

He	O
appeared	O
to	O
be	O
doing	O
well	O
and	O
was	O
transferred	O
to	O
the	O
SDU	O
on	O
this	O
day	O
.	O

He	O
did	O
have	O
burst	O
of	O
atrial	O
fibrillation	O
and	O
was	O
started	O
on	O
a	B-procedure
Amiodarone	I-procedure
gtt	I-procedure
.	O

His	B-procedure
beta	I-procedure
blockers	I-procedure
were	O
also	O
titrated	O
for	O
maximal	B-procedure
BP	I-procedure
and	I-procedure
HR	I-procedure
control	I-procedure
.	O

Chest	B-procedure
tubes	I-procedure
were	O
removed	O
on	O
post-op	O
day	O
two	O
and	O
epicardial	B-procedure
pacing	I-procedure
wires	I-procedure
on	O
post-op	O
day	O
three	O
.	O

Over	O
the	O
next	O
several	O
days	O
he	O
continued	O
to	O
improve	O
his	O
ambulation	O
and	O
mobility	O
with	O
physical	B-procedure
therapy	I-procedure
.	O

He	O
had	O
no	O
further	O
episodes	O
of	O
AFIB	O
while	O
on	O
po	B-procedure
Amiodarone	I-procedure
.	O

On	O
post-op	O
day	O
five	O
he	O
appeared	O
to	O
have	O
left	O
arm	O
phlebitis	O
and	O
was	O
started	O
on	O
antibiotics	B-procedure
.	O

He	O
was	O
discharged	O
home	O
on	O
post-op	O
day	O
six	O
with	O
antibiotics	B-procedure
and	O
appropriate	B-procedure
meds	I-procedure
.	O

He	O
will	O
have	O
VNA	B-procedure
services	I-procedure
and	O
make	O
the	O
appropriate	O
follow-up	O
appointments	O
.	O

Medications	O
on	O
Admission	O
:	O

Aspirin	B-procedure
81	O
mg	O
qd	O
,	O
Toprol	B-procedure
XL	O
50	O
mg	O
qd	O
,	O
MVI	B-procedure
,	O
Flexeril	B-procedure
10	O
mg	O
qhs	O
,	O
Plavix	B-procedure
75	O
mg	O
qd	O
(	O
last	O
on	O
10-18	O
)	O

Discharge	O
Medications	O
:	O

1.	O
Docusate	B-procedure
Sodium	I-procedure
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Aspirin	B-procedure
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Ranitidine	B-procedure
HCl	I-procedure
150	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

4.	O
Oxycodone	B-procedure
-	I-procedure
Acetaminophen	I-procedure
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	O
.	O

Disp	O
:*	O
40	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Atorvastatin	B-procedure
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

6.	O
Amiodarone	B-procedure
200	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
):	O
please	O
take	O
400	O
mg	O
twice	O
a	O
day	O
until	O
11-02	O
then	O
decrease	O
to	O
400	O
mg	O
once	O
a	O
day	O
for	O
1	O
week	O
and	O
then	O
decrease	O
to	O
200	O
mg	O
once	O
a	O
day	O
.	O

Disp	O
:*	O
40	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

7.	O
Metoprolol	B-procedure
Succinate	I-procedure
50	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
24	O
HR	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
Sustained	O
Release	O
24	O
HR	O
(s)*	O
Refills	O
:*	O
0	O
*	O

8.	O
Ferrous	B-procedure
Gluconate	I-procedure
300	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

9.	O
Ascorbic	B-procedure
Acid	I-procedure
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

10.	O
Cephalexin	B-procedure
500	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
for	O
6	O
days	O
:	O
please	O
complete	O
full	O
course	O
.	O

Disp	O
:*	O
24	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

11.	O
Furosemide	B-procedure
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
for	O
2	O
weeks	O
.	O

Disp	O
:*	O
14	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

12.	O
Potassium	B-procedure
Chloride	I-procedure
10	O
mEq	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
DAILY	O
(	O
Daily	O
)	O
for	O
2	O
weeks	O
.	O

Disp	O
:*	O
14	O
Capsule	O
,	O
Sustained	O
Release	O
(s)*	O
Refills	O
:*	O
0	O
*	O

13.	O
Lisinopril	B-procedure
5	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
15	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

Coronary	O
artery	O
disease	O
s/p	O
Coronary	B-procedure
Artery	I-procedure
Bypass	I-procedure
Graft	I-procedure
x3	O

PMH	O
:	O
Carpal	O
tunnel	O
syndrome	O
,	O
Hypertension	O
,	O
Hyperlipidemia	O
,	O
Arthritis	O

Discharge	O
Condition	O
:	O

good	O

Discharge	O
Instructions	O
:	O

May	O
shower	O
,	O
no	O
baths	O
or	O
swimming	O

Monitor	O
wounds	O
for	O
infection	O
-	O
redness	O
,	O
drainage	O
,	O
or	O
increased	O
pain	O

Report	O
any	O
fever	O
greater	O
than	O
101	O

Report	O
any	O
weight	O
gain	O
of	O
greater	O
than	O
2	O
pounds	O
in	O
24	O
hours	O
or	O
5	O
pounds	O
in	O
a	O
week	O

No	O
creams	B-procedure
,	O
lotions	B-procedure
,	O
powders	B-procedure
,	O
or	O
ointments	B-procedure
to	O
incisions	O

No	O
driving	O
for	O
approximately	O
one	O
month	O

No	O
lifting	O
more	O
than	O
10	O
pounds	O
for	O
10	O
weeks	O

Please	O
call	O
with	O
any	O
questions	O
or	O
concerns	O

Left	O
Arm	O
continue	O
with	O
elevation	B-procedure
,	O
ice	B-procedure
,	O
and	O
complete	O
all	B-procedure
antibiotics	I-procedure

Followup	O
Instructions	O
:	O

Dr	O
Day	O
in	O
4	O
weeks	O
((	O
469	O
)	O
587-0462	O
)	O
please	O
call	O
for	O
appointment	O

Dr	O
Miller	O
in	O
1	O
week	O
(	O
262-575-0600	O
)	O
please	O
call	O
for	O
appointment	O

Dr	O
Scott	O
Raines	O
in	O
2-3	O
weeks	O
please	O
call	O
for	O
appointment	O

Wound	O
check	O
appointment	O
4	O
East	O
as	O
instructed	O
by	O
nurse	O
(	O
280-5326	O
)	O

For	O
surgical	O
incision	O
and	O
left	O
arm	O

Craig	O
Douglas	O
MD	O
10-898	O

Completed	O
by	O
:	O
Reyes	O
Marengo	O
PA	O
80	O
-	O
BMD	O
2018-11-19	O
@	O
1536	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jeffrey	O
Collins	O
on	O
:	O
WED	O
2018-11-21	O
9:28	O
AM	O

(	O
End	O
of	O
Report	O
)	O

332803550	O

PUOMC	O

6548851	O

97371/52b3	O

854510	O

6/22/1993	O
12:00:00	O
AM	O

CHRONIC	O
OBSTRUCTIVE	O
PULMONARY	O
DISEASE	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

06-22-93	O

DISCHARGE	O
DATE	O
:	O

06-27-93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Chronic	O
obstructive	O
pulmonary	O
disease	O

ASSOCIATED	O
DIAGNOSES	O
:	O

Steroid	O
complications	O
,	O
including	O
cataract	O
,	O
osteoporosis	O
,	O
diffuse	O
fibrocystic	O
breast	O
disease	O
,	O
trigeminal	O
neuralgia	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mrs.	O
Cast	O
is	O
a	O
50	O
year	O
old	O
white	O
female	O
with	O
a	O
history	O
of	O
chronic	O
obstructive	O
pulmonary	O
disease	O
and	O
evidence	O
of	O
severe	O
lobular	O
emphysema	O
,	O
who	O
has	O
progressive	O
shortness	O
of	O
breath	O
and	O
inability	O
to	O
carry	O
on	O
with	O
activities	O
of	O
daily	O
living	O
without	O
assistance	O
.	O

She	O
was	O
admitted	O
to	O
the	O
hospital	O
for	O
a	B-procedure
pre	I-procedure
lung	I-procedure
transplant	I-procedure
evaluation	I-procedure
.	O

The	O
patient	O
has	O
been	O
steroid	O
dependent	O
for	O
two	O
years	O
and	O
has	O
been	O
intubated	B-procedure
in	O
the	O
past	O
only	O
once	O
for	O
a	B-procedure
surgical	I-procedure
repair	I-procedure
of	I-procedure
trigeminal	I-procedure
neuralgia	I-procedure
.	O

Her	O
previous	O
occupation	O
was	O
an	O
executive	O
secretary	O
,	O
home	O
trainer	O
/	O
nurse	O
,	O
rental	O
aide	O
.	O

She	O
has	O
no	O
history	O
of	O
asbestos	O
exposure	O
or	O
tuberculosis	O
exposure	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Notable	O
for	O
a	O
history	O
of	O
trigeminal	O
neuralgia	O
,	O
left	B-procedure
shoulder	I-procedure
surgery	I-procedure
,	O
fibrocystic	O
breast	O
disease	O
,	O
endometriosis	O
and	O
status	O
post	O
total	O
abdominal	O
hysterectomy	O
.	O

ALLERGIES	O
:	O

History	O
of	O
gastrointestinal	O
intolerance	O
to	O
Tetracycline	B-procedure
,	O
Erythromycin	B-procedure
,	O
declomycin	B-procedure
associated	O
with	O
edema	O
and	O
rash	O
,	O
Talwin	B-procedure
associated	O
with	O
disorientation	O
and	O
gastrointestinal	O
symptoms	O
,	O
Dilantin	B-procedure
has	O
caused	O
rash	O
and	O
edema	O
,	O
morphine	B-procedure
associated	O
with	O
itching	O
and	O
gastrointestinal	O
symptoms	O
,	O
Demerol	B-procedure
unclear	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
a	O
divorced	O
mother	O
of	O
two	O
on	O
Medicaid	O
.	O

FAMILY	O
HISTORY	O
:	O

Non	O
contributory	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Notable	O
for	O
her	O
diffuse	O
expiratory	O
wheezes	O
and	O
scattered	O
expiratory	O
crackles	O
.	O

Cranial	O
nerves	O
were	O
intact	O
except	O
for	O
paresthesias	O
on	O
the	O
left	O
in	O
the	O
VII	O
and	O
VIII	O
distribution	O
.	O

The	O
breasts	O
were	O
notable	O
for	O
fibrocystic	O
changes	O
.	O

LABORATORY	O
DATA	O
:	O

Serum	B-procedure
sodium	I-procedure
141	O
,	O
potassium	B-procedure
4.0	O
,	O
chloride	B-procedure
106	O
,	O
C02	B-procedure
29.6	O
,	O
calcium	B-procedure
9.2	O
,	O
phosphorus	B-procedure
3.6	O
.	O

Magnesium	B-procedure
1.7	O
.	O

BUN	B-procedure
12	O
,	O
creatinine	B-procedure
0.6	O
,	O
glucose	B-procedure
92	O
,	O
uric	B-procedure
acid	I-procedure
3.3.	O
Cholesterol	B-procedure
236	O
,	O
triglycerides	B-procedure
115	O
,	O
HDL	B-procedure
99	O
,	O
LDL	B-procedure
114	O
,	O
total	B-procedure
protein	I-procedure
6.2	O
,	O
globulin	B-procedure
2.6	O
,	O
direct	B-procedure
bilirubin	I-procedure
0	O
,	O
total	B-procedure
bilirubin	I-procedure
0.2	O
,	O
alkaline	B-procedure
phosphatase	I-procedure
59	O
,	O
amylase	B-procedure
64	O
,	O
SGOT	B-procedure
16	I-procedure
,	O
LDH	B-procedure
141	I-procedure
,	O
CPK	B-procedure
57	O
.	O

The	B-procedure
LH	I-procedure
was	O
4.9	O
,	O
FSH	B-procedure
3.3	O
.	O

TSH	B-procedure
was	O
124	O
,	O
cortisol	B-procedure
2.1	O
,	O
25	B-procedure
hydroxy	I-procedure
vitamin	I-procedure
D	I-procedure
,	I-procedure
and	I-procedure
125	I-procedure
dihydroxy	I-procedure
vitamin	I-procedure
D	I-procedure
levels	I-procedure
were	O
pending	O
.	O

Urine	B-procedure
cotenine	I-procedure
level	O
none	O
detected	O
.	O

Estradialol	B-procedure
pending	O
.	O

White	B-procedure
blood	I-procedure
count	I-procedure
9.6	O
,	O
hematocrit	B-procedure
38.8	O
,	O
platelet	B-procedure
348,000	O
,	O
mean	B-procedure
corpuscular	I-procedure
volume	I-procedure
85	O
and	O
86	O
,	O
MCH	B-procedure
29	O
,	O
MCHC	B-procedure
34	O
.	O

PT	B-procedure
9.5/10.0	O
,	O
PTT	B-procedure
23.9	O
.	O

Urinalysis	B-procedure
was	O
normal	O
.	O

Sed	B-procedure
rate	I-procedure
6	O
.	O

Varicella	B-procedure
antibody	I-procedure
positive	O
,	O
CMV	B-procedure
antibody	I-procedure
positive	O
,	O
toxo	B-procedure
negative	O
,	O
RPR	B-procedure
non	O
reactive	O
.	O

The	O
patient	O
was	O
A+	O
.	O

FEV1	B-procedure
0.78	O
liters	O
,	O
vital	B-procedure
capacity	I-procedure
2.12	O
liters	O
,	O
total	B-procedure
lung	I-procedure
capacity	I-procedure
5.51	O
liters	O
,	O
single	B-procedure
breath	I-procedure
DLCO	I-procedure
5.3	O
(	O
25%	O
predicted	O
)	O
.	O

Cardiopulmonary	B-procedure
exercise	I-procedure
study	I-procedure
results	O
are	O
pending	O
.	O

Echocardiogram	B-procedure
showed	O
normal	O
right	O
ventricular	O
and	O
left	O
ventricular	O
size	O
and	O
systolic	O
function	O
.	O

A	B-procedure
left	I-procedure
and	I-procedure
right	I-procedure
heart	I-procedure
catheterization	I-procedure
and	O
coronary	B-procedure
angiogram	I-procedure
revealed	O
aortic	B-procedure
120/70	O
,	O
mean	B-procedure
95	O
,	O
PA	B-procedure
26/10	O
,	O
mean	B-procedure
17	O
,	O
PC	B-procedure
7	O
,	O
RV	B-procedure
26/6	O
,	O
RA	B-procedure
4	O
,	O
cardiac	B-procedure
output	I-procedure
5.7	O
,	O
index	B-procedure
3.8	O
.	O

Systemic	B-procedure
arterial	I-procedure
resistance	I-procedure
12/81	O
.	O

The	B-procedure
electrocardiogram	I-procedure
showed	O
a	O
short	O
PR	O
interval	O
with	O
no	O
delta	O
wave	O
,	O
clockwise	O
rotation	O
present	O
.	O

A	B-procedure
quantitative	I-procedure
VQ	I-procedure
scan	I-procedure
of	O
the	O
lung	O
showed	O
42%	O
ventilation	B-procedure
to	I-procedure
the	I-procedure
left	I-procedure
,	O
57%	O
ventilation	B-procedure
to	I-procedure
the	I-procedure
right	I-procedure
,	O
42%	O
perfusion	B-procedure
to	I-procedure
the	I-procedure
left	I-procedure
,	O
57%	O
perfusion	B-procedure
to	I-procedure
the	I-procedure
right	I-procedure
.	O

Abdominal	B-procedure
ultrasound	I-procedure
was	O
unremarkable	O
.	O

HIV	B-procedure
testing	I-procedure
results	O
pending	O
.	O

Hepatitis	B-procedure
serologies	I-procedure
pending	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
a	O
variety	O
of	O
consultants	O
including	O
Infectious	O
Disease	O
,	O
Cardiology	O
,	O
Endocrine	O
,	O
Psychiatry	O
,	O
ENT	O
,	O
and	O
Neuro-ophthalmology	O
.	O

She	O
was	O
noted	O
to	O
have	O
mild	O
cataracts	O
,	O
possibly	O
due	O
to	O
chronic	B-procedure
steroids	I-procedure
,	O
as	O
well	O
as	O
a	O
subtle	O
temporal	O
disc	O
pallor	O
OD	O
,	O
possibly	O
due	O
to	O
previous	O
episode	O
of	O
optic	O
neuritis	O
.	O

No	O
acute	O
pathology	O
was	O
noted	O
and	O
no	O
treatment	O
was	O
necessary	O
at	O
this	O
time	O
.	O

Dr.	O
Koteelks	O
indicated	O
that	O
the	O
patient	O
did	O
not	O
have	O
sinus	O
problems	O
currently	O
but	O
thought	O
that	O
the	O
trigeminal	O
pain	O
might	O
be	O
investigated	O
further	O
and	O
that	O
the	O
sphenoid	O
might	O
account	O
for	O
some	O
of	O
the	O
patient	O
&apos;s	O
discomfort	O
.	O

If	O
so	O
,	O
he	O
considers	O
the	O
possibility	O
that	O
this	O
could	O
be	O
opened	O
.	O

This	O
is	O
left	O
for	O
further	O
follow	O
up	O
as	O
an	O
outpatient	O
.	O

Dr.	O
Tikkerth	O
felt	O
that	O
the	O
patient	O
had	O
mild	O
adjustment	O
related	O
anxiety	O
under	O
good	O
control	O
with	O
a	O
history	O
of	O
tobacco	O
abuse	O
in	O
the	O
past	O
.	O

The	O
patient	O
completed	O
the	B-procedure
studies	I-procedure
and	O
to	O
be	O
informed	O
of	O
the	O
results	O
as	O
an	O
outpatient	O
.	O

She	O
knows	O
to	O
return	O
to	O
her	O
local	O
physician	O
for	O
her	B-procedure
routine	I-procedure
care	I-procedure
with	O
her	O
condition	O
unchanged	O
at	O
the	O
time	O
of	O
discharge	O
.	O

I	O
L.	O
STERPSKOLK	O
,	O
M.D.	O

TR	O
:	O

bg	O
/	O
bmot	O

DD	O
:	O

09-08-93	O

TD	O
:	O

09/09/93	O

CC	O
:	O

Admission	O
Date	O
:	O

2019-01-09	O

Discharge	O
Date	O
:	O

2019-01-15	O

Date	O
of	O
Birth	O
:	O

1973-11-18	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Erythromycin	B-procedure
Base	I-procedure

Attending	O
:	O
Stephanie	O
I	O
Sept	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Syncope	O
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

None	O
.	O

History	O
of	O
Present	O
Illness	O
:	O

45M	O
w/no	O
PMH	O
presented	O
to	O
Chelseahospital	O
after	O
a	O
syncopal	O
episode	O
on	O
the	O
morning	O
of	O
admission	O
.	O

Pt	O
was	O
preparing	O
lunch	O
when	O
suddenly	O
felt	O
lightheaded	O
/	O
faint	O
and	O
immediately	O
fell	O
to	O
the	O
kitchen	O
floor	O
face	O
first	O
.	O

He	O
denies	O
LOC	O
.	O

Immediately	O
there	O
after	O
he	O
was	O
very	O
short	O
of	O
breath	O
,	O
felt	O
lightheaded	O
again	O
and	O
called	O
911	O
.	O

At	O
Springfield	O
,	O
CT	B-procedure
chest	I-procedure
was	O
positive	O
for	O
saddle	O
PE	O
.	O

VS	B-procedure
were	O
with	O
stable	O
BPs	O
,	O
tachy	O
to	O
110-120	O
,	O
sat	B-procedure
98%	O
RA	O
.	O

He	O
received	O
Lovenox	B-procedure
91	O
mg	O
SC	O
prior	O
to	O
transport	O
and	O
was	O
transferred	O
to	O
Arbour	O
Hospital	O
for	O
further	O
care	O
.	O

Mr.	O
Anders	O
states	O
that	O
2	O
weeks	O
prior	O
to	O
his	O
presentation	O
he	O
hurt	O
his	O
left	O
knee	O
.	O

He	O
was	O
sitting	O
on	O
the	O
floor	O
legs	O
crossed	O
and	O
stood	O
up	O
when	O
he	O
heard	O
his	O
knee	O
CMED	O
CCU	O
.	O

Then	O
again	O
on	O
Sunday	O
,	O
3	O
days	O
PTA	O
,	O
again	O
from	O
sitting	O
to	O
standing	O
heard	O
his	O
knee	O
CMED	O
CCU	O
.	O

He	O
was	O
essentially	O
bed	O
bound	O
for	O
3	O
days	O
prior	O
to	O
admission	O
,	O
unable	O
to	O
ambulate	O
.	O

He	O
started	O
to	O
notice	O
inflammation	O
of	O
his	O
L	O
calf	O
/	O
leg	O
worse	O
2	O
days	O
prior	O
to	O
presentation	O
.	O

In	O
this	O
2	O
week	O
interval	O
he	O
denied	O
having	O
CP	O
/	O
chest	O
discomfort	O
or	O
difficulty	O
breathing	O
,	O
no	O
cough	O
or	O
hemoptysis	O
.	O

No	O
f/c/	O
sweats	O
.	O

Pt	O
denied	O
any	O
bleeding	O
or	O
clotting	O
disorders	O
and	O
has	O
never	O
had	O
a	O
clot	O
in	O
the	O
past	O
.	O

Past	O
Medical	O
History	O
:	O

Left	O
knee	O
injury	O
.	O

Seasonal	O
allergies	O
.	O

Social	O
History	O
:	O

-	O
Lives	O
w/	O
wife	O
&	O
son	O
in	O
Jose	O
,	O
MA	O

-	O
Denies	O
TOB	O
use	O
,	O
occasional	O
ETOH	O
use	O

Family	O
History	O
:	O

-	O
M	O
:	O

HTN	O
,	O
DM	O

-	O
F	O
:	O

COPD	O
,	O
Prostate	O
CA	O

-	O
Grandfather	O
died	O
of	O
MI	O
at	O
age	O
75	O

Physical	O
Exam	O
:	O

VS	B-procedure
:	O
99.4	O
HR	B-procedure
111	O
BP	B-procedure
110/64	O
RR16	B-procedure
97%	O
2LNC	B-procedure

GEN	O
:	O
NAD	O
,	O
pleasant	O
speaking	O
in	O
full	O
sentences	O

HEENT	O
:	O
MMM	O
,	O
OP	O
clear	O
,	O
dried	O
blood	O
in	O
nasal	O
mucosa	O

RESP	O
:	O
CTABL	O
,	O
no	O
crackles	O
,	O
no	O
wheezing	O
or	O
rhonchi	O

CV	O
:	O
Reg	O
,	O
tachy	O
Nml	O
S1	O
,	O
S2	O
,	O
no	O
M/R/G	O

ABD	O
:	O
soft	O
ND/NT	O
+BS	O

EXT	O
:	O
L	O
leg/calf	O
swollen	O
,	O
+	O
Johnson	B-procedure
sign	I-procedure
,	O
not	O
tense	O
,	O
no	O
cord	O
palpable	O
,	O
L	O
knee	O
w/	O
medial	O
meniscus	O
area	O
inflammed	O
,	O
not	O
warm	O
,	O
no	O
crepitus	O
,	O
feet-2+DP	B-procedure
pulses	I-procedure
b/l	O

Pertinent	O
Results	O
:	O

1.	O
CT	B-procedure
OF	I-procedure
HEAD	I-procedure
WITHOUT	I-procedure
CONTRAST	I-procedure
:	O

No	O
evidence	O
of	O
acute	O
intracranial	O
hemorrhage	O
or	O
fractures	O
.	O

2.	O
ECHO	B-procedure

Conclusions	O
:	O

The	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

The	B-procedure
estimated	I-procedure
right	I-procedure
atrial	I-procedure
pressure	I-procedure
is	O
16-20	O
mmHg	O
.	O

Left	B-procedure
ventricular	I-procedure
wall	I-procedure
thicknesses	I-procedure
are	O
normal	O
.	O

The	B-procedure
left	I-procedure
ventricular	I-procedure
cavity	I-procedure
is	O
small	O
.	O

Left	B-procedure
ventricular	I-procedure
systolic	I-procedure
function	I-procedure
is	O
hyperdynamic	O
(	O
EF	B-procedure
>	O
75%	O
)	O
.	O

There	O
is	O
no	O
ventricular	O
septal	O
defect	O
.	O

The	O
right	O
ventricular	O
cavity	O
is	O
mildly	O
dilated	O
.	O

Right	B-procedure
ventricular	I-procedure
systolic	I-procedure
function	I-procedure
is	O
borderline	O
normal	O
.	O

The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	O
regurgitation	O
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

There	O
is	O
no	O
mitral	O
valve	O
prolapse	O
.	O

There	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	O
hypertension	O
.	O

There	O
is	O
no	O
pericardial	O
effusion	O
.	O

Impression	O
:	O
mildly	O
dilated	O
right	O
ventricle	O
;	O
small	O
,	O
hyperdynamic	O
left	O
ventricle	O
;	O
at	O
least	O
moderate	O
pulmonary	O
hypertension	O

3.	O
BILATERAL	B-procedure
LENI	I-procedure
's	I-procedure

IMPRESSION	O
:	O

No	O
evidence	O
of	O
DVT	O
in	O
either	O
lower	O
limb	O
.	O

OSH	B-procedure
IMAGING	I-procedure
:	O

-	O
saddle	O
PE	O
,	O
no	O
CD	O
or	O
report	O
sent	O

EKG	B-procedure
:	O

-	O
Sinus	O
Tach	O
,	O
normal	O
axis	O
HR	B-procedure
119	O
ST	O
Depression	O
V3-V5	O
;	O
S1Q3T3	O
,	O
p-pulmonale	O
.	O

01-11	O
MRI	B-procedure
Left	I-procedure
Knee	I-procedure
w/o	I-procedure
Contrast	I-procedure

1.	O
Bucket	O
handle	O
medial	O
meniscal	O
tear	O
with	O
flipped	O
fragment	O
in	O
the	O
intercondylar	O
notch	O
.	O

Complex	O
tear	O
involving	O
the	O
posterior	O
Ellison	O
and	O
body	O
.	O

2.	O
Moderate	O
knee	O
joint	O
effusion	O
with	O
possible	O
ganglion	O
cyst	O
at	O
the	O
insertion	O
of	O
the	O
PCL	O
.	O

3.	O
Discoid	O
lateral	O
meniscus	O
.	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Anders	O
was	O
admitted	O
for	O
anticoagulation	B-procedure
and	O
hemodynamic	B-procedure
monitoring	I-procedure
in	O
the	O
setting	O
of	O
saddle	O
pulmonary	O
embolus	O
and	O
left	O
knee	O
injury	O
.	O

#.	O
PE	O
:	O

Given	O
no	O
other	O
risk	O
factors	O
or	O
likely	O
causes	O
,	O
the	O
most	O
likely	O
etiology	O
for	O
his	O
embolus	O
is	O
DVT	O
from	O
the	O
left	O
leg	O
.	O

He	O
has	O
no	O
known	O
clotting	O
disorder	O
but	O
did	O
have	O
trauma	O
to	O
leg	O
prompting	O
immobility	O
and	O
stasis	O
.	O

He	O
remained	O
hemodynmically	O
stable	O
throughout	O
his	O
hospitalization	O
and	O
did	O
not	O
have	O
an	O
oxygen	O
requirement	O
upon	O
discharge	O
.	O

Given	O
no	O
evidence	O
of	O
hemodynamic	O
instability	O
,	O
lysis	B-procedure
was	O
not	O
required	O
.	O

He	O
was	O
anticoagulated	O
with	O
heparin	B-procedure
and	O
coumadin	B-procedure
.	O

He	O
will	O
need	O
to	O
follow	O
up	O
with	O
hematology	O
for	O
an	B-procedure
outpatient	I-procedure
thrombophilia	I-procedure
work-up	I-procedure
(	O
not	O
done	O
as	O
inpatient	O
as	O
results	O
would	O
not	O
change	O
acute	B-procedure
management	I-procedure
of	O
PE	O
).	O

He	O
will	O
also	O
require	O
close	O
follow	O
up	O
with	O
his	O
primary	O
care	O
provider	O
for	O
coumadin	B-procedure
management	I-procedure
.	O

Duration	O
of	O
his	B-procedure
coumadin	I-procedure
therapy	I-procedure
to	O
be	O
determined	O
by	O
hematology	O
,	O
but	O
likely	O
to	O
be	O
at	O
least	O
6	O
months	O
in	O
duration	O
.	O

#.	O
Syncope	O
:	O

In	O
setting	O
of	O
PE	O
.	O

Remainder	O
of	O
his	B-procedure
cardiac	I-procedure
workup	I-procedure
was	O
negative	O
.	O

He	O
did	O
have	O
a	O
small	O
troponin	O
leak	O
,	O
felt	O
to	O
be	O
related	O
to	O
right	O
heart	O
strain	O
in	O
the	O
setting	O
of	O
P-pulmonale	O
related	O
to	O
clot	O
burden	O
.	O

His	B-procedure
tronponin	I-procedure
quickly	O
trended	O
down	O
and	O
he	O
did	O
not	O
have	O
EKG	B-procedure
evidence	O
of	O
ischemia	O
.	O

An	B-procedure
ECHO	I-procedure
did	O
not	O
reveal	O
any	O
wall	O
motion	O
abnormalities	O
related	O
to	O
ischemia	O
.	O

#.	O
Hematocrit	B-procedure
:	O

Dropped	O
from	O
42.7	O
to	O
36	O
in	O
setting	O
of	O
anticoagulation	B-procedure
for	O
saddle	O
PE	O
and	O
IV	B-procedure
fluids	I-procedure
.	O

No	O
active	O
bleeding	O
noted	O
.	O

Pt	O
asymptomatic	O
.	O

#.	O
L	O
knee	O
injury	O
:	O

Given	O
his	O
history	O
and	O
physical	B-procedure
exam	I-procedure
,	O
Mr.	O
Anders	O
presented	O
with	O
an	O
injury	O
most	O
consistent	O
with	O
meniscal	O
tear	O
.	O

In	O
order	O
to	O
facilitate	O
therapy	B-procedure
and	O
to	O
promote	O
mobility	O
,	O
an	B-procedure
MRI	I-procedure
of	I-procedure
the	I-procedure
knee	I-procedure
was	O
done	O
.	O

He	O
was	O
seen	O
by	O
physical	O
therapy	O
and	O
will	O
need	O
to	O
follow	O
up	O
with	O
orthopaedics	O
upon	O
discharge	O
for	O
repeat	B-procedure
evaluation	I-procedure
.	O

#.	O
CODE	O
:	O

FULL	O
CODE	O
.	O

Medications	O
on	O
Admission	O
:	O

-	O
Claritin	B-procedure
prn	O

-	O
Flonase	B-procedure
prn	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Pulmonary	O
embolus	O

Left	O
knee	O
meniscal	O
tear	O

Discharge	O
Condition	O
:	O

Stable	O

Discharge	O
Instructions	O
:	O

You	O
were	O
admitted	O
to	O
the	O
hospital	O
for	O
a	O
pulmonary	O
embolism	O
.	O

You	O
were	O
treated	O
with	O
blood	B-procedure
thinners	I-procedure
.	O

You	O
have	O
been	O
started	O
on	O
an	B-procedure
oral	I-procedure
blood	I-procedure
thinner	I-procedure
called	O
Coumadin	B-procedure
(	I-procedure
Warfarin	I-procedure
).	O

Please	O
continue	O
to	O
take	O
this	B-procedure
medication	I-procedure
as	O
prescribed	O
.	O

You	O
must	O
have	O
your	B-procedure
INR	I-procedure
(	O
blood	B-procedure
levels	I-procedure
)	O
checked	O
on	O
a	O
regular	O
basis	O
until	O
your	B-procedure
INR	I-procedure
levels	I-procedure
remain	O
01-19	O
.	O

The	B-procedure
MRI	I-procedure
of	I-procedure
your	I-procedure
knee	I-procedure
showed	O
a	O
meniscal	O
tear	O
.	O

Please	O
schedule	O
an	O
appointment	O
with	O
your	O
orthopedic	O
surgeon	O
to	O
determine	O
a	O
plan	O
for	O
treatment	B-procedure
.	O

Please	O
follow-up	O
with	O
your	O
Primary	O
Care	O
doctor	O
Marion	O
Bock	O
as	O
below	O
.	O

Please	O
return	O
to	O
the	O
hospital	O
if	O
you	O
experience	O
chest	O
pain	O
,	O
shortness	O
of	O
breath	O
,	O
lightheadedness	O
or	O
dizziness	O
.	O

Followup	O
Instructions	O
:	O

Please	O
follow-up	O
with	O
your	O
Primary	O
care	O
doctor	O
Larry	O
Bock	O
2019-01-16	O
at	O
8:30	O
AM	O
.	O

At	O
this	O
appointment	O
,	O
you	O
should	O
confirm	O
orthopedic	O
follow-up	O
and	O
request	O
a	O
hematology	O
referral	O
.	O

Call	O
to	O
reschedule	O
.	O

Heidi	O
Laura	O
MD	O
44-725	O

Completed	O
by	O
:	O
Daniel	O
Tapaha	O
MD	O
73-060	O
2019-01-15	O
@	O
0918	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Steven	O
W.	O
Weekley	O
on	O
:	O
Sandra	O
2019-01-15	O
10:22	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2018-03-04	O

Discharge	O
Date	O
:	O

2018-03-09	O

Date	O
of	O
Birth	O
:	O

1957-08-17	O

Sex	O
:	O

M	O

Service	O
:	O

UROLOGY	O

Allergies	O
:	O

Sulfonamides	B-procedure
/	O
Penicillins	B-procedure
/	O
Tetracyclines	B-procedure
/	O
Azithromycin	B-procedure
/	O
Iodine	B-procedure
/	O
Shellfish	O
/	O
Ace	B-procedure
Inhibitors	I-procedure
/	O
Ciprofloxacin	B-procedure

Attending	O
:	O

Donald	O
E.	O
Jacquet	O
,	O
M.D.	O

Chief	O
Complaint:	O

Chronic	O
prostatitis	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O

TURP	B-procedure

History	O
of	O
Present	O
Illness:	O

Justin	O
Searle	O
a	O
60-year-old	O
man	O
with	O
a	O
long	O
history	O
of	O
chronic	O
prostatitis	O
status	O
post	O
two	B-procedure
transurethral	I-procedure
resection	I-procedure
of	I-procedure
the	I-procedure
prostate	I-procedure
procedures	O
in	O
2007	O
and	O
1998	O
.	O

He	O
also	O
has	O
a	O
diagnosis	O
of	O
interstitial	O
cystitis	O
and	O
more	O
significantly	O
has	O
a	O
history	O
of	O
coronary	O
artery	O
disease	O
with	O
a	B-procedure
recent	I-procedure
catheterization	I-procedure
,	O
supraventricular	O
tachycardia	O
,	O
and	O
a	O
progressive	O
mitochondrial	O
myopathy	O
.	O

He	O
has	O
had	O
symptoms	O
of	O
dribbling	O
,	O
stress	O
incontinence	O
,	O
hematuria	O
,	O
but	O
has	O
no	O
dysuria	O
.	O

He	O
was	O
preadmitted	O
for	O
cardiac	O
clearance	O
by	O
Dr.	O
Lair	O
,	O
his	O
cardiologist	O
.	O

Past	O
Medical	O
History:	O

1.	O
Coronary	O
artery	O
disease	O
(	O
s/p	O
stents	B-procedure
to	I-procedure
LAD	I-procedure
and	I-procedure
3rd	I-procedure
OM	I-procedure
)	O

2.	O
Supraventricular	O
tachycardia	O
(	O
on	O
a	B-procedure
beta	I-procedure
blocker	I-procedure
)	O
.	O

3.	O
Mitochondrial	O
myopathy	O
.	O

4.	O
History	O
of	O
orthostasis	O
with	O
tilt	B-procedure
table	I-procedure
testing	I-procedure
done	O
in	O
the	O
past	O
.	O

5.	O
Status	O
post	O
transurethral	B-procedure
resection	I-procedure
of	I-procedure
prostate	I-procedure
times	O
two	O
(	O
in	O
2007	O
and	O
1998	O
)	O
.	O

6.	O
Interstitial	O
cystitis	O
.	O

7.	O
Pericarditis	O
.	O

8.	O
Hypertension	O
.	O

9.	O
Hypercholesterolemia	O
.	O

10.	O
Gastrointestinal	O
bleed	O

Social	O
History	O
:	O

denies	O
any	O
tobacco.	O
Divorced	O
,	O
lives	O
in	O
Wisconsin	O

Family	O
History	O
:	O

Father	O
had	O
MI	O
at	O
42	O

Mother	O
died	O
of	O
MI	O
at	O
76	O

Physical	O
Exam	O
:	O

Gen	O
:	O

NAD	O

HEENT	O
:	O

MMM	O

CV	O
:	O

RRR	O
,	O
no	O
m/r/g	O

Lungs	O
:	O

CTAB	O

Abd	O
:	O
soft	O
,	O
+distension	O
with	O
tympany	O
,	O
no	O
HSM	O
,	O
hyperactive	O
BS	O

Ext	O
:	O
no	O
c/c/e	O

Neuro	O
:	O

A&O	O
x3	O
.	O

ECG	B-procedure
:	O

NSR	B-procedure
at	O
62	O
,	O
nl	O
axis	O
,	O
nl	O
intervals	O
,	O
Q	O
waves	O
in	O
III	O
,	O
avR	B-procedure
,	I-procedure
V1	B-procedure
.	O

TWI	O
's	O
in	O
III	O
,	O
V1	O
.	O

Pertinent	O
Results:	O

2018-03-04	O
01:02PM	O

GLUCOSE	B-procedure
-	O
94	O
UREA	B-procedure
N	I-procedure
-	O
22*	O
CREAT	B-procedure
-	O
1.4*	O
SODIUM	B-procedure
-	O
142	O

POTASSIUM	B-procedure
-	O
5.9*	O
CHLORIDE	B-procedure
-	O
108	O
TOTAL	B-procedure
CO2	I-procedure
-	O
23	O
ANION	B-procedure
GAP	I-procedure
-	O
17	O

2018-03-04	O
01:02PM	O

CALCIUM	B-procedure
-	O
9.7	O
PHOSPHATE	B-procedure
-	O
3.9	O
MAGNESIUM	B-procedure
-	O
1.9	O

2018-03-04	O
01:02PM	O

WBC	B-procedure
-	O
7.5	O
RBC	B-procedure
-	O
5.09	O
HGB	B-procedure
-	O
15.4	O
HCT	B-procedure
-	O
43.7	O
MCV	B-procedure
-	O
86	O

MCH	B-procedure
-	O
30.2	O
MCHC	B-procedure
-	O
35.2*	O
RDW	B-procedure
-	O
13.6	O

2018-03-04	O
01:02PM	O

PLT	B-procedure
COUNT	I-procedure
-	O
257#	O

2018-03-04	O
01:02PM	O

PT	B-procedure
-	O
12.2	O
PTT	B-procedure
-	O
23.8	O
INR	B-procedure
(	I-procedure
PT	I-procedure
)	I-procedure
-	O
0.9	O

Brief	O
Hospital	O
Course:	O

On	O
HD2	O
,	O
cardiac	B-procedure
clearance	I-procedure
was	O
obtained	O
by	O
Dr.	O
Sanchez	O
.	O

Patient	O
tolerated	O
procedure	B-procedure
on	O
2018-03-05	O
and	O
was	O
transferred	O
to	O

ICU	O
for	O
24hr	O
post-op	O
cardiac	B-procedure
monitoring	I-procedure
.	O

Stay	O
was	O
uneventful	O
.	O

On	O
POD1	O
,	O
patient	O
was	O
transferred	O
out	O
of	O
FICU	O
to	O
12R	O
.	O

Catheter	B-procedure
was	O
removed	O
.	O

He	O
was	O
started	O
on	O
Pyridium	B-procedure
.	O

On	O
POD2	O
,	O
patient	O
was	O
deemed	O
suitable	O
and	O
stable	O
for	O
discharge	O
.	O

On	O
POD4	O
,	O
patient	O
was	O
discharged	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Hydroxyzine	B-procedure
HCl	I-procedure
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

2.	O
Atorvastatin	B-procedure
Calcium	I-procedure
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

3.	O
Ezetimibe	B-procedure
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

4.	O
Simethicone	B-procedure
80	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
0.5-1	O
Tablet	O
,	O
Chewable	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
indigestion/gas	O
pain	O
.	O

5.	O
Aluminum-Magnesium	B-procedure
Hydroxide	I-procedure
225-200	O
mg/5	O
mL	O
Suspension	O
Sig	O
:	O
15-30	O
MLs	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
indigestion	O
.	O

6.	O
Atenolol	B-procedure
100	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

7.	O
Hyoscyamine	B-procedure
Sulfate	I-procedure
0.125	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
.	O

8.	O
Phenazopyridine	B-procedure
HCl	I-procedure
100	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
for	O
3	O
days	O
.	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Chronic	O
prostatitis	O

Interstitial	O
cystitis	O

Discharge	O
Condition	O
:	O

Good	O

Discharge	O
Instructions	O
:	O

Go	O
to	O
an	O
Emergency	O
Room	O
if	O
you	O
experience	O
symptoms	O
including	O
,	O
but	O
not	O
necessarily	O
limited	O
to	O
:	O
new	O
and	O
continuing	O
nausea	O
,	O
vomiting	O
,	O
fevers	O
(	O
>101.5	O
F	O
)	O
,	O
chills	O
,	O
or	O
shortness	O
of	O
breath	O
.	O

Proceed	O
to	O
the	O
ER/EW/Monica	O
if	O
your	O
wound	O
becomes	O
red	O
,	O
swollen	O
,	O
warm	O
,	O
or	O
produces	O
pus	O
.	O

You	O
may	O
remove	O
your	B-procedure
dressings	I-procedure
2	O
days	O
after	O
your	B-procedure
surgery	I-procedure
if	O
they	O
were	O
not	O
removed	O
in	O
the	O
hospital	O
.	O

Leave	O
the	B-procedure
steri	I-procedure
strips	I-procedure
on	O
until	O
they	O
begin	O
to	O
peel	O
,	O
then	O
you	O
may	O
remove	O
them.	O
Staples	B-procedure
and	O
stitches	B-procedure
will	O
remain	O
until	O
your	O
follow-up	O
appointment	O
.	O

If	O
you	O
experience	O
clear	O
drainage	O
from	O
your	O
wounds	O
,	O
cover	O
them	O
with	O
a	B-procedure
clean	I-procedure
dressing	I-procedure
and	O
stop	O
showering	O
until	O
the	O
drainage	O
subsides	O
for	O
at	O
least	O
2	O
days	O
.	O

No	O
heavy	O
lifting	O
or	O
exertion	O
for	O
at	O
least	O
6	O
weeks	O
.	O

No	O
driving	O
while	O
taking	O
pain	B-procedure
medications	I-procedure
.	O

Narcotics	B-procedure
can	O
cause	O
constipation	O
.	O

Please	O
take	O
an	B-procedure
over	I-procedure
the	I-procedure
counter	I-procedure
stool	I-procedure
softener	I-procedure
such	O
as	O
Colace	B-procedure
or	O
a	B-procedure
gentle	I-procedure
laxative	I-procedure
such	O
as	O
Milk	B-procedure
of	I-procedure
Magnesia	I-procedure
if	O
you	O
experience	O
constipation	O
.	O

You	O
may	O
resume	O
your	O
regular	O
diet	O
as	O
tolerated	O
.	O

You	O
may	O
take	O
showers	O
(	O
no	O
baths	O
)	O
after	O
your	B-procedure
dressings	I-procedure
have	O
been	O
removed	O
from	O
your	O
wounds	O
.	O

Continue	O
taking	O
your	B-procedure
home	I-procedure
medications	I-procedure
unless	O
otherwise	O
contraindicated	O
and	O
follow	O
up	O
with	O
PCP	O
.	O

Followup	O
Instructions	O
:	O

F/U	O
with	O
Rau	O
.	O

Call	O
for	O
appointment	O

F/U	O
with	O
Dr.	O
Ross	O
in	O
2-3	O
weeks	O
.	O

Michael	O
Morgan	O
MD	O
43-508	O

Completed	O
by	O
:	O

Justin	O
RAO	O
MD	O
71-039	O
2018-03-09	O
@	O
0842	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Freddy	O
Darr	O
on	O
:	O

FRI	O
2018-03-23	O
9:45	O
AM	O

(	O
End	O
of	O
Report	O
)	O

130959255	O

FIH	O

1431063	O

10119/hy66	O

738478	O

6/15/1994	O
12:00:00	O
AM	O

RIGHT	O
OCCIPITAL	O
HEMORRHAGIC	O
STROKE	O
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

6-15-94	O

DISCHARGE	O
DATE	O
:	O

6-26-94	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Right	O
occipital	O
hemorrhagic	O
stroke	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ms.	O
Tlandkotesmitskote	O
is	O
a	O
patient	O
who	O
came	O
complaining	O
of	O
feeling	O
dizzy	O
and	O
bumping	O
into	O
objects	O
on	O
her	O
left	O
side	O
.	O

She	O
is	O
a	O
seventy-one	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
hypertension	O
who	O
is	O
in	O
otherwise	O
good	O
health	O
.	O

This	O
morning	O
while	O
on	O
a	O
cruise	O
ship	O
,	O
she	O
was	O
eating	O
breakfast	O
when	O
she	O
suddenly	O
noticed	O
she	O
could	O
not	O
see	O
a	O
roll	O
on	O
her	O
plate	O
although	O
she	O
knew	O
that	O
it	O
was	O
there	O
.	O

She	O
also	O
felt	O
dizzy	O
and	O
the	O
room	O
was	O
spinning	O
.	O

While	O
walking	O
,	O
she	O
kept	O
bumping	O
into	O
object	O
on	O
her	O
left	O
side	O
.	O

She	O
also	O
complained	O
of	O
a	O
dull	O
,	O
right	O
sided	O
headache	O
over	O
the	O
right	O
eyebrow	O
.	O

Symptoms	O
lasted	O
about	O
five	O
hours	O
and	O
then	O
gradually	O
resolved	O
except	O
for	O
the	O
change	O
in	O
vision	O
.	O

She	O
denied	O
having	O
any	O
weakness	O
,	O
numbness	O
,	O
or	O
pain	O
.	O

She	O
also	O
denies	O
having	O
hoarseness	O
,	O
difficulties	O
in	O
finding	O
words	O
,	O
speaking	O
,	O
hiccups	O
,	O
or	O
diplopia	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
past	O
medical	O
history	O
is	O
significant	O
for	O
hypertension	O
.	O

The	O
past	O
surgical	O
history	O
is	O
negative	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Atenolol	B-procedure
,	O
25	O
mg	O
PO	O
qd	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	O
drug	O
allergies	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

On	O
review	O
of	O
systems	O
,	O
the	O
patient	O
denied	O
any	O
history	O
of	O
transient	O
ischemic	O
attacks	O
.	O

FAMILY	O
HISTORY	O
:	O

Father	O
and	O
mother	O
died	O
in	O
their	O
eighties	O
of	O
heart	O
disease	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
denied	O
using	O
tobacco	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	B-procedure
examination	I-procedure
,	O
she	O
was	O
a	O
very	O
pleasant	O
,	O
moderately	O
obese	O
female	O
in	O
no	O
apparent	O
distress	O
.	O

She	O
was	O
afebrile	O
and	O
her	B-procedure
vital	I-procedure
signs	I-procedure
were	O
stable	O
.	O

The	O
head	O
was	O
normocephalic	O
and	O
atraumatic	O
.	O

The	O
pupils	O
were	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
.	O

The	O
tympanic	O
membranes	O
were	O
gray	O
.	O

The	O
fundi	O
were	O
sharp	O
.	O

The	O
neck	O
was	O
supple	O
with	O
full	O
range	O
of	O
movement	O
.	O

The	O
lungs	O
were	O
clear	O
to	O
auscultation	B-procedure
bilaterally	O
,	O
without	O
rales	O
or	O
wheezes	O
.	O

The	O
heart	O
had	O
a	O
recovery	O
regular	O
rate	O
and	O
rhythm	O
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	O
,	O
nondistended	O
.	O

Extremities	O
revealed	O
2+	O
pitting	O
edema	O
in	O
the	O
knees	O
bilaterally	O
.	O

The	B-procedure
neurological	I-procedure
examination	I-procedure
revealed	O
that	O
the	O
patient	O
was	O
awake	O
,	O
alert	O
and	O
oriented	O
to	O
person	O
,	O
place	O
and	O
time	O
.	O

She	O
was	O
able	O
to	O
subtract	O
serial	O
sevens	O
,	O
remember	O
three	O
out	O
of	O
three	O
objects	O
after	O
five	O
minutes	O
,	O
and	O
there	O
was	O
notable	O
aphasia	O
or	O
word	O
finding	O
difficulty	O
.	O

The	O
cranial	O
nerves	O
showed	O
pupils	O
were	O
bilaterally	O
active	O
from	O
3	O
to	O
2	O
mm	O
.	O

There	O
was	O
a	O
dense	O
hemianopsia	O
on	O
the	O
left	O
side	O
.	O

The	O
extra	O
ocular	O
muscles	O
were	O
intact	O
bilaterally	O
.	O

Corneals	O
were	O
present	O
bilaterally	O
.	O

Sensation	O
was	O
intact	O
to	O
light	B-procedure
touch	I-procedure
and	O
pin	B-procedure
prick	I-procedure
bilaterally	O
.	O

Face	O
was	O
symmetric	O
.	O

Eye	O
closing	O
was	O
tight	O
.	O

Hearing	O
was	O
intact	O
bilaterally	O
.	O

Palate	O
was	O
midline	O
.	O

Gag	O
was	O
intact	O
.	O

The	O
sternocleidomastoid	O
and	O
trapezius	O
had	O
good	O
strength	O
.	O

Tongue	O
was	O
midline	O
.	O

Strength	O
was	O
5/5	O
in	O
bilateral	O
upper	O
extremities	O
and	O
bilateral	O
lower	O
extremities	O
in	O
detail	O
.	O

There	O
was	O
no	O
pronator	O
drift	O
.	O

Sensation	O
was	O
intact	O
to	O
light	B-procedure
touch	I-procedure
,	O
pin	B-procedure
prick	I-procedure
,	O
and	O
proprioception	B-procedure
.	O

Cerebellar	B-procedure
examination	I-procedure
revealed	O
in	O
intention	O
tremor	O
on	O
the	O
right	O
side	O
.	O

The	O
patient	O
had	O
considerable	O
difficulty	O
with	O
left	O
finger-to-nose	O
movement	O
,	O
most	O
likely	O
secondary	O
to	O
hemianopsia	O
.	O

There	O
was	O
no	O
nystagmus	O
,	O
except	O
for	O
some	O
fine	O
fast	O
beat	O
nystagmus	O
bilateral	O
extremes	O
of	O
abduction	O
.	O

Reflexes	O
were	O
symmetric	O
and	O
2+	O
bilaterally	O
at	O
the	O
biceps	O
tendon	O
,	O
2+	O
bilaterally	O
at	O
brachial	O
radialis	O
,	O
2+	O
bilaterally	O
at	O
the	O
patellar	O
tendon	O
,	O
1+	O
bilaterally	O
Achilles	O
tendon	O
.	O

The	O
toes	O
were	O
downgoing	O
bilaterally	O
.	O

Gait	O
:	O

patient	O
had	O
difficulty	O
with	O
tandem	O
gait	O
and	O
fell	O
forward	O
while	O
standing	O
on	O
his	O
his	O
toes	O
.	O

Otherwise	O
,	O
the	O
gait	O
was	O
normal	O
.	O

LABORATORY	O
DATA	O
:	O

Laboratory	O
studies	O
on	O
admission	O
demonstrated	O
a	B-procedure
sodium	I-procedure
of	O
144	O
,	O
potassium	B-procedure
4.1	O
,	O
chloride	B-procedure
106	O
,	O
bicarbonate	B-procedure
20.0	O
,	O
BUN	B-procedure
and	O
creatinine	B-procedure
12/0.7	O
,	O
glucose	B-procedure
99	O
,	O
white	B-procedure
blood	I-procedure
count	I-procedure
of	O
5.7	O
,	O
hematocrit	B-procedure
of	O
40.6	O
,	O
platelet	B-procedure
count	I-procedure
of	O
226	O
,	O
prothrombin	B-procedure
time	I-procedure
was	O
9.4	O
,	O
partial	B-procedure
thromboplastin	I-procedure
time	I-procedure
was	O
29	O
.	O

The	B-procedure
computerized	I-procedure
tomography	I-procedure
scan	I-procedure
was	O
performed	O
and	O
showed	O
a	O
right	O
occipital	O
hemorrhage	O
.	O

SUMMARY	O
:	O

The	O
patient	O
is	O
a	O
seventy-one	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
hypertension	O
who	O
now	O
presents	O
with	O
a	O
right	O
occipital	O
hemorrhagic	O
stroke	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
for	O
further	B-procedure
evaluation	I-procedure
and	O
work	B-procedure
up	I-procedure
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Intermediate	O
Care	O
Unit	O
in	O
the	O
Neurology	O
Intensive	O
Care	O
Unit	O
.	O

However	O
,	O
she	O
was	O
soon	O
moved	O
out	O
of	O
there	O
as	O
her	B-procedure
examination	I-procedure
appeared	O
to	O
be	O
stable	O
.	O

A	O
Neurosurgery	O
Service	O
consultation	O
was	O
obtained	O
and	O
they	O
felt	O
that	O
no	O
surgical	B-procedure
intervention	I-procedure
was	O
required	O
.	O

The	O
patient	O
underwent	O
a	O
number	O
of	O
tests	B-procedure
.	O

She	O
had	O
a	B-procedure
magnetic	I-procedure
resonance	I-procedure
imaging	I-procedure
study	I-procedure
and	O
magnetic	B-procedure
resonance	I-procedure
imaging	I-procedure
angiogram	I-procedure
performed	O
which	O
showed	O
a	O
large	O
hemorrhagic	O
lesion	O
on	O
the	O
occipital	O
lobe	O
.	O

There	O
was	O
no	O
clear	O
enhancing	O
mass	O
,	O
but	O
follow	O
up	O
was	O
suggested	O
.	O

So	O
an	B-procedure
magnetic	I-procedure
resonance	I-procedure
imaging	I-procedure
angiogram	I-procedure
was	O
obtained	O
and	O
showed	O
the	O
right	O
parietal	O
occipital	O
hemorrhage	O
.	O

The	B-procedure
MRA	I-procedure
showed	O
mild	O
narrowing	O
of	O
the	O
left	O
ICA	O
just	O
distal	O
to	O
the	O
bifurcation	O
.	O

There	O
was	O
also	O
scattered	O
T2	O
hyperintense	O
foci	O
within	O
the	O
periventricular	O
and	O
left	O
frontal	O
white	O
matter	O
consistent	O
with	O
small	O
vessel	O
disease	O
,	O
gliosis	O
or	O
demyelination	O
.	O

A	B-procedure
Holter	I-procedure
monitor	I-procedure
was	O
obtained	O
and	O
showed	O
that	O
the	O
patient	O
was	O
in	O
normal	O
sinus	O
rhythm	O
.	O

The	B-procedure
heart	I-procedure
rate	I-procedure
was	O
53	O
to	O
106	O
.	O

There	O
were	O
some	O
very	O
rare	O
atrial	O
premature	O
contractions	O
.	O

There	O
were	O
no	O
ventricular	O
premature	O
contractions	O
.	O

An	B-procedure
echocardiogram	I-procedure
was	O
obtained	O
and	O
showed	O
that	O
the	B-procedure
ejection	I-procedure
fraction	I-procedure
was	O
60%	O
and	O
there	O
was	O
no	O
thrombus	O
.	O

It	O
was	O
felt	O
to	O
be	O
within	O
normal	O
limits	O
.	O

Over	O
the	O
ensuing	O
days	O
,	O
the	O
patient	O
had	O
several	O
episodes	O
of	O
confusion	O
at	O
night	O
.	O

However	O
,	O
these	O
gradually	O
resolved	O
.	O

She	O
also	O
developed	O
what	O
appeared	O
to	O
be	O
urinary	O
tract	O
infection	O
and	O
was	O
placed	O
on	O
PO	B-procedure
Bactrim	I-procedure
.	O

By	O
6-26-94	O
,	O
the	O
patient	O
was	O
felt	O
to	O
be	O
ready	O
for	O
discharge	O
.	O

At	O
that	O
time	O
,	O
she	O
was	O
afebrile	O
and	O
her	B-procedure
vital	I-procedure
signs	I-procedure
were	O
stable	O
.	O

She	O
was	O
tolerating	O
a	O
regular	O
diet	O
.	O

She	O
was	O
awake	O
,	O
alert	O
and	O
oriented	O
to	O
person	O
,	O
place	O
,	O
and	O
time	O
.	O

She	O
continued	O
to	O
have	O
a	O
dense	O
left	O
hemianopsia	O
,	O
but	O
otherwise	O
was	O
neurologically	O
intact	O
.	O

The	O
patient	O
was	O
discharged	O
home	O
with	O
Santea	O
Gehawhi	O
General	O
Hospital	O
care	O
and	O
instructed	O
to	O
follow	O
up	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

The	O
patient	O
was	O
discharged	O
on	O
Tenormin	B-procedure
,	O
25	O
mg	O
PO	O
qd	O
;	O
Bactrim	B-procedure
DS	I-procedure
,	O
one	O
PO	O
bid	O
x5	O
days	O
.	O

TATAJO	O
SEE	O
,	O
M.D.	O

TR	O
:	O

ba	O
/	O
bmot	O

DD	O
:	O

8-4-94	O

TD	O
:	O

08/06/94	O

CC	O
:	O

Admission	O
Date	O
:	O

2012-11-06	O

Discharge	O
Date	O
:	O

2012-11-11	O

Date	O
of	O
Birth	O
:	O

1965-09-22	O

Sex	O
:	O

M	O

Service	O
:	O

CCU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
47	O
-	O
year-old	O
male	O
with	O
a	O
past	O
medical	O
history	O
of	O
coronary	O
artery	O
disease	O
,	O
status	B-procedure
post	I-procedure
2-vessel	I-procedure
percutaneous	I-procedure
transluminal	I-procedure
coronary	I-procedure
angioplasty	I-procedure
in	O
2005	O
,	O
3-vessel	B-procedure
percutaneous	I-procedure
transluminal	I-procedure
coronary	I-procedure
angioplasty	I-procedure
in	O
2009	O
,	O
hypertension	O
,	O
new	O
onset	O
type	O
2	O
diabetes	O
,	O
and	O
hypercholesterolemia	O
who	O
presents	O
with	O
the	O
sudden	O
onset	O
of	O
substernal	O
chest	O
pain	O
status	O
post	O
exercise	O
.	O

The	O
patient	O
presented	O
to	O
Bournewood	O
Hospital	O
on	O
the	O
morning	O
of	O
admission	O
with	O
a	O
chief	O
complaint	O
of	O
substernal	O
burning	O
without	O
radiation	O
which	O
developed	O
while	O
doing	O
exercise	O
.	O

Of	O
note	O
,	O
this	O
is	O
the	O
second	O
time	O
the	O
patient	O
has	O
exercised	O
in	O
many	O
months	O
.	O

The	O
pain	O
became	O
worse	O
over	O
the	O
next	O
few	O
minutes	O
to	O
07-12	O
and	O
increased	O
to	O
10-12	O
while	O
he	O
was	O
in	O
the	O
ambulance	O
.	O

His	B-procedure
nitroglycerin	I-procedure
patch	I-procedure
did	O
not	O
help	O
,	O
and	O
he	O
only	O
had	O
slight	O
relief	O
with	O
sublingual	B-procedure
nitroglycerin	I-procedure
times	O
three	O
.	O

In	O
addition	O
,	O
he	O
had	O
slight	O
shortness	O
of	O
breath	O
but	O
denies	O
headache	O
,	O
change	O
in	O
vision	O
,	O
dizziness	O
,	O
nausea	O
,	O
vomiting	O
,	O
abdominal	O
pain	O
,	O
change	O
in	O
bowel	O
or	O
urinary	O
habits	O
,	O
or	O
fevers	O
,	O
chills	O
,	O
and	O
sweats	O
.	O

Of	O
note	O
,	O
he	O
had	O
a	O
negative	O
stress	O
test	O
in	O
2012-07-03	O
.	O

He	O
was	O
sent	O
to	O
Bournewood	O
Hospital	O
via	O
ambulance	O
.	O

In	O
the	O
Emergency	O
Department	O
he	O
received	O
aspirin	B-procedure
,	O
nitroglycerin	B-procedure
drip	I-procedure
,	O
heparin	B-procedure
drip	I-procedure
,	O
Dilaudid	B-procedure
,	O
and	O
TNK	B-procedure
with	O
decreased	O
in	O
his	O
pain	O
but	O
without	O
resolution	O
of	O
symptoms	O
.	O

Electrocardiogram	B-procedure
at	O
that	O
time	O
showed	O
ST	O
elevations	O
and	O
J	O
point	O
elevations	O
in	O
V2	O
through	O
V4	O
.	O

The	O
patient	O
was	O
transferred	O
to	O
Sturdy	O
Memorial	O
where	O
he	O
underwent	O
catheterization	B-procedure
.	O

Catheterization	B-procedure
results	I-procedure
showed	O
100%	O
occlusion	O
of	O
the	O
proximal	O
left	O
anterior	O
descending	O
artery	O
and	O
50%	O
stenosis	O
of	O
first	O
diagonal	O
.	O

Angio-Jet	B-procedure
percutaneous	I-procedure
transluminal	I-procedure
coronary	I-procedure
angioplasty	I-procedure
and	O
stenting	B-procedure
was	O
performed	O
on	O
proximal	O
left	O
anterior	O
descending	O
artery	O
and	O
the	B-procedure
percutaneous	I-procedure
transluminal	I-procedure
coronary	I-procedure
angioplasty	I-procedure
was	O
performed	O
on	O
first	O
diagonal	O
with	O
good	O
results	O
.	O

An	B-procedure
intra-aortic	I-procedure
balloon	I-procedure
pump	I-procedure
was	O
placed	O
at	O
this	O
time	O
as	O
well	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Coronary	O
artery	O
disease	O
;	O
the	O
patient	O
is	O
status	B-procedure
post	I-procedure
percutaneous	I-procedure
transluminal	I-procedure
coronary	I-procedure
angioplasty	I-procedure
times	O
three	O
in	O
2009	O
at	O
Clinton	O
Hospital	O
;	O
the	O
patient	O
is	O
status	B-procedure
post	I-procedure
percutaneous	I-procedure
transluminal	I-procedure
coronary	I-procedure
angioplasty	I-procedure
times	O
two	O
in	O
2005	O
at	O
Waltham/Weston	O
Hospital	O
.	O

2.	O
Type	O
2	O
diabetes	O
.	O

3.	O
Hypercholesterolemia	O
.	O

4.	O
Hypertension	O
.	O

FAMILY	O
HISTORY	O
:	O

The	O
patient	O
's	O
father	O
died	O
of	O
a	O
myocardial	O
infarction	O
at	O
age	O
40	O
,	O
and	O
a	O
brother	O
who	O
died	O
of	O
a	O
myocardial	O
infarction	O
at	O
age	O
40	O
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
ethanol	O
use	O
.	O

No	O
tobacco	O
at	O
this	O
time	O
;	O
he	O
quit	O
20	O
years	O
ago	O
.	O

The	O
patient	O
is	O
married	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Diltiazem	B-procedure
180	O
mg	O
p.o.	O
q.d.	O
,	O
Lipitor	B-procedure
10	O
mg	O
p.o.	O
q.d.	O
,	O
Glyset	B-procedure
25	O
mg	O
p.o.	O
q.d.	O
,	O
Prevacid	B-procedure
30	O
mg	O
p.o.	O
q.d.	O
,	O
metoprolol	B-procedure
50	O
mg	O
p.o.	O
b.i.d.	O
,	O
Glucophage	B-procedure
500	O
mg	O
p.o.	O
q.d.	O

ALLERGIES	O
:	O

Allergies	O
included	O
PENICILLIN	B-procedure
and	O
IODINE	B-procedure
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

Temperature	B-procedure
maximum	I-procedure
98.7	O
,	O
temperature	B-procedure
current	I-procedure
98.3	O
,	O
pulse	B-procedure
ranged	O
from	O
82	O
to	O
92	O
,	O
blood	B-procedure
pressure	I-procedure
104	O
to	O
124/67	O
to	O
74	O
with	O
a	O
mean	O
of	O
86	O
to	O
99	O
,	O
respiratory	B-procedure
rate	I-procedure
of	O
11	O
to	O
16	O
,	O
oxygen	B-procedure
saturation	I-procedure
94%	O
to	O
98%	O
on	O
2	O
liters	O
.	O

Pulmonary	B-procedure
artery	I-procedure
pressure	I-procedure
was	O
29/15	O
with	O
a	O
mean	O
of	O
22	O
.	O

Cardiac	B-procedure
output	I-procedure
was	O
7	O
(	O
that	O
was	O
on	O
6	O
of	O
dopamine	B-procedure
)	O
.	O

Intra-aortic	B-procedure
balloon	I-procedure
pump	I-procedure
augmented	I-procedure
systole	I-procedure
was	O
109	O
,	O
augmented	B-procedure
diastole	I-procedure
was	O
111	O
.	O

The	O
patient	O
was	O
lying	O
flat	O
in	O
no	O
apparent	O
distress	O
.	O

HEENT	O
revealed	O
extraocular	O
movements	O
were	O
intact	O
.	O

Pupils	O
were	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

The	O
oropharynx	O
was	O
clear	O
with	O
moist	O
mucosa	O
.	O

Neck	O
was	O
supple	O
.	O

No	O
lymphadenopathy	O
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	B-procedure
bilaterally	O
,	O
anteriorly	O
and	O
laterally	O
.	O

Cardiovascular	O
revealed	O
jugular	O
venous	O
distention	O
not	O
appreciated	O
.	O

Carotids	O
had	O
normal	O
upstroke	O
and	O
normal	O
volume	O
with	O
bilateral	O
bruits	O
.	O

A	O
regular	O
rate	O
.	O

Normal	O
S1	O
and	O
S2	O
.	O

No	O
S3	O
or	O
S4	O
.	O

No	O
murmurs	O
,	O
rubs	O
or	O
gallops	O
.	O

Abdomen	O
had	O
decreased	O
bowel	O
sounds	O
,	O
soft	O
,	O
nontender	O
,	O
and	O
nondistended	O
.	O

No	O
hepatosplenomegaly	O
.	O

Liver	O
was	O
about	O
5	O
cm	O
.	O

Extremities	O
had	O
no	O
edema	O
.	O

The	O
right	O
groin	O
revealed	O
intra-aortic	B-procedure
balloon	I-procedure
pump	I-procedure
site	O
and	O
pulmonary	B-procedure
artery	I-procedure
catheterization	I-procedure
site	O
were	O
clean	O
,	O
dry	O
and	O
intact	O
without	O
tenderness	O
.	O

Dorsalis	B-procedure
pedis	I-procedure
pulses	I-procedure
were	O
2+	O
bilaterally	O
.	O

Neurologic	B-procedure
examination	I-procedure
revealed	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

Cranial	O
nerves	O
II	O
through	O
XII	O
were	O
intact	O
.	O

LABORATORY	O
DATA	O
ON	O
ADMISSION	O
:	O

Laboratories	B-procedure
on	O
admission	O
revealed	O
white	B-procedure
count	I-procedure
7.8	O
,	O
hematocrit	B-procedure
was	O
41.7	O
,	O
platelets	B-procedure
of	O
252	O
,	O
MCV	B-procedure
89	O
,	O
RDW	B-procedure
12.7	O
.	O

Chem-7	B-procedure
revealed	O
sodium	B-procedure
of	O
136	O
,	O
potassium	B-procedure
4.7	O
,	O
chloride	B-procedure
103	O
,	O
bicarbonate	B-procedure
22	O
,	O
BUN	B-procedure
16	O
,	O
creatinine	B-procedure
0.8	O
,	O
glucose	B-procedure
284	O
.	O

PT	B-procedure
14.2	O
,	O
PTT	B-procedure
108.5	O
,	O
INR	B-procedure
1.3	O
.	O

Creatine	B-procedure
kinase	I-procedure
at	O
11	O
a.m.	O
was	O
83	O
,	O
at	O
5	O
p.m.	O
was	O
3021	O
.	O

Arterial	B-procedure
blood	I-procedure
gas	I-procedure
at	O
11	O
a.m.	O
was	O
7.33/46/115	O
.	O

Creatine	B-procedure
kinases	I-procedure
trended	O
from	O
11:15	O
on	O
the	O
day	O
of	O
admission	O
from	O
83	O
to	O
3021	O
at	O
5	O
p.m.	O
to	O
3450	O
at	O
11	O
p.m.	O
,	O
to	O
1734	O
at	O
5:30	O
a.m.	O
on	O
11-07	O
,	O
to	O
1277	O
at	O
11:30	O
a.m.	O
on	O
11-07	O
,	O
to	O
83	O
at	O
9:30	O
a.m.	O
on	O
11-11	O
.	O

RADIOLOGY	O
/	O
IMAGING	O
:	O

Electrocardiogram	B-procedure
post	O
catheterization	B-procedure
showed	O
continued	O
ST	O
elevations	O
and	O
J	O
point	O
elevations	O
in	O
V2	O
through	O
V3	O
.	O

Post	B-procedure
catheterization	I-procedure
echocardiogram	I-procedure
showed	O
an	B-procedure
ejection	I-procedure
fraction	I-procedure
of	O
30%	O
,	O
moderate	O
systolic	O
dysfunction	O
,	O
basal	O
anterior	O
hypokinesis	O
,	O
mid	O
anterior	O
akinesis	O
,	O
basal	O
anteroseptal	O
hypokinesis	O
,	O
mid	O
anteroseptal	O
akinesis	O
.	O

Anterior	O
apex	O
akinesis	O
,	O
inferior	O
apex	O
akinesis	O
,	O
and	O
apex	O
akinesis	O
.	O

The	O
was	O
trace	O
mitral	O
regurgitation	O
and	O
trace	O
tricuspid	O
regurgitation	O
.	O

IMPRESSION	O
:	O

This	O
is	O
a	O
47	O
-	O
year-old	O
male	O
with	O
a	O
past	O
medical	O
history	O
of	O
type	O
2	O
diabetes	O
,	O
high	O
cholesterol	O
,	O
hypertension	O
,	O
and	O
coronary	O
artery	O
disease	O
,	O
status	B-procedure
post	I-procedure
percutaneous	I-procedure
transluminal	I-procedure
coronary	I-procedure
angioplasty	I-procedure
times	O
two	O
,	O
who	O
presented	O
with	O
acute	O
coronary	O
syndrome	O
refractory	O
to	O
medical	B-procedure
treatment	I-procedure
and	O
TNK	B-procedure
,	O
now	O
status	B-procedure
post	I-procedure
Angio-Jet	I-procedure
percutaneous	I-procedure
transluminal	I-procedure
coronary	I-procedure
angioplasty	I-procedure
and	O
stent	B-procedure
of	I-procedure
proximal	I-procedure
left	I-procedure
anterior	I-procedure
descending	I-procedure
artery	I-procedure
and	O
percutaneous	B-procedure
transluminal	I-procedure
coronary	I-procedure
angioplasty	I-procedure
of	O
first	O
diagonal	O
with	O
intra-aortic	B-procedure
balloon	I-procedure
pump	I-procedure
placement	I-procedure
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
Mass.	O
Mental	O
Health	O
Center	O
hospital	O
course	O
was	O
unremarkable	O
.	O

Dopamine	B-procedure
was	O
discontinued	O
on	O
day	O
one	O
.	O

The	B-procedure
intra-aortic	I-procedure
balloon	I-procedure
pump	I-procedure
was	O
discontinued	O
on	O
day	O
two	O
.	O

The	O
patient	O
was	O
continued	O
on	O
heparin	B-procedure
throughout	O
his	O
hospital	O
course	O
and	O
transitioned	O
to	O
Coumadin	B-procedure
on	O
hospital	O
day	O
four	O
.	O

The	O
patient	O
was	O
continued	O
on	O
Lipitor	B-procedure
and	O
aspirin	B-procedure
,	O
and	O
Plavix	B-procedure
was	O
added	O
and	O
will	O
be	O
continued	O
for	O
30	O
days	O
post	O
catheterization	B-procedure
.	O

The	O
patient	O
was	O
continued	O
on	O
Lopressor	B-procedure
and	O
captopril	B-procedure
throughout	O
his	O
hospital	O
course	O
,	O
and	O
changed	O
to	O

Zestril	B-procedure
10	O
mg	O
q.d.	O
and	O
atenolol	B-procedure
25	O
mg	O
q.d.	O
at	O
discharge	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
the	O
medical	O
floor	O
on	O
hospital	O
day	O
three	O
and	O
discharged	O
from	O
the	O
hospital	O
once	O
his	B-procedure
INR	I-procedure
was	O
within	O
the	O
2	O
to	O
2.5	O
range	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

The	O
patient	O
's	O
condition	O
on	O
discharge	O
was	O
stable	O
.	O

DISCHARGE	O
STATUS	O
:	O

He	O
was	O
discharged	O
home	O
.	O

DISCHARGE	O
FOLLOWUP	O
:	O

Instructions	O
to	O
follow	O
up	O
with	O
his	O
primary	O
care	O
physician	O
on	O
the	O
Heather	O
after	O
discharge	O
.	O

Primary	O
care	O
physician	O
was	O
to	O
check	O
INR	B-procedure
and	O
titrate	O
Zestril	B-procedure
up	O
and	O
atenolol	B-procedure
as	O
tolerated	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Lipitor	B-procedure
10	O
mg	O
p.o.	O
q.d.	O

2.	O
Aspirin	B-procedure
325	O
mg	O
p.o.	O
q.d.	O

3.	O
Plavix	B-procedure
75	O
mg	O
p.o.	O
q.d.	O
times	O
30	O
days	O
.	O

4.	O
Prevacid	B-procedure
30	O
mg	O
p.o.	O
q.d.	O

5.	O
Atenolol	B-procedure
25	O
mg	O
p.o.	O
q.d.	O

6.	O
Zestril	B-procedure
10	O
mg	O
p.o.	O
q.d.	O

7.	O
Glyset	B-procedure
25	O
mg	O
p.o.	O
q.d.	O

8.	O
Glucophage	B-procedure
500	O
mg	O
p.o.	O
q.d.	O

9.	O
Coumadin	B-procedure
5	O
mg	O
p.o.	O
q.d.	O

Tina	O
Squillace	O
,	O
M.D.	O
30-977	O

Dictated	O
By	O
:	O
Lloyd	O
U.	O
King	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-11-12	O
21:57	O

T	O
:	O
2012-11-15	O
14:05	O

JOB	O
#	O
:	O
15711	O

cc	O
:	O
Beau	O
J.	O
Box	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2010-10-04	O

Discharge	O
Date	O
:	O

2010-10-17	O

Date	O
of	O
Birth	O
:	O

1929-11-09	O

Sex	O
:	O

F	O

Service	O
:	O

There	O
will	O
be	O
further	O
addendum	O
.	O

Respiratory	O
distress	O
-	O
On	O
10-12	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
Medicine	O
Intensive	O
Care	O
Unit	O
secondary	O
to	O
respiratory	O
distress	O
.	O

In	O
the	O
Medicine	O
Intensive	O
Care	O
Unit	O
,	O
the	O
patient	O
was	O
initially	O
placed	O
on	O
high-flow	B-procedure
60%	I-procedure
oxygen	I-procedure
face	I-procedure
mask	I-procedure
and	O
they	O
diuresed	O
approximately	O
5	O
liters	O
off	O
into	O
the	B-procedure
intravenous	I-procedure
Lasix	I-procedure
.	O

The	O
patient	O
actually	O
was	O
improved	O
.	O

She	O
came	O
back	O
to	O
the	O
floor	O
on	O
10-14	O
.	O

Since	O
then	O
the	O
patient	O
's	O
oxygenation	O
has	O
been	O
improving	O
and	O
today	O
,	O
10-17	O
,	O
she	O
is	O
requiring	O
.5	O
liters	O
of	O
keep	O
her	B-procedure
saturations	I-procedure
above	O
94	O
.	O

The	O
patient	O
continues	O
to	O
be	O
diuresed	O
with	O
approximately	O
20	O
mg	O
of	O
Lasix	B-procedure
a	O
day	O
and	O
she	O
has	O
had	O
good	O
urine	O
output	O
.	O

Anemia	O
-	O
The	B-procedure
patient	I-procedure
's	I-procedure
hematocrit	I-procedure
dropped	O
in	O
the	O
Intensive	O
Care	O
Unit	O
to	O
the	O
mid	O
20s	O
and	O
she	O
received	O
one	O
unit	O
of	O
packed	O

red	B-procedure
blood	I-procedure
cells	I-procedure
with	O
a	O
good	O
response	O
up	O
to	O
30	O
.	O

Hypotension	O
-	O
On	O
the	O
night	O
of	O
10-16	O
,	O
the	O
patient	O
was	O
diuresed	O
with	O
20	O
mg	O
of	O
intravenous	B-procedure
Lasix	I-procedure
.	O

This	O
is	O
the	O
normal	O
dose	O
that	O
she	O
puts	O
out	O
too	O
.	O

The	O
patient	O
became	O
hypotensive	O
into	O
the	O
70	O
s	O
without	O
any	O
symptoms	O
.	O

Her	B-procedure
oxygen	I-procedure
saturations	I-procedure
were	O
greater	O
than	O
94%	O
at	O
the	O
time	O
.	O

The	O
patient	O
was	O
given	O
250	O
cc	O
of	O
normal	B-procedure
saline	I-procedure
and	O
her	B-procedure
blood	I-procedure
pressure	I-procedure
responded	O
coming	O
back	O
up	O
to	O
the	O
high	O
90	O
s.	O

No	O
further	O
episodes	O
of	O
hypotension	O
were	O
noted	O
.	O

As	O
of	O
the	O
time	O
of	O
this	O
dictation	O
,	O
on	O
2010-10-17	O
,	O
the	O
patient	O
appears	O
to	O
be	O
getting	O
better	O
.	O

Recent	B-procedure
chest	I-procedure
x-ray	I-procedure
shows	O
resolving	O
right	O
lower	O
lobe	O
pneumonia	O
.	O

She	O
continues	O
on	O
her	B-procedure
Prednisone	I-procedure
taper	I-procedure
for	O
her	O
asthma	O
and	O
this	O
is	O
day	O
#	O
14	O
of	O
antibiotics	B-procedure
.	O

MARK	O
Shorter	O
,	O
M.D.	O

94-264	O

Dictated	O
By	O
:	O
Donna	O
Q	O
Fisher	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2010-10-17	O
12:22	O

T	O
:	O
2010-10-17	O
17:21	O

JOB	O
#:	O

33371	O

(	O
End	O
of	O
Report	O
)	O

767751445	O
ELMVH	O

45154940	O

6035801	O

12/6/2005	O
12:00:00	O
AM	O

COPD	O
exacerbation	O
with	O
NSTEMI	O

DIS	O

Admission	O
Date	O
:	O

12/06/2005	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

12/10/2005	O

******	O
FINAL	O
DISCHARGE	O
ORDERS	O
******	O

SCHOELLSULLKOTEFONG	O
,	O
MAUSTINIE	O

161-66-98-5	O
W53	O

Room	O
:	O

66R-249	O

Service	O
:	O

MED	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

12/09/05	O
AT	O
08:00	O
PM	O

CONTINGENT	O
UPON	O

Attending	B-procedure
evaluation	I-procedure

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

FREIERMFUSC	O
,	O
SHAIGAYDONA	O
,	O
M.D.	O
,	O
M.DIV.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Home	O
w/	O
services	O

DISCHARGE	O
MEDICATIONS	O
:	O

VITAMIN	B-procedure
C	I-procedure
(	I-procedure
ASCORBIC	I-procedure
ACID	I-procedure
)	I-procedure
1,000	O
MG	O
PO	O
QD	O
ECASA	B-procedure
(	I-procedure
ASPIRIN	I-procedure
ENTERIC	I-procedure
COATED	I-procedure
)	I-procedure
81	O
MG	O
PO	O
QD	O
CALCIUM	B-procedure
CARBONATE	I-procedure
(	I-procedure
500	I-procedure
MG	I-procedure
ELEMENTAL	I-procedure
CA++	I-procedure
)	I-procedure
500	O
MG	O
PO	O
BID	O
PREDNISONE	B-procedure
20	O
MG	O
PO	O
QAM	O
Starting	O
Today	O
(	O
12/09	O
)	O

Instructions	O
:	O

taper	O
over	O
2	O
weeks	O
MULTIVITAMIN	B-procedure
THERAPEUTIC	I-procedure
(	I-procedure
THERAPEUTIC	I-procedure
MULTIVI	I-procedure
...	I-procedure
)	I-procedure
5	O
MILLILITERS	O
PO	O
QD	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
12/07/05	O
by	O
BELB	O
,	O
BRITHERL	O
,	O
M.D.	O
on	O
order	O
for	O
ATORVASTATIN	B-procedure
PO	I-procedure
(	O
ref	O
#	O
33823759	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

NIACIN	B-procedure
,	O
VIT	B-procedure
.	O

B-3	B-procedure
and	O
ATORVASTATIN	B-procedure
CALCIUM	I-procedure

Reason	O
for	O
override	O
:	O

md	O
aware	O

Previous	O
override	O
information	O
:	O

Override	O
added	O
on	O
12/06/05	O
by	O
BELB	O
,	O
BRITHERL	O
,	O
M.D.	O
on	O
order	O
for	O
ZOCOR	B-procedure
PO	I-procedure
(	O
ref	O
#	O
33033281	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

NIACIN	B-procedure
,	O
VIT	B-procedure
.	O

B-3	B-procedure
and	O
SIMVASTATIN	B-procedure

Reason	O
for	O
override	O
:	O

md	O
aware	O

FLOVENT	B-procedure
(	I-procedure
FLUTICASONE	I-procedure
PROPIONATE	I-procedure
)	I-procedure
44	O
MCG	O
INH	O
BID	O
Starting	O
Today	O
(	O
12/09	O
)	O
LEVAQUIN	B-procedure
(	I-procedure
LEVOFLOXACIN	I-procedure
)	I-procedure
500	O
MG	O
PO	O
QD	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Administer	O
iron	B-procedure
products	I-procedure
a	O
minimum	O
of	O
2	O
hours	O
before	O
or	O
after	O
a	O
levofloxacin	B-procedure
or	O
ciprofloxacin	B-procedure
dose	O
dose	O

If	O
on	O
tube	B-procedure
feeds	I-procedure
,	O
please	O
cycle	O
(	O
hold	O
1	O
hr	O
before	O
to	O
2	O
hr	O
after	O
)	O

Take	O
2	O
hours	O
before	O
or	O
2	O
hours	O
after	O
dairy	O
products	O
.	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
12/06/05	O
by	O
BELB	O
,	O
BRITHERL	O
,	O
M.D.	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SALMETEROL	B-procedure
XINAFOATE	I-procedure
and	O
LEVOFLOXACIN	B-procedure

Reason	O
for	O
override	O
:	O

md	O
aware	O

SEREVENT	B-procedure
DISKUS	I-procedure
(	I-procedure
SALMETEROL	I-procedure
DISKUS	I-procedure
)	I-procedure
1	O
PUFF	O
INH	O
BID	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
12/06/05	O
by	O
BELB	O
,	O
BRITHERL	O
,	O
M.D.	O
on	O
order	O
for	O
LEVAQUIN	B-procedure
PO	I-procedure
(	O
ref	O
#	O
57095042	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SALMETEROL	B-procedure
XINAFOATE	I-procedure
and	O
LEVOFLOXACIN	B-procedure

Reason	O
for	O
override	O
:	O

md	O
aware	O

LISINOPRIL	B-procedure
5	O
MG	O
PO	O
QD	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
12/08/05	O
by	O
:	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

POTASSIUM	B-procedure
CHLORIDE	I-procedure
and	O
LISINOPRIL	B-procedure

Reason	O
for	O
override	O
:	O

md	O
aware	O

TOPROL	B-procedure
XL	I-procedure
(	I-procedure
METOPROLOL	I-procedure
SUCCINATE	I-procedure
EXTENDED	I-procedure
RELEASE	I-procedure
)	I-procedure
25	O
MG	O
PO	O
QD	O
Starting	O
Today	O
(	O
12/09	O
)	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
consistently	O
with	O
meals	O
or	O
on	O
empty	O
stomach	O
.	O

ALENDRONATE	B-procedure
70	O
MG	O
PO	O
QWEEK	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Give	O
on	O
an	O
empty	O
stomach	O
(	O
give	O
1hr	O
before	O
or	O
2hr	O
after	O
food	O
)	O

Take	O
with	O
8	O
oz	O
of	O
plain	O
water	O
ALBUTEROL	B-procedure
INHALER	I-procedure
2	O
PUFF	O
INH	O
QID	O
Starting	O
Today	O
(	O
12/09	O
)	O
ATROVENT	B-procedure
INHALER	I-procedure
(	I-procedure
IPRATROPIUM	I-procedure
INHALER	I-procedure
)	I-procedure
2	O
PUFF	O
INH	O
QID	O
Starting	O
Today	O
(	O
12/09	O
)	O

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Gento	O
Yaneslaunt	O
03/17/06	O
scheduled	O
,	O

Arois	O
Maillliepslighsint	O
02/18/06	O
scheduled	O
,	O

ALLERGY	O
:	O

NKA	O
ADMIT	O
DIAGNOSIS	O
:	O

COPD	O
exacerbation	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
COPD	O
exacerbation	O
with	O
NSTEMI	O

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

severe	O
COPD	O
Pneumonia	O
recovering	O
alcoholic	O
recovering	O
barbituate	O
abuse	O
unexplained	O
hct	O
drop	O
poor	O
appetite	O
x	O
1	O
week	O

STEROID	O
PSYCHOSIS	O
NO	O
BENZOS	B-procedure

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

none	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

Heparin	B-procedure
while	O
having	O
a	O
demand	O
ischemic	O
episode	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

*	O
CC	O
:	O

82F	O
with	O
COPD	O
exacerpation	O

*	O
DDx	O
:	O

COPD	O
exacerpation	O
with	O
troponin	O
leak	O
likely	O
NSTEMI	O
secondary	O
to	O
demand	O
ischemia	O
.	O

*	O
HPI	O
:	O

4	O
days	O
of	O
worsening	O
SOB	O
with	O
sore	O
throat	O
and	O
cough	O
productive	O
of	O
yellow	O
/	O
green	O
sputum	O
.	O

Fatigue	O
secondary	O
to	O
worsening	O
dyspnea	O
.	O

took	O
Prednisone	B-procedure
40	I-procedure
at	O
home	O
and	O
presented	O
to	O
ED	O
where	O
found	O
to	O
have	O
1mm	O
lateral	O
ST	O
depressions	O
and	O
slight	O
troponin	O
and	O
MB	O
leak	O
.	O

no	O
N	O
/	O
V/HA	O
/	O
D	O
no	O
sweats	O
,	O
no	O
chills	O
,	O
of	O
abdominal	O
pain	O
,	O
no	O
chest	O
pain	O
,	O
no	O
pleuricy	O
,	O
no	O
LEE	O
,	O
no	O
paresthesias	O
,	O
no	O
numbness	O
,	O
no	O
shoulder	O
pain	O
,	O
no	O
jaw	O
pain	O
.	O

*	O
PMH	O
:	O

COPD	O
(	O
s	O
/	O
p	O
lung	B-procedure
resection	I-procedure
FEV1	B-procedure
25%	O
)	O
,	O
chronic	O
pericardial	O
effusion	O
,	O
PVD	O
,	O
R	O
renal	O
artery	O
stenosis	O
,	O
osteoporosis	O
,	O
presbylaryngis	O

**************	O
PATIENT	O
STATUS	O
********************	O

98.4	O
,	O
94	O
,	O
22	O
,	O
120/96	O
,	O
98%	O
on	O
2L.	O
NAD	O
,	O
using	O
scalenes	B-procedure
,	O
AT	O
/	O
NC	O
,	O
no	O
oral	O
lesions	O
,	O
Bibasilar	O
rales	O
otherwise	O
clear	O
,	O
good	O
air	O
movement	O
,	O
RRR	O
,	O
no	O
MRG	O
,	O
NTND	O
+BS	O
,	O
no	O
CCE	O
,	O
2+	O
DPs	O
.	O

Guiac	O
negative	O

***************	O
STUDIES	O
***********************	O

LABS	O
:	O

WBC	B-procedure
12.91	O

CXR	O
:	O

small	O
pleural	O
effusion	O
,	O
flat	O
diaphrams	O
no	O
acute	O
changes	O

Echo	B-procedure
-	O

***********	O
HOSPITAL	O
COURSE	O
****************	O

1.	O
CV	O
:	O

likely	O
having	O
a	O
NSTEMI	O
secondary	O
to	O
demand	O
.	O

Cardiac	B-procedure
enzymes	I-procedure
trending	O
down	O
on	O
12.7.05	O
,	O
anticoagulated	O
while	O
having	O
leak	B-procedure
.	O

I	O
-	O
heparin	B-procedure
for	O
PTT	O
50-70	O
durin	O
enzyme	O
leak	O
.	O
metoprolol	B-procedure
12	O
QID	O
.	O

Cardiac	B-procedure
enzymes	I-procedure
BID	O
while	O
actively	O
having	O
leak	O
,	O
ASA	B-procedure

R	O
-	O
monitor	O
on	O
telemetry	B-procedure

P	O
-	O
no	O
evidence	O
of	O
failure	O

-	O
Echo	O
:	O

2.	O
COPD	O
:	O

likely	O
exacerbation	O
possibly	O
from	O
URI	O
/	O
pneumonia	O
.	O

Aputum	B-procedure
cultures	I-procedure
pending	O
.	O

Treated	O
with	O
:	O

atrovent	B-procedure
NEB	I-procedure
QID	O
,	O
albuterol	B-procedure
Neb	I-procedure
QID	O
,	O
ipratropium	B-procedure
NEB	I-procedure
BID	O
,	O
flovent	B-procedure
INH	I-procedure
BID	O
,	O
Serevent	B-procedure
INH	I-procedure
BID	O
,	O
and	O
prednisone	B-procedure
30	O
QD	O
taper	O
.	O

Levaquin	B-procedure
500	O
QD	O
empirically	O

3.	O
GI	O
:	O

PPI	B-procedure
prophylaxis	I-procedure

4.	O
FEN	O
:	O

MVI	O
,	O
Cardiac	O
diet	O

ADDITIONAL	O
COMMENTS	O
:	O

Please	O
make	O
an	O
appointment	O
to	O
see	O
dr.	O
Arois	O
Maillliepslighsint	O
within2-3	O
weeks	O
after	O
you	O
leave	O
the	O
hospital	O

Please	O
taper	O
off	O
your	O
prednisone	B-procedure
within	O
2	O
weeks	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

PT	O
:	O

please	O
evaluate	O
ambutlation	O
ability	O
and	O
O2	B-procedure
requirement	I-procedure

Please	O
evaluate	O
resolution	O
of	O
cardiac	O
troponin	O
leak	O
and	O
stable	O
EKG	O
.	O

Please	O
evaluate	O
resolution	O
of	O
COPD	O
exacerbation	O
and	O
need	O
for	O
any	B-procedure
further	I-procedure
antibiocis	I-procedure

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

BELB	O
,	O
BRITHERL	O
,	O
M.D.	O
(	O
IL35	O
)	O
12/10/05	O
02:50	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2013-11-04	O

Discharge	O
Date	O
:	O

2013-11-16	O

Date	O
of	O
Birth	O
:	O

1930-12-19	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Sulfa	B-procedure
(	I-procedure
Sulfonamides	I-procedure
)	O
/	O
Penicillins	B-procedure
/	O
Macrodantin	B-procedure
/	O
Ivp	B-procedure
Dye	I-procedure
,	O
Iodine	B-procedure
Containing	I-procedure

Attending	O
:	O
Robert	O
E	O
Goldschmidt	O
,	O
M.D.	O

Addendum	O
:	O

Just	O
prior	O
to	O
discharge	O
on	O
11-14	O
,	O
pt	B-procedure
's	I-procedure
BP	I-procedure
was	O
found	O
to	O
be	O
70/40	O
P70	O
s	O
just	O
after	O
receiving	O
her	B-procedure
am	I-procedure
BP	I-procedure
meds	I-procedure
.	O

She	O
was	O
asymptomatic	O
.	O

The	O
patient	O
was	O
kept	O
in	O
the	O
hospital	O
and	O
the	O
following	O
issues	O
were	O
addressed	O
:	O

1.	O
Hypotension	O
:	O
The	B-procedure
patient	I-procedure
'd	I-procedure
pm	I-procedure
BP	I-procedure
meds	I-procedure
were	O
held	O
11-14	O
and	O
she	O
was	O
administered	O
1.5L	O
NS	B-procedure
over	O
the	O
course	O
of	O
the	O
day	O
with	O
subsequent	O
SBP	B-procedure
s	I-procedure
in	O
the	O
high	O
90	O
s,	O
low	O
100	O
s,.	O

The	O
hypotension	O
was	O
likely	O
due	O
to	O
volume	O
depletion	O
caused	O
by	O
her	O
diarrhea	O
/	O
loose	O
stools	O
in	O
addition	O
to	O
decreased	O
PO	O
intake	O
secondary	O
to	O
her	O
GERD	O
and	O
thrush	O
.	O

All	O
of	O
this	O
occurred	O
in	O
the	O
setting	O
of	O
aggressive	B-procedure
BP	I-procedure
management	I-procedure
with	O
metoprolol	B-procedure
25	O
BID	O
,	O
HCTZ	B-procedure
/	O
Triampterene	B-procedure
(	O
as	O
a	O
replacment	O
for	O
lasix	B-procedure
due	O
to	O
recurrent	O
hypokalemia	O
),	O
Benicar	B-procedure
20	O
mg	O
QD	O
,	O
and	O
Imdur	B-procedure
30	O
mg	O
QD	O
.	O

Infection	O
/	O
sepsis	O
was	O
not	O
likely	O
given	O
she	O
was	O
afebrile	O
and	O
had	O
no	O
localizing	O
sx	O
with	O
an	O
improving	O
lung	B-procedure
exam	I-procedure
and	O
02	O
requirement	O
.	O

Given	O
the	O
patient	O
's	O
recent	O
RP	O
bleed	O
,	O
there	O
was	O
concern	O
for	O
a	O
recurrent	O
bleed	O
.	O

Her	B-procedure
groin	I-procedure
exam	I-procedure
was	O
unchanged	O
.	O

Her	B-procedure
Hct	I-procedure
dropped	O
from	O
Hct	B-procedure
38.9	O
before	O
fluids	B-procedure
to	O
35.5	O
s/p	O
1.5L	O
NS	B-procedure
and	O
was	O
thought	O
to	O
be	O
dilutional	O
.	O

Repeat	B-procedure
hcts	I-procedure
were	O
stable	O
.	O

The	O
patient	O
was	O
kept	O
an	O
additional	O
two	O
days	O
to	O
follow	O
her	B-procedure
hcts	I-procedure
and	O
titrate	O
her	B-procedure
BP	I-procedure
meds	I-procedure
.	O

As	O
volume	O
depletion	O
was	O
thought	O
to	O
be	O
the	O
cause	O
of	O
her	O
low	O
BP	O
,	O
only	O
the	B-procedure
BBlocker	I-procedure
was	O
restarted	O
.	O

She	O
was	O
also	O
placed	O
on	O
on	O
low	B-procedure
dose	I-procedure
spironolactone	I-procedure
as	O
a	B-procedure
K	I-procedure
sparing	I-procedure
diuretic	I-procedure
and	O
for	O
BP	B-procedure
control	I-procedure
in	O
addition	O
to	O
Toprol	B-procedure
XL	I-procedure
25	O
mg	O
QD	O
for	O
her	O
coronary	O
disease	O
.	O

She	O
tolerated	O
these	B-procedure
meds	I-procedure
with	O
SBP	B-procedure
s	I-procedure
in	O
the	O
high	O
90	O
s	O
to	O
100	O
s	O
and	O
was	O
therefore	O
discharged	O
on	O
this	B-procedure
regimen	I-procedure
.	O

She	O
will	O
need	O
follow	O
up	O
with	O
her	O
PCP	O
within	O
B	O
week	O
after	O
discharge	O
from	O
the	O
extended	O
care	O
facility	O
for	O
further	B-procedure
BP	I-procedure
titration	I-procedure
and	O
monitoring	B-procedure
of	I-procedure
her	I-procedure
electrolytes	I-procedure
.	O

2.	O
Thrush	O
:	O
This	O
is	O
likely	O
secondary	O
to	O
her	B-procedure
steroid	I-procedure
inhalers	I-procedure
and	O
PO	B-procedure
prednisone	I-procedure
for	O
COPD	O
exacerbation	O
.	O

She	O
was	O
started	O
on	O
nystatin	B-procedure
swish	O
and	O
swallow	O
QID	O
.	O

The	O
patient	O
was	O
encouraged	O
to	O
take	B-procedure
PO	I-procedure
liquids	I-procedure
to	O
prevent	O
volume	O
depletion	O
.	O

3.	O
diarrhea	O
:	O
The	O
patient	O
has	O
been	O
having	O
loose	O
stools	O
at	O
night	O
and	O
was	O
guiac	O
pos	O
x	O
2	O
.	O

Stool	B-procedure
for	I-procedure
C.diff	I-procedure
toxin	I-procedure
was	O
sent	O
x	O
1	O
and	O
was	O
negative	O
.	O

Her	B-procedure
bowel	I-procedure
regimen	I-procedure
is	O
prn	O
.	O

Gastroenteritis	O
is	O
possible	O
but	O
she	O
has	O
no	O
vomiting	O
and	O
only	O
occ	O
nausea	O
with	O
meds	B-procedure
.	O

There	O
is	O
no	O
evidence	O
of	O
obstruction	O
on	O
AXR	B-procedure
.	O

Therefore	O
,	O
the	O
cause	O
of	O
her	O
mild	O
diarrhea	O
(	O
few	O
loose	O
BM	O
/	O
liquid	O
stool	O
/	O
night	O
)	O
may	O
be	O
either	O
viral	O
or	O
secondary	O
to	O
resolving	O
abdominal	O
hematoma	O
with	O
resultant	O
irritation	O
of	O
GI	O
system	O
.	O

We	O
have	O
advised	O
a	B-procedure
BRAT	I-procedure
diet	I-procedure
.	O

4.	O
guiac	O
pos	O
stool	O
:	O
Given	O
the	O
patient	O
's	O
sx	O
of	O
GERD	O
,	O
current	O
PO	B-procedure
steroid	I-procedure
regimen	I-procedure
,	O
and	O
ASA	B-procedure
for	O
her	B-procedure
stents	I-procedure
,	O
the	O
ddx	O
for	O
her	O
guiac	O
positive	O
stools	O
would	O
include	O
gastritis	O
/	O
gastric	O
ulcer	O
in	O
addition	O
to	O
lower	O
GI	O
pathology	O
.	O

However	O
,	O
she	O
has	O
no	O
vomiting	O
and	O
only	O
mild	O
nausea	O
with	O
medications	B-procedure
.	O

She	O
also	O
has	O
no	O
gross	O
blood	O
per	O
rectum	O
and	O
her	B-procedure
hct	I-procedure
is	O
stable	O
.	O

Upon	O
discharge	O
the	O
patient	O
was	O
changed	O
to	O
a	B-procedure
BID	I-procedure
protonix	I-procedure
regimen	I-procedure
.	O

Dr.	O
Valerio	O
office	O
was	O
notified	O
about	O
the	O
patient	O
's	O
discharge	O
plans	O
and	O
status	O
.	O

She	O
will	O
need	O
outpatient	O
follow	O
up	O
for	O
her	O
guiac	O
pos	O
stools	O
with	O
endoscopy	B-procedure
vs	O
EGD	B-procedure
+/-	O
H.pylori	B-procedure
serologies	I-procedure
.	O

A	O
copy	O
of	O
this	O
dc	O
summary	O
will	O
be	O
faxed	O
to	O
her	O
PCP	O
to	O
ensure	O
proper	O
follow	O
up	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Atorvastatin	B-procedure
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

2.	O
Pantoprazole	B-procedure
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
twice	O
a	O
day	O
.	O

3.	O
Acetaminophen	B-procedure
500	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
).	O

Disp	O
:*	O
240	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

4.	O
Oxycodone	B-procedure
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	O
.	O

Disp	O
:*	O
90	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Fluticasone	B-procedure
50	O
mcg	O
/	O
Actuation	O
Aerosol	O
,	O
Spray	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Spray	O
Nasal	O
DAILY	O
(	O
Daily	O
).	O

6.	O
Fluticasone	B-procedure
110	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Puff	O
Inhalation	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

7.	O
Tiotropium	B-procedure
Bromide	I-procedure
18	O
mcg	O
Capsule	O
,	O
w/	O
Inhalation	O
Device	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
Inhalation	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Cap	O
(s)*	O
Refills	O
:*	O
2	O
*	O

8.	O
Clopidogrel	B-procedure
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

9.	O
Albuterol	B-procedure
Sulfate	I-procedure
0.083	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
puff	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
for	O
shortness	O
of	O
breath	O
or	O
wheezing	O
.	O

Disp	O
:*	O
1	O
inhaler	O
*	O
Refills	O
:*	O
1	O
*	O

10.	O
Aluminum	B-procedure
-	I-procedure
Magnesium	I-procedure
Hydroxide	I-procedure
225-200	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
15-30	O
ML	O
s	O
PO	O
PRN	O
(	O
as	O
needed	O
).	O

11.	O
Senna	B-procedure
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

12.	O
Prednisone	B-procedure
10	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
DAILY	O
(	O
Daily	O
)	O
for	O
4	O
days	O
:	O
Please	O
take	O
two	O
pills	O
for	O
one	O
day	O
starting	O
11-17	O
,	O
then	O
take	O
one	O
pill	O
for	O
three	O
days	O
.	O

Disp	O
:*	O
5	O
Tablet	O
(s)*	O
Refills	O
:	O
*	O
0	O
*	O

13.	O
oxygen	B-procedure
continue	O
02	B-procedure
at	O
1L/min	O
continuous	O
to	O
keep	O
sats	B-procedure
in	O
90	O
's.	O

14.	O
Spironolactone	B-procedure
25	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

15.	O
Metoprolol	B-procedure
Succinate	I-procedure
25	O
mg	O
Tablet	O
Sustained	O
Release	O
24HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
24HR	O
PO	O
DAILY	O
(	O
Daily	O
).	O

16.	O
Nystatin	B-procedure
100,000	O
unit	O
/	O
mL	O
Suspension	O
Sig	O
:	O
Ten	O
(	O
10	O
)	O
ML	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
for	O
7	O
days	O
.	O

17.	O
Aspirin	B-procedure
325	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

3133	O
W.	O
Third	O
Ave.	O
Rehab	O
&	O
Nursing	O
Center	O
-	O
Westwood	O
Lodge	O
Hospital	O

Discharge	O
Diagnosis	O
:	O

1)	O
Rapid	O
atrial	O
fibrillation	O
with	O
demand	O
ischemia	O

2)	O
Retroperitoneal	O
bleed	O

Discharge	O
Condition	O
:	O

Stable	O

Discharge	O
Instructions	O
:	O

Please	O
follow	O
up	O
with	O
your	O
PCP	O
Richard	O
,	O
Kevin	O
Robinson	O
(	O
771	O
)	O
937-5400	O
upon	O
discharge	O
.	O

If	O
you	O
experience	O
CP	O
,	O
SOB	O
,	O
dizzyness	O
,	O
or	O
any	O
other	O
symptoms	O
that	O
concern	O
you	O
please	O
call	O
your	O
PCP	O
or	O
return	O
to	O
the	O
ER	O
.	O

Note	O
:	O
you	O
have	O
had	O
a	B-procedure
cardiac	I-procedure
stent	I-procedure
placed	O
during	O
this	O
admission	O
.	O

You	O
must	O
take	O
your	B-procedure
aspirin	I-procedure
and	O
plavix	B-procedure
every	O
day	O
to	O
prevent	O
failure	O
of	O
these	O
stents	O
which	O
could	O
be	O
life	O
threatening	O
.	O

Please	O
take	O
all	B-procedure
medications	I-procedure
as	O
prescribed	O
.	O

Followup	O
Instructions	O
:	O

1)	O
Please	O
follow	O
up	O
with	O
your	O
PCP	O
and	O
cardiologist	O
,	O
David	O
,	O
Larry	O
Robinson	O
(	O
771	O
)	O
937-5400	O
,	O
upon	O
discharge	O
.	O

2)	O
You	O
are	O
scheduled	O
to	O
have	O
your	B-procedure
staples	I-procedure
removed	O
on	O
2013-11-20	O
3:00	O
with	O
provider	O
:	O
Leah	O
,	O
Paula	O
G.	O
Wilson	O
SURGERY	O
(	O
NHB	O
)	O

Date	O
/	O
Time	O
:	O
2013-11-20	O
3:00	O
.	O

Lashonda	O
Christopher	O
MD	O
48-669	O

Completed	O
by	O
:	O
Jill	O
Kelly	O
MD	O
47-482	O
2013-11-16	O
@	O
1550	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Lee	O
V.	O
Young	O
on	O
:	O
FRI	O
2013-12-20	O
4:59	O
PM	O

(	O
End	O
of	O
Report	O
)	O

105732749	O

FIH	O

7017973	O

715894	O

55714	O

9/10/1999	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

STERPKOTENEISH	O
,	O
LYDELL	O
A	O

UNIT	O
NUMBER	O
:	O

712-67-96	O

ADMISSION	O
DATE	O
:	O

09/10/1999	O

DISCHARGE	O
DATE	O
:	O

09/14/1999	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Pancreatic	O
carcinoma	O
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Laparoscopy	B-procedure
with	O
biopsy	B-procedure
for	O
diagnosis	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ms.	O
Sterpkoteneish	O
is	O
a	O
69-year-old	O
woman	O
,	O
who	O
over	O
the	O
past	O
six	O
months	O
has	O
noted	O
increasing	O
pain	O
in	O
her	O
left	O
upper	O
quadrant	O
radiating	O
to	O
the	O
back	O
.	O

She	O
described	O
the	O
pain	O
as	O
being	O
exacerbated	O
by	O
eating	O
and	O
described	O
an	O
associated	O
weight	O
loss	O
.	O

She	O
presented	O
to	O
her	O
primary	O
care	O
physician	O
,	O
Dr.	O
Tlandtaze	O
,	O
in	O
Aersing	O
Rocuch	O
Sun	O
,	O
who	O
obtained	O
a	B-procedure
CT	I-procedure
scan	I-procedure
,	O
which	O
demonstrated	O
a	O
mass	O
in	O
the	O
tail	O
of	O
the	O
pancreas	O
.	O

She	O
was	O
then	O
referred	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
under	O
the	O
El	O
Memorial	O
and	O
was	O
seen	O
by	O
Dr.	O
Blinjesc	O
,	O
who	O
scheduled	O
her	O
for	O
an	B-procedure
exploratory	I-procedure
laparoscopy	I-procedure
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Is	O
significant	O
for	O
spinal	O
stenosis	O
and	O
a	O
series	O
of	O
operations	B-procedure
including	O
repair	B-procedure
of	O
a	O
ureteral	O
stricture	O
;	O
cataract	B-procedure
implants	I-procedure
;	O
two	B-procedure
partial	I-procedure
hysterectomies	I-procedure
;	O
and	O
an	B-procedure
appendectomy	I-procedure
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Oxycontin	B-procedure
10	O
mg	O
PO	O
q.day	O
.	O

Darvocet	B-procedure
.	O

Estratab	B-procedure
.	O

Aspirin	B-procedure
325	O
mg	O
PO	O
q.day	O
.	O

ALLERGIES	O
:	O

No	O
known	O
drug	O
allergies	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	B-procedure
blood	I-procedure
pressure	I-procedure
was	O
150/86	O
;	O
pulse	B-procedure
82	O
;	O
respirations	B-procedure
16	O
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	B-procedure
bilaterally	O
.	O

Heart	O
:	O

regular	O
S1	O
and	O
S2	O
;	O
no	O
murmurs	O
.	O

Abdomen	O
:	O

soft	O
;	O
nontender	O
;	O
no	O
palpable	O
masses	O
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
through	O
same	O
day	O
surgery	O
and	O
taken	O
to	O
the	O
operating	O
room	O
where	O
Dr.	O
Blinjesc	O
,	O
assisted	O
by	O
Dr.	O
Zockbeathe	O
,	O
performed	O
a	B-procedure
diagnostic	I-procedure
laparoscopy	I-procedure
with	O
peritoneal	B-procedure
washings	I-procedure
.	O

Findings	O
included	O
no	O
gross	O
evidence	O
seating	O
in	O
the	O
abdominal	O
wall	O
;	O
one	O
nodule	O
on	O
the	O
posterior	O
surface	O
of	O
the	O
right	O
lobe	O
of	O
the	O
liver	O
;	O
one	O
nodule	O
in	O
the	O
inferior	O
edge	O
of	O
the	O
falciform	O
ligament	O
.	O

Specimens	B-procedure
sent	O
to	O
pathology	O
included	O
peritoneal	B-procedure
washings	I-procedure
and	O
permanent	B-procedure
specimens	I-procedure
from	I-procedure
the	I-procedure
liver	I-procedure
and	O
falciform	O
nodules	O
.	O

There	O
were	O
no	O
complications	O
,	O
and	O
the	O
patient	O
tolerated	O
the	B-procedure
procedure	I-procedure
well	O
.	O

Postoperatively	O
,	O
the	O
patient	O
had	O
some	O
abdominal	O
bloating	O
with	O
evidence	O
of	O
subcutaneous	O
emphysema	O
over	O
the	O
abdomen	O
.	O

She	O
was	O
uncomfortable	O
and	O
slow	O
to	O
have	O
bowel	O
movements	O
,	O
although	O
she	O
did	O
have	O
flatus	O
.	O

She	O
tolerated	O
a	O
full	O
diet	O
well	O
,	O
but	O
continued	O
to	O
have	O
abdominal	O
cramping	O
and	O
a	O
mild	O
ileus	O
for	O
the	O
following	O
three	O
days	O
.	O

She	O
was	O
treated	O
with	O
repeated	B-procedure
Fleet	I-procedure
&apos;s	I-procedure
enemas	I-procedure
,	O
and	O
on	O
postoperative	O
day	O
three	O
,	O
she	O
had	O
a	O
number	O
of	O
bowel	O
movements	O
,	O
was	O
considerably	O
more	O
comfortable	O
,	O
and	O
deemed	O
ready	O
for	O
discharge	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Was	O
excellent	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Included	O
aspirin	B-procedure
325	O
mg	O
PO	O
q.day	O
.	O

Percocet	B-procedure
one	O
to	O
two	O
whenever	O
necessary	O
q.	O
four	O
to	O
six	O
hours	O
for	O
pain	O
.	O

Estratab	B-procedure
one	O
PO	O
q.day	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
cytopathology	B-procedure
specimens	I-procedure
had	O
been	O
negative	O
,	O
and	O
surgical	B-procedure
pathology	I-procedure
specimens	I-procedure
were	O
still	O
pending	O
.	O

She	O
was	O
instructed	O
to	O
call	O
Dr.	O
Blinjesc	O
for	O
the	O
results	O
of	O
these	B-procedure
tests	I-procedure
and	O
to	O
follow	O
up	O
with	O
him	O
for	O
further	O
management	O
if	O
necessary	O
.	O

STA	O
BODEJOVE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

______________________________	O
LONSHI	O
OCK	O
,	O
M.D.	O

TR	O
:	O

hjr	O

DD	O
:	O

09/14/1999	O

TD	O
:	O

09/17/1999	O
2:26	O
P	O

cc	O
:	O

LONSHI	O
OCK	O
,	O
M.D.	O

cc	O
:	O

Telshey	O
K.	O
Swatlleebtik	O
,	O
M.D.	O
Rinime	O
Hawnspantkote	O
Arkansas	O

Admission	O
Date	O
:	O

2016-11-21	O

Discharge	O
Date	O
:	O

2016-11-30	O

Date	O
of	O
Birth	O
:	O

1953-10-19	O

Sex	O
:	O

M	O

Service	O
:	O

CMED	O
CCU	O

CHIEF	O
COMPLAINT	O
AND	O
HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Jackson	O
is	O
a	O
63-year-old	O
male	O
with	O
squamous	O
cell	O
carcinoma	O
of	O
the	O
floor	O
of	O
mouth	O
(	O
stage	O
T2	O
N0	O
)	O
that	O
was	O
biopsied	O
by	O
his	O
dentist	O
.	O

Pathology	B-procedure
was	O
reviewed	O
revealing	O
invasive	O
squamous	O
cell	O
carcinoma	O
.	O

He	O
presented	O
on	O
2016-11-21	O
for	O
resection	B-procedure
.	O

He	O
was	O
admitted	O
on	O
2016-11-21	O
following	O
his	B-procedure
surgery	I-procedure
.	O

He	O
underwent	O
a	B-procedure
joint	I-procedure
procedure	I-procedure
by	O
Otolaryngology	O
and	O
Plastic	O
Surgery	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Includes	O
hypertension	O
and	O
chronic	O
obstructive	O
pulmonary	O
disease	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Polypectomy	B-procedure
in	O
2011	O
,	O
tooth	B-procedure
extraction	I-procedure
(	O
all	O
)	O
in	O
1980	O
,	O
and	O
hernia	O
in	O
1977	O
.	O

ALLERGIES	O
:	O

TOMATO	O
(	O
causing	O
anaphylaxis	O
)	O
and	O
TETANUS	B-procedure
SHOT	I-procedure
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Triamterene/hydrochlorothiazide	B-procedure
37.5/25	O
mg	O
one	O
tablet	O
by	O
mouth	O
once	O
daily	O
and	O
lorazepam	B-procedure
1	O
mg	O
three	O
times	O
daily	O
as	O
needed	O
(	O
for	O
anxiety	O
)	O
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
has	O
a	O
half-pack	O
per	O
day	O
smoking	O
history	O
and	O
drinks	O
approximately	O
three	O
to	O
four	O
alcoholic	O
beverages	O
per	O
day	O
.	O

PROCEDURES	O
PERFORMED:	O

1.	O
Tracheostomy	B-procedure
.	O

2.	O
Diagnostic	B-procedure
laryngoscopy	I-procedure
and	O
biopsy	B-procedure
.	O

3.	O
Bilateral	B-procedure
supraomohyoid	I-procedure
neck	I-procedure
dissection	I-procedure
.	O

4.	O
Resection	B-procedure
of	O
floor	O
of	O
mouth	O
tumor	O
.	O

SUMMARY	O
OF	O
HOSPITAL	O
COURSE	O
:	O

Surgeon	O
was	O
Dr.	O
Kelsey	O
K	O
Sanchez	O
.	O

Assistant	O
was	O
Dr.	O
Justin	O
K..	O
Velez	O
.	O

Frozen	B-procedure
section	I-procedure
sent	O
to	O
pathology	O
revealing	O
invasive	O
squamous	O
cell	O
carcinoma	O
.	O

No	O
complications	O
.	O

The	O
Plastic	O
Team	O
then	O
took	O
over	O
for	O
reconstruction	B-procedure
consisting	O
of	O
radial	B-procedure
forearm	I-procedure
free	I-procedure
flap	I-procedure
to	O
floor	O
of	O
mouth	O
.	O

Surgeon	O
was	O
Dr.	O
Jude.	O
Christopher	O
Swinney	O
.	O

Total	B-procedure
intravenous	I-procedure
fluids	I-procedure
of	O
7300	O
cc	O
.	O

Estimated	O
blood	O
loss	O
of	O
300	O
cc	O
.	O

Urine	B-procedure
output	I-procedure
of	O
900	O
cc	O
.	O

No	O
complications	O
.	O

In	O
addition	O
,	O
the	O
patient	O
was	O
prepared	O
for	O
an	B-procedure
attempted	I-procedure
percutaneous	I-procedure
endoscopic	I-procedure
gastrostomy	I-procedure
tube	I-procedure
.	O

The	B-procedure
percutaneous	I-procedure
endoscopic	I-procedure
gastrostomy	I-procedure
was	O
unsuccessful	O
,	O
and	O
the	B-procedure
procedure	I-procedure
was	O
converted	O
to	O
an	B-procedure
open	I-procedure
gastrostomy	I-procedure
tube	I-procedure
which	O
then	O
proceeded	O
without	O
complications	O
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
postoperatively	O
.	O

He	O
was	O
sedated	O
and	O
ventilated	O
by	O
his	B-procedure
tracheostomy	I-procedure
6	I-procedure
cuff	I-procedure
Shiley	I-procedure
tube	I-procedure
.	O

He	O
had	O
three	O
Westwood-Pocasset	B-procedure
drains	I-procedure
-	O
two	O
in	O
the	O
neck	O
and	O
one	O
in	O
his	O
right	O
arm	O
.	O

G-tube	B-procedure
was	O
to	O
gravity	O
,	O
Foley	B-procedure
to	O
gravity	O
,	O
left	B-procedure
radial	I-procedure
A-line	I-procedure
.	O

The	B-procedure
flap	I-procedure
was	O
pink	O
with	O
a	B-procedure
strong	I-procedure
Doppler	I-procedure
signal	I-procedure
.	O

He	O
underwent	O
flap	B-procedure
checks	I-procedure
every	O
15	O
minutes	O
initially	O
with	O
a	B-procedure
dextran	I-procedure
infusion	I-procedure
.	O

He	O
was	O
placed	O
on	O
Unasyn	B-procedure
3	O
grams	O
IV	B-procedure
q.6h.	O

Nothing	O
by	O
mouth	O
initially	O
with	O
morphine	B-procedure
as	O
needed	O
for	O
pain	O
and	O
Ativan	B-procedure
around	O
the	O
clock	O
for	O
delirium	B-procedure
tremens	I-procedure
prophylaxis	I-procedure
.	O

In	O
addition	O
,	O
he	O
received	O
metoprolol	B-procedure
q.4.h.	O
,	O
a	B-procedure
regular	I-procedure
insulin	I-procedure
sliding	I-procedure
scale	I-procedure
,	O
and	O
adequate	O
gastrointestinal	O
prophylaxis	O
with	O
Protonix	B-procedure
.	O

Postoperative	B-procedure
laboratories	I-procedure
revealed	O
sodium	B-procedure
was	O
134	O
,	O
potassium	B-procedure
was	O
4.1	O
,	O
chloride	B-procedure
was	O
102	O
,	O
bicarbonate	B-procedure
was	O
28	O
,	O
blood	B-procedure
urea	I-procedure
nitrogen	I-procedure
was	O
18	O
,	O
creatinine	B-procedure
was	O
0.8	O
,	O
and	O
glucose	B-procedure
was	O
148	O
.	O

Calcium	B-procedure
was	O
7.6	O
.	O

Magnesium	B-procedure
was	O
2.2	O
.	O

Complete	B-procedure
blood	I-procedure
count	I-procedure
revealed	O
white	B-procedure
count	I-procedure
was	O
5.4	O
,	O
hematocrit	B-procedure
was	O
31.3	O
,	O
and	O
platelets	B-procedure
were	O
160	O
.	O

ALT	B-procedure
was	O
14	O
,	O
AST	B-procedure
was	O
31	O
,	O
alkaline	B-procedure
phosphatase	I-procedure
was	O
42	O
,	O
total	B-procedure
bilirubin	I-procedure
was	O
0.9	O
,	O
albumin	B-procedure
was	O
2.2	O
.	O

A	B-procedure
chest	I-procedure
x-ray	I-procedure
postoperatively	O
showed	O
clear	O
lung	O
fields	O
.	O

Tracheostomy	B-procedure
tube	I-procedure
in	O
good	O
position	O
.	O

No	O
pneumothorax	O
.	O

By	O
systems	O
:	O

CMED	O
CSRU	O
and	O
Plastic	O
Surgery	O
flap	B-procedure
checks	I-procedure
,	O
tracheostomy	B-procedure
care	I-procedure
,	O
and	O
Westwood-Pocasset	B-procedure
management.	I-procedure

Cardiovascular	O
:	O

Lopressor	B-procedure
5	O
intravenously	O
q.4.h.	O

Respiratory	O
:	O

Nebulizers	B-procedure
as	O
needed	O
,	O
weaning	O
from	O
ventilation	B-procedure
.	O

Gastrointestinal	O
:	O

Medications	B-procedure
per	O
gastrostomy	B-procedure
tube	I-procedure
on	O
postoperative	O
day	O
one	O
.	O

Genitourinary	O
:	O

Foley	B-procedure
catheter	I-procedure
for	O
strict	B-procedure
monitoring	I-procedure
of	I-procedure
ins	I-procedure
and	I-procedure
outs	I-procedure
.	O

Hematologic	O
:	O

Hematocrit	B-procedure
stable	O
.	O

Infectious	O
Disease	O
:	O

Unasyn	B-procedure
for	O
antibiotic	B-procedure
coverage	I-procedure
.	O

Flap	B-procedure
checks	I-procedure
carried	O
out	O
q.2h.	O
initially	O
in	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
showing	O
positive	O
biphasic	O
Doppler	O
signals	O
.	O

Pink	O
flap	O
with	O
good	O
refill	O
.	O

Right	O
arm	O
neurovascularly	O
intact	O
.	O

He	O
was	O
weaned	O
from	O
ventilation	B-procedure
on	O
postoperative	O
day	O
one	O
to	O
pressure	B-procedure
support	I-procedure
ventilation	I-procedure
and	O
then	O
to	O
spontaneous	O
breathing	O
on	O
postoperative	O
day	O
two	O
.	O

His	B-procedure
Westwood-Pocasset	I-procedure
output	I-procedure
for	O
postoperative	O
day	O
one	O
on	O
the	O
left	O
was	O
60	O
,	O
right	O
neck	O
93	O
,	O
in	O
the	O
arm	O
20	O
.	O

Tube	B-procedure
feedings	I-procedure
were	O
started	O
48	O
hours	O
after	O
the	B-procedure
procedure	I-procedure
.	O

The	O
cuff	O
on	O
his	B-procedure
tracheostomy	I-procedure
tube	I-procedure
was	O
put	O
down	O
on	O
11-23	O
,	O
postoperative	O
day	O
two	O
which	O
he	O
tolerated	O
well	O
with	O
minimal	O
secretions	O
and	O
a	O
strong	O
adequate	O
cough	O
.	O

Due	O
to	O
bed	O
issues	O
,	O
he	O
was	O
transferred	O
from	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
on	O
postoperative	O
day	O
three	O
.	O

His	B-procedure
tube	I-procedure
feedings	I-procedure
were	O
advanced	O
.	O

He	O
was	O
out	O
of	O
bed	O
to	O
a	O
chair	O
.	O

He	O
continued	O
with	O
pulmonary	B-procedure
toilet	I-procedure
and	O
q.2h.	B-procedure
flap	I-procedure
checks	I-procedure
.	O

The	B-procedure
Westwood-Pocasset	I-procedure
in	I-procedure
his	I-procedure
right	I-procedure
arm	I-procedure
was	O
removed	O
on	O
2016-11-25	O
.	O

His	B-procedure
tracheostomy	I-procedure
was	O
changed	O
to	O
a	B-procedure
6	I-procedure
cuffless	I-procedure
Shiley	I-procedure
on	O
2016-11-26	O
and	O
sutures	B-procedure
in	O
place	O
with	O
a	B-procedure
3-0	I-procedure
silk	I-procedure
.	O

The	O
patient	O
tolerated	O
this	B-procedure
procedure	I-procedure
well	O
.	O

This	O
is	O
the	O
end	O
of	O
part	O
1	O
of	O
this	O
dictation	O
summary	O
for	O
Patricia	O
Jackson	O
.	O

To	O
be	O
continued	O
in	O
a	O
separate	O
dictation	O
.	O

Nola	O
Daniel	O
,	O
Hawaii	O
31699	O

Dictated	O
By:Joe	O
C.	O
Roa	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O

2016-11-30	O
10:56:11	O

T	O
:	O

2016-11-30	O
11:44:01	O

Job#	O
:	O

77004	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Michael	O
Z	O
Waldroup	O
on	O
:	O

MON	O
2016-12-19	O
10:13	O
AM	O

(	O
End	O
of	O
Report	O
)	O

095889687	O
WGH	O

9786774	O

224527	O

311732	O

10/24/2001	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

SOURS	O
,	O
NANONIFF	O
ELLMI	O

MRN	O
:	O

9786774	O

Age	O
:	O

31y	O

REGISTRATION	O
DATE	O
:	O

10/24/2001	O
07:57	O
AM	O

Provider	O
:	O

LICHEREANYVE	O
CHIRDKOTEKERTH	O

PRELIMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

10/24/2001	O
10:07	O

Discharge	O
Status	O
:	O

Discharged	O
Condition	O
on	O
Discharge	O
:	O

Stable	O
Patient	O
States	O
Complaint	O
:	O

SWOLLEN	O
PAINFUL	O
L	O
SIDE	O
FC	O

Diagnosis	O
:	O

L	O
upper	O
lip	O
/	O
L	O
nostril	O
abscess	O

Treatment	O
Rendered	O
:	O

5	O
cc	O
of	O
purulent	O
material	O
drained	O
by	O
needle	B-procedure
aspiration	I-procedure

Discharge	O
Medications	O
:	O

Augmentin	B-procedure
875	O
mg	O
twice	O
a	O
day	O
for	O
10	O
days	O
.	O

Follow	O
up	O
Service	O
:	O

Please	O
see	O
your	O
PCP	O
in	O
follow	O
up	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Return	O
immediately	O
for	O
worsening	O
signs	O
of	O
infection	O
(	O
increased	O
swelling	O
,	O
pain	O
,	O
redness	O
)	O
or	O
for	O
any	O
neurologic	O
changes	O
(	O
blurry	O
or	O
double	O
vision	O
,	O
headaches	O
,	O
trouble	O
walking	O
,	O
etc	O
)	O
.	O

PCP	O
Name	O
:	O

CLEV	O
,	O
NISHA	O

Provider	O
Number	O
:	O

53476	O

This	O
report	O
was	O
created	O
by	O
CHIRDKOTEKERTH	O
,	O
LICHEREANYVE	O
10/24/2001	O
10:09	O
AM	O

115026438	O
SC	O

23754357	O

049885	O

8/25/2002	O
12:00:00	O
AM	O

s	O
/	O
p	O
NSVD	O

DIS	O

Admission	O
Date	O
:	O

08/25/2002	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

08/27/2002	O

******	O
DISCHARGE	O
ORDERS	O
******	O

HEMPWIERST	O
,	O
E	O

904-74-17-7	O
Z57	O

Room	O
:	O

FXP2-288	O

Service	O
:	O

OBS	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

08/27/02	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

HO	B-procedure
evaluation	I-procedure

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

BAWNREEF	O
,	O
CENTEKANEELD	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

DOCUSATE	B-procedure
SODIUM	I-procedure
100	O
MG	O
PO	O
BID	O
PRN	O
IBUPROFEN	B-procedure
200-600	O
MG	O
PO	O
Q4-6H	O
PRN	O
PAIN	O

DIET	O
:	O

No	O
Restrictions	O

Activity	O
-	O
As	O
tolerated	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

OB	O
Clinic	O
2	O
weeks	O
and	O
6	O
weeks	O
,	O
No	O
Known	O
Allergies	O

ADMIT	O
DIAGNOSIS	O
:	O

postdates	O
pregnancy	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
s	O
/	O
p	O
NSVD	O

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

none	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Primary	O
Anesthesia	O
:	O

Epidural	O
Secondary	O
Anesthesia	O
:	O

Local	O
Vaginal	O
delivery	O
:	O

Spontaneous	O
Episiotomy	O
:	O

Median	O
Placenta	O
:	O

Delivery	O
:	O

Manual	O
Condition	O
:	O

Normal	O
Delivering	O
Resident	O
/	O
Staff	O
:	O

GOINGNETHBUMPS	O
,	O
NANSO	O
R.	O
,	O
M.D.	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G2	O
T0	O
P0	O
A1	O
L0	O
Estimated	O
EDC	O
:	O

02/03/02	O

Indications	O
for	O
induction	O
:	O

Post	O
dates	O

Maternal	O
transfer	O
:	O

No	O

Initial	B-procedure
newborn	I-procedure
exam	I-procedure
:	O

No	O
observed	O
abnormalities	O

Baby	O
1	O

MRN	O
:	O

70632019	O

Delivery	O
date	O
:	O

02/13/02	O
01:20	O
AM	O

Apgars	B-procedure
8,9	O

Weight	B-procedure
:	O

9lb	O
4	O
oz	O
4196	O
grams	O

Sex	O
:	O

Female	O

ADDITIONAL	O
COMMENTS	O
:	O

Nothing	O
in	O
the	O
vagina	O
for	O
6	O
weeks	O
-	O
no	O
tampons	B-procedure
,	O
no	O
douching	B-procedure
,	O
no	O
intercourse	O
.	O

If	O
you	O
experience	O
fever	O
&gt;	O
100.4	O
,	O
bleeding	O
&gt;	O
1	O
pad	O
/	O
hour	O
,	O
foul	O
smelling	O
discharge	O
,	O
abdominal	O
pain	O
,	O
or	O
other	O
worrisome	O
symptoms	O
,	O
please	O
call	O
your	O
doctor	O
or	O
return	O
to	O
the	O
hospital	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

GOINGNETHBUMPS	O
,	O
NANSO	O
R.	O
,	O
M.D.	O
(	O
HK18	O
)	O
02/14/02	O
08:39	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

412141256	O

FIH	O

3833231	O

39626/6vf7	O

817292	O

10/3/1994	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

10-03-94	O

DISCHARGE	O
DATE	O
:	O

10-06-94	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
85	O
year	O
old	O
man	O
was	O
admitted	O
because	O
of	O
the	O
new	O
onset	O
of	O
focal	O
left-sided	O
seizure	O
and	O
unresponsiveness	O
.	O

He	O
had	O
a	O
past	O
history	O
of	O
ischemic	O
cardiomyopathy	O
with	O
an	B-procedure
ejection	I-procedure
fraction	I-procedure
of	O
10	O
,	O
mild	O
aortic	O
stenosis	O
and	O
a	O
right	O
middle	O
cerebral	O
artery	O
territory	O
stroke	O
in	O
07/94	O
.	O

He	O
was	O
at	O
Orlak	O
on	O
the	O
day	O
of	O
admission	O
and	O
was	O
found	O
unresponsive	O
with	O
left	O
tonic-clonic	O
movements	O
,	O
greater	O
in	O
the	O
arms	O
than	O
in	O
the	O
legs	O
.	O

He	O
was	O
transferred	O
to	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
,	O
where	O
seizures	O
were	O
stopped	O
with	O
2	O
mg	O
of	O
Ativan	B-procedure
.	O

He	O
was	O
loaded	O
with	O
IV	B-procedure
Dilantin	I-procedure
.	O

He	O
remained	O
unresponsive	O
with	O
poor	O
airway	O
protection	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Eyes	O
were	O
deviated	O
to	O
the	O
left	O
.	O

He	O
was	O
flaccid	O
bilaterally	O
.	O

He	O
had	O
no	O
oculocephalic	O
reflexes	O
.	O

After	O
one	O
hour	O
his	O
eyes	O
were	O
midline	O
and	O
he	O
remained	O
unresponsive	O
.	O

HOSPITAL	O
COURSE	O
:	O

By	O
the	O
patient	O
and	O
his	O
family	O
&apos;s	O
prior	O
wishes	O
,	O
the	O
patient	O
was	O
extubated	O
.	O

An	B-procedure
electroencephalogram	I-procedure
revealed	O
generalized	O
slowing	O
without	O
ictal	O
events	O
.	O

He	O
had	O
no	O
carotid	O
bruits	O
.	O

He	O
had	O
stertorous	O
breathing	O
,	O
positional	O
tremors	O
of	O
the	O
left	O
upper	O
extremity	O
,	O
a	O
spastic	O
left	O
hemiparesis	O
in	O
flexion	O
.	O

He	O
withdrew	O
both	O
legs	O
to	O
painful	B-procedure
stimuli	I-procedure
.	O

The	O
right	O
upper	O
extremity	O
was	O
flaccid	O
and	O
paresthetic	O
.	O

Again	O
,	O
comfort	O
measures	O
only	O
were	O
undertaken	O
as	O
per	O
the	O
patient	O
&apos;s	O
previous	O
wishes	O
and	O
the	O
family	O
&apos;s	O
current	O
insistence	O
.	O

At	O
1:15	O
PM	O
on	O
10/06/94	O
,	O
the	O
patient	O
was	O
found	O
unresponsive	O
with	O
no	O
heart	O
sounds	O
,	O
carotid	O
pulse	O
,	O
respiratory	O
excursions	O
,	O
or	O
pupillary	O
reactions	O
.	O

His	O
family	O
was	O
notified	O
.	O

Consent	O
for	O
autopsy	B-procedure
was	O
denied	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Left	O
middle	O
cerebral	O
artery	O
territory	O
cerebral	O
infarction	O
.	O

2.	O
Cardiomyopathy	O
.	O

3.	O
Residual	O
of	O
previous	O
right	O
middle	O
cerebral	O
artery	O
stroke	O
.	O

RE	O
RHALTFETHFONGPOCE	O
,	O
M.D.	O

TR	O
:	O

cnm	O
/	O
bmot	O

DD	O
:	O

10-18-94	O

TD	O
:	O

10/19/94	O

CC	O
:	O

Admission	O
Date	O
:	O

2013-11-21	O

Discharge	O
Date	O
:	O

2013-11-26	O

Date	O
of	O
Birth	O
:	O

1949-07-18	O

Sex	O
:	O

F	O

Service	O
:	O

PLASTIC	O

Allergies	O
:	O

Trazodone	B-procedure
/	O
Ambien	B-procedure
/	O
Sinequan	B-procedure

Attending	O
:	O
Bobby	O
Z.S.	O
Ruiz	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

ACQUIRED	O
DEFECT	O
FROM	O
BASAL	B-procedure
CELL	I-procedure
CARCINOMA	I-procedure
RESECTION	I-procedure

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

RIGHT	B-procedure
NOSE	I-procedure
/	I-procedure
ALA	I-procedure
RECONSTRUCTION	I-procedure
USING	O
RIGHT	B-procedure
CHEEK	I-procedure
ADVANCEMENT	I-procedure
AND	O
FOREHEAD	B-procedure
LOCAL	I-procedure
FLAP	I-procedure

History	O
of	O
Present	O
Illness	O
:	O

MS.	O
Marshall	O
IS	O
A	O
64-YEAR	O
OLD	O
,	O
MENTALLY	O
RETARDED	O
,	O
FEMALE	O
WHO	O
PRESENTED	O
WITH	O
AN	O
AQUIRED	O
DEFECT	O
OF	O
THE	O
RIGHT	O
NASAL	O
ALA	O
AND	O
MEDIAL	O
CHEEK	O
REGION	O
AFTER	O
BASAL	O
CELL	O
CARCINOMA	O
WAS	O
RESECTED	O
BY	O
DERMATOLOGY	O
.	O

Past	O
Medical	O
History	O
:	O

MENTAL	O
RETARDATION	O

DIABETES	O

BIPOLAR	O
DISORDER	O

Social	O
History	O
:	O

LIVES	O
IN	O
A	O
NURSING	O
HOME	O
,	O
HAS	O
A	O
BROTHER	O
WHO	O
IS	O
THE	O
HEALTH	O
CARE	O
PROXY	O
.	O

NO	O
Tifany	O
,	O
ETOH	O
,	O
OR	O
REC	O
DRUG	O
USE	O
.	O

Physical	O
Exam	O
:	O

ON	O
PRESENTATION	O
,	O
PT	O
WAS	O
AFEBRILE	O
WITH	O
NORMAL	O
VITAL	O
SIGNS	O

GEN	O
:	O
NO	O
ACUTE	O
DISTRESS	O
,	O
ABLE	O
TO	O
COMMUNICATE	O
AND	O
FOLLOW	O
ORDERS	O

HEAD	O
AND	O
NECK	O
:	O
5	O
CM	O
CIRCULAR	O
FULL	O
THICKNESS	O
DEFECT	O
AT	O
THE	O
JUNCTION	O
OF	O
THE	O
RIGHT	O
ALA	O
AND	O
CHEEK	O

HEART	O
:	O
REGULAR	O
RATE	O
AND	O
RHYTHM	O

LUNGS	O
:	O
CLEAR	O
TO	O
ASCULATION	B-procedure

ABDOMEN	O
:	O
SOFT	O
,	O
NON-TENDER	O
,	O
NON-DISTENDED	O

EXTREMITIES	O
:	O
NO	O
EDEMA	O
,	O
CYANOSIS	O
,	O
FULL	O
RANGE	O
OF	O
MOTION	O

Brief	O
Hospital	O
Course	O
:	O

UPON	O
ADMISSION	O
,	O
THE	O
PATIENT	O
WAS	O
PRE-OP	O
'D	O
AND	O
MADE	O
NPO	B-procedure
/	O
IVF	B-procedure
.	O

SHE	O
WENT	O
TO	O
SURGERY	B-procedure
THE	O
NEXT	O
MORNING	O
AND	O
TOLERATED	O
THE	B-procedure
SURGERY	I-procedure
WELL	O
.	O

HOWEVER	O
,	O
SHE	O
WAS	O
SLOW	O
TO	O
AWAKE	O
FROM	O
ANESTHESIA	B-procedure
,	O
AND	O
WAS	O
ADMITTED	O
TO	O
THE	O
CMED	O
CCU	O
OBSERVATION	B-procedure
.	O

SHE	O
WAS	O
TRANSFERED	O
TO	O
THE	O
FLOOR	O
POST-OP	O
DAY	O
2	O
WHERE	O
SHE	O
HAD	O
BEEN	O
AFEBRILE	O
WITH	O
NORMAL	O
VITALS	O
,	O
MAKING	O
GOOD	O
URINE	O
,	O
AND	O
TOLERATING	O
A	O
REGULAR	O
DIET	O
.	O

HER	O
WOUND	O
HAS	O
REMAIND	O
DRY	O
AND	O
CLOSED	O
,	O
WITHOUT	O
EVIDENCE	O
OF	O
INFECTION	O
OR	O
BREAKDOWN	O
.	O

SHE	O
HAS	O
BEEN	O
WATCHED	O
BY	O
A	O
SITTER	O
AT	O
ALL	O
TIMES	O
.	O

SHE	O
WILL	O
BE	O
DISCHARGED	O
TODAY	O
BACK	O
TO	O
HER	O
NURSING	O
HOME	O
IN	O
GOOD	O
CONDITION	O
,	O
ON	O
PAIN	B-procedure
MEDS	I-procedure
,	O
ANTIBIOTICS	B-procedure
,	O
AND	O
WITH	O
ANTICIPATED	O
1:1	O
WATCH	O
.	O

SHE	O
WILL	O
FOLLOW	O
UP	O
WITH	O
DR.	O
Karen	O
IN	O
1	O
WEEK	O
.	O

STAGE	O
TWO	O
OF	O
HER	B-procedure
SURGERY	I-procedure
WILL	O
BE	O
DONE	O
IN	O
3	O
WEEKS	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Paroxetine	B-procedure
HCl	I-procedure
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
AM	O
().	O

2.	O
Multivitamin	B-procedure
Capsule	I-procedure
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
PO	O
QAM	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
morning	O
)).	O

3.	O
Divalproex	B-procedure
Sodium	I-procedure
500	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
QAM	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
morning	O
)).	O

4.	O
Docusate	B-procedure
Sodium	I-procedure
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
:	O
constipation	O
.	O

Disp	O
:*	O
30	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Triamcinolone	B-procedure
Acetonide	I-procedure
0.1	O
%	O
Cream	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

6.	O
Divalproex	B-procedure
Sodium	I-procedure
Oral	O

7.	O
Atorvastatin	B-procedure
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O

8.	O
Oxybutynin	B-procedure
Chloride	I-procedure
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
QPM	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
evening	O
)).	O

9.	O
Hydrocodone-Acetaminophen	B-procedure
5-500	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
).	O

Disp	O
:*	O
40	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

10.	O
Bacitracin-Polymyxin-Neosp	B-procedure
HC	I-procedure
Ointment	I-procedure
Sig	O
:	O
One	O
(	O
1	O
)	O
Topical	O
three	O
times	O
a	O
day	O
.	O

Disp	O
:*	O
1	O
500	O
/	O
gram	O
*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

AQUIRED	O
DEFORMITY	O
OF	O
THE	O
RIGHT	O
ALA	O
/	O
NOSE	O
AND	O
MEDIAL	O
CHEEK	O
FROM	O
BASAL	B-procedure
CELL	I-procedure
CARCINOMA	I-procedure
RESECTION	I-procedure

Discharge	O
Condition	O
:	O

GOOD	O

Discharge	O
Instructions	O
:	O

PLEASE	O
GIVE	O
PATIENT	O
MEDICATIONS	B-procedure
AS	O
PRESCRIBED	O
AND	O
READ	O
WARNING	O
LABELS	O
CAREFULLY	O
.	O

IF	O
SIGNS	O
AND	O
SYMPTOMS	O
OF	O
INFECTION	O
,	O
SUCH	O
AS	O
FEVERS	O
/	O
CHILLS	O
,	O
PURULENT	O
DISCHARGE	O
FROM	O
WOUND	O
/	O
INCISION	O
SITE	O
,	O
INCREASED	O
REDNESS	O
,	O
INCREASED	O
PAIN	O
,	O
PLEASE	O
CALL	O
OR	O
GO	O
TO	O
THE	O
EMERGENCY	O
ROOM	O
.	O

REMEMBER	O
TO	O
CALL	O
TO	O
SCHEDULE	O
HER	O
FOLLOW	O
UP	O
APPOINTMENT	O
(	O
BELOW	O
).	O

LIGHT	O
ACTIVITIES	O
UNTIL	O
SEEN	O
IN	O
CLINIC	O
.	O

STAGE	O
2	O
OF	O
THE	B-procedure
SURGERY	I-procedure
WILL	O
BE	O
DONE	O
IN	O
3	O
WEEKS	O
.	O

MAY	O
SHOWER	O
--	O
DAB	O
DRY	O
,	O
DO	O
NOT	O
SCRUB	O
.	O

PLEASE	O
CLEAN	O
INCISION	O
SITE	O
WITH	O
NORMAL	B-procedure
SALINE	I-procedure
OR	O
CLEAN	O
WATER	O
THREE	O
TIMES	O
A	O
DAY	O
AND	O
PLACE	O
ANTIBIOTIC	B-procedure
OINTMENT	I-procedure
(	O
GIVEN	O
)	O
ON	O
TOP	O
OF	O
WOUND	O
.	O

PLEASE	O
KEEP	O
PATIENT	O
AWAY	O
FROM	O
THE	O
SUN	O
.	O

MOST	O
IMPORTANTLY	O
,	O
THE	O
PATIENT	O
MUST	O
BE	O
WATCH	O
ONE-ON-ONE	O
SO	O
THAT	O
SHE	O
DOES	O
NOT	O
PICK	O
AT	O
HER	O
WOUND	O
.	O

Followup	O
Instructions	O
:	O

PLEASE	O
CALL	O
DR.Parson	O
OFFICE	O
FOR	O
A	O
FOLLOW	O
UP	O
(	O
989-5361	O
Mauricio	O
(	O
540-4644	O

Nancy	O
Lois	O
MD	O
88-449	O

Completed	O
by	O
:	O
Mary	O
Lisa	O
MD	O
53-914	O
2013-11-26	O
@	O
1134	O

Signed	O
electronically	O
by	O
:	O
DR.	O
David	O
Randazzo	O
on	O
:	O
MON	O
2013-12-16	O
7:25	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2014-02-21	O

Discharge	O
Date	O
:	O

2014-03-25	O

Date	O
of	O
Birth	O
:	O

1928-07-25	O

Sex	O
:	O

F	O

Service	O
:	O

SURGERY	O

Allergies	O
:	O

Sulfa	B-procedure
(	I-procedure
Sulfonamides	I-procedure
)	I-procedure

Attending	O
:	O
Mattie	O
R.	O
A.	O
Hamilton	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Nausea	O
,	O
vomiting	O
,	O
Abdominal	O
pain	O
,	O
distention	O
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

1.	O
Subtotal	B-procedure
colectomy	I-procedure
,	O
end	B-procedure
ileostomy	I-procedure
,	O
Hartmann's	B-procedure
pouch	I-procedure
,	O
G-tube	B-procedure

2.	O
Completion	B-procedure
sigmoid	I-procedure
colectomy	I-procedure
,	O
repair	B-procedure
of	O
colovesicular	O
fistula	O
,	O
small	B-procedure
bowel	I-procedure
repair	I-procedure

History	O
of	O
Present	O
Illness	O
:	O

Ms	O
Crossman	O
is	O
an	O
84	O
year	O
old	O
female	O
with	O
complaints	O
of	O
abdominal	O
pain	O
,	O
diarrhea	O
,	O
nausea	O
and	O
vomiting	O
x	O
1	O
week	O
,	O
who	O
presented	O
to	O
an	O
outside	O
hospital	O
.	O

She	O
was	O
transferred	O
to	O
Arbour	O
Hospital	O
on	O
2015-02-21	O
for	O
bowel	O
obstruction	O
,	O
ischemia	O
and	O
worsening	O
abdominal	O
distention	O
and	O
pain	O
.	O

Past	O
Medical	O
History	O
:	O

CAD	O
s/p	O
MI	O
,	O
HTN	O
,	O
DMII	O

Social	O
History	O
:	O

Lives	O
independently	O
,	O
but	O
in	O
the	O
same	O
building	O
with	O
daughter	O
.	O

Amy	O
3	O
children	O
,	O
2	O
daughters	O
and	O
1	O
son	O
.	O

Daughter	O
Lurline	O
is	O
Durable	O
Power	O
of	O
Attorney	O
.	O

The	O
other	O
daughter	O
was	O
recently	O
in	O
a	O
car	O
accident	O
and	O
underwent	O
surgery	B-procedure
at	O
Saint	O
Vincent	O
Hospital	O
.	O

Family	O
History	O
:	O

NC	O

Physical	O
Exam	O
:	O

At	O
time	O
of	O
discharge	O
:	O

Afebrile	O
,	O
VSS	O

A&O	O
X	O
3	O
,	O
NAD	O

RRR	O

CTAB	O
,	O
mildly	O
decreased	O
breath	O
sounds	O
b/l	O

Abd	O
soft	O
,	O
NT/ND	O
,	O
+	O
bs	O
,	O
no	O
masses	O
,	O
ostomy	B-procedure
in	I-procedure
RLQ	I-procedure
pink	O
,	O
with	O
stool	O

G-tube	B-procedure
in	O
place	O

LE	O
trace	O
edema	O

Pertinent	O
Results	O
:	O

2014-02-21	O
12:20	O
PM	O
BLOOD	B-procedure
WBC	B-procedure
-	O
10.2	O
RBC	B-procedure
-	O
5.32	O
Hgb	B-procedure
-	O
14.9	O
Hct	B-procedure
-	O
43.4	O
MCV	B-procedure
-	O
82	O
MCH	B-procedure
-	O
28.0	O
MCHC	B-procedure
-	O
34.4	O
RDW	B-procedure
-	O
16.0	O
*	O
Plt	B-procedure
Ct	I-procedure
-	O
204	O

2014-02-21	O
12:20	O
PM	O
BLOOD	B-procedure
PT	B-procedure
-	O
12.9	O
PTT	B-procedure
-	O
32.5	O
INR(PT)	B-procedure
-	O
1.1	O

2014-02-21	O
12:20	O
PM	O
BLOOD	B-procedure
Glucose	B-procedure
-	O
345	O
*	O
UreaN	B-procedure
-	O
34	O
*	O
Creat	B-procedure
-	O
1.0	O
Na	B-procedure
-	O
137	O
K	B-procedure
-	O
4.3	O
Cl	B-procedure
-	O
99	O
HCO3	B-procedure
-	O
24	O
AnGap	B-procedure
-	O
18	O

2014-02-21	O
12:20	O
PM	O
BLOOD	B-procedure
ALT	B-procedure
-	O
17	O
AST	B-procedure
-	O
27	O
AlkPhos	B-procedure
-	O
119	O
*	O
Amylase	B-procedure
-	O
27	O
TotBili	B-procedure
-	O
0.9	O

2014-02-21	O
12:20	O
PM	O
BLOOD	B-procedure
Lipase	B-procedure
-	O
11	O

2014-02-21	O
12:20	O
PM	O
BLOOD	B-procedure
CK-MB	B-procedure
-	O
7	O
cTropnT	B-procedure
-<	O
0.01	O

2014-03-09	O
02:59	O
AM	O
BLOOD	B-procedure
cTropnT	B-procedure
-	O
0.21	O
*	O

2014-03-09	O
11:29	O
AM	O
BLOOD	B-procedure
CK-MB	B-procedure
-	O
35	O
*	O
MB	B-procedure
Indx	I-procedure
-	O
25.5	O
*	O
cTropnT	B-procedure
-	O
0.45	O
*	O

2014-03-09	O
07:52	O
PM	O
BLOOD	B-procedure
CK-MB	B-procedure
-	O
NotDone	O
cTropnT	B-procedure
-	O
0.55	O
*	O

2014-03-10	O
05:25	O
PM	O
BLOOD	B-procedure
cTropnT	B-procedure
-	O
0.42	O
*	O

2014-03-11	O
02:00	O
AM	O
BLOOD	B-procedure
cTropnT	B-procedure
-	O
0.45	O
*	O

2014-03-19	O
07:13	O
AM	O
BLOOD	B-procedure
CK-MB	B-procedure
-	O
3	O
cTropnT	B-procedure
-	O
0.19	O
*	O

2014-03-19	O
01:33	O
PM	O
BLOOD	B-procedure
CK-MB	B-procedure
-	O
NotDone	O
cTropnT	B-procedure
-	O
0.17	O
*	O

2014-03-21	O
09:58	O
AM	O
BLOOD	B-procedure
CK-MB	B-procedure
-	O
NotDone	O
cTropnT	B-procedure
-	O
0.06	O
*	O

03-07	O
wound	B-procedure
swab	I-procedure
:	O
VRE	O

CT	B-procedure
Abd	I-procedure
02-21	O
:	O

1.	O
Markedly	O
dilated	O
colon	O
throughout	O
ascending	O
,	O
transverse	O
,	O
and	O
descending	O
colon	O
with	O
air-fluid	O
levels	O
,	O
overall	O
unchanged	O
since	O
prior	B-procedure
study	I-procedure
performed	O
on	O
the	O
same	O
day	O
with	O
pneumatosis	O
in	O
the	O
ascending	O
colon	O
.	O

Sigmoid	O
diverticulosis	O
with	O
focal	O
narrowing	O
of	O
the	O
sigmoid	O
colon	O
just	O
distal	O
to	O
the	O
dilatation	O
with	O
wall	O
thickening	O
,	O
due	O
to	O
diverticulitis	O
.	O

This	O
area	O
can	O
be	O
a	O
leading	O
point	O
of	O
obstruction	O
.	O

An	O
underlying	O
mass	O
lesion	O
or	O
cancer	O
cannot	O
be	O
excluded	O
in	O
this	O
area	O
,	O
and	O
further	B-procedure
clinical	I-procedure
investigation	I-procedure
is	O
recommended	O
.	O

2.	O
Limited	B-procedure
evaluation	I-procedure
for	O
known	O
sigmoid-vesicle	O
fistula	O
.	O

3.	O
Small	O
amount	O
of	O
ascites	O
,	O
somewhat	O
increased	O
anterior	O
to	O
the	O
liver	O
.	O

4.	O
Bilateral	O
renal	O
cysts	O
.	O

5.	O
Heavy	O
calcification	O
of	O
the	O
aorta	O
and	O
SMA	O
and	O
its	O
branches	O
.	O

Due	O
to	O
atherosclerosis	O
,	O
assessment	B-procedure
of	I-procedure
the	I-procedure
intraluminal	I-procedure
process	I-procedure
of	O
these	O
branches	O
is	O
limited	O
.	O

CTA/CT	B-procedure
abd	I-procedure
03-07	O
:	O

1.	O
No	O
evidence	O
of	O
pulmonary	O
embolism	O
.	O

Small	O
bilateral	O
pleural	O
effusions	O
with	O
compressive	O
atelectasis	O
.	O

2.	O
Left	O
lower	O
quadrant	O
thick-walled	O
peripherally	O
enhancing	O
fluid	O
collection	O
,	O
which	O
appears	O
to	O
communicate	O
with	O
the	O
sutured	O
end	O
of	O
the	O
proximal	O
sigmoid	O
colon	O
via	O
a	O
small	O
collection	O
of	O
extraluminal	O
gas	O
.	O

In	O
the	O
correct	O
clincial	O
setting	O
,	O
this	O
could	O
be	O
consistent	O
with	O
an	O
abscess	O
.	O

3.	O
Moderate	O
intraabdominal	O
ascites	O
.	O

4.	O
Status	O
post	O
ileostomy	B-procedure
without	O
evidence	O
of	O
small-bowel	O
obstruction	O
.	O

5.	O
Distended	O
gallbladder	O
.	O

6.	O
Diverticulosis	O
within	O
the	O
right	O
remnant	O
sigmoid	O
colon	O
.	O

03-21	O
VCUG	B-procedure
-	O
no	O
leak	O

Brief	O
Hospital	O
Course	O
:	O

Ms	O
Crossman	O
was	O
admitted	O
on	O
2015-02-21	O
from	O
an	O
outside	O
hospital	O
to	O
the	O
ICU	O
.	O

Neuro	O
:	O
Developed	O
confusion	O
during	O
her	O
first	O
5	O
days	O
in	O
the	O
ICU	O
.	O

Post-operatively	O
mental	O
status	O
improved	O
.	O

Intermitent	O
delirium	O
throughout	O
admission	O
.	O

Required	O
restraints	B-procedure
to	O
prevent	O
DC	O
of	O
pertinent	B-procedure
therapies	I-procedure
while	O
in	O
the	O
ICU	O
.	O

Currently	O
AAOx3	O
.	O

Cardiovascular	O
:	O
Complained	O
of	O
chest	O
pain	O
during	O
first	O
few	O
days	O
of	O
admission	O
,	O
a	O
cardiology	O
consult	O
was	O
obtained	O
.	O

She	O
recieved	O
serial	B-procedure
enzymes	I-procedure
and	O
EKGs	B-procedure
.	O

Troponins	B-procedure
remained	O
mildly	O
elevated	O
as	O
high	O
as	O
0.6	O
throughout	O
her	O
admission	O
,	O
and	O
most	O
recent	O
result	O
now	O
0.1	O
.	O

She	O
was	O
treated	O
in	O
IUC	O
for	O
unstable	O
angina	O
with	O
nitroglycerin	B-procedure
.	O

It	O
was	O
recommended	O
to	O
maximize	O
her	B-procedure
medical	I-procedure
treatment	I-procedure
with	O
Beta	B-procedure
blockers	I-procedure
,	O
aspirin	B-procedure
,	O
a	B-procedure
statin	I-procedure
and	O
an	B-procedure
ACE	I-procedure
Inhibitor	I-procedure
.	O

Required	O
diuresis	B-procedure
of	O
>	O
9	O
L	O
while	O
in	O
the	O
ICU	O
,	O
after	O
2nd	B-procedure
surgery	I-procedure
.	O

Continues	O
to	O
have	O
trace	O
lower	O
extremity	O
edema	O
,	O
and	O
recieves	O
lasix	B-procedure
po	I-procedure
.	O

Respiratory	O
:	O
She	O
was	O
intubated	B-procedure
briefly	O
post-op	O
subtotal	B-procedure
colectomy	I-procedure
and	O
again	O
for	O
several	O
days	O
after	O
second	B-procedure
surgery	I-procedure
.	O

Recieved	O
nebulizer	B-procedure
treatments	I-procedure
post-op	O
in	O
the	O
ICU	O
,	O
after	O
successfully	O
extubated	O
.	O

Gastrointestinal	O
:	O
Her	B-procedure
initial	I-procedure
CT	I-procedure
scan	I-procedure
showed	O
dilated	O
Turner	O
colon	O
,	O
wall	O
thickening	O
and	O
pneumatosis	O
see	O
pertinent	O
results	O
.	O

She	O
was	O
initially	O
treated	O
nonoperatively	O
with	O
IV	B-procedure
fluids	I-procedure
,	O
antibiotics	B-procedure
,	O
serial	B-procedure
exams	I-procedure
and	O
NGT	B-procedure
decompression	I-procedure
.	O

On	O
HD#5	O
flexible	B-procedure
sigmoidoscopy	I-procedure
was	O
performed	O
for	O
colonic	B-procedure
decompression	I-procedure
.	O

On	O
HD#6	O
,	O
colonscopy	B-procedure
was	O
performed	O
for	O
decompression	B-procedure
,	O
and	O
revealed	O
pseudomembrane	O
and	O
friable	O
colonic	O
tissue	O
.	O

Her	O
abdomen	O
remained	O
tender	O
and	O
distended	O
despite	O
attempted	O
decompression	B-procedure
.	O

She	O
was	O
taken	O
to	O
the	O
OR	O
for	O
Subtotal	B-procedure
Colectomy	I-procedure
,	O
G	B-procedure
tube	I-procedure
and	O
ileostomy	B-procedure
due	O
to	O
unresponsiveness	O
to	O
non-operative	B-procedure
treatment	I-procedure
.	O

Ileostomy	B-procedure
remains	O
pink	O
and	O
intact	O
,	O
draining	O
green-brown	O
soft	O
stool	O
.	O

Her	O
post-operative	O
course	O
continued	O
uneventfully	O
in	O
the	O
ICU	O
,	O
and	O
she	O
was	O
transferred	O
to	O
the	O
floor	O
POD#6	O
.	O

She	O
developed	O
additional	O
abdominal	O
tenderness	O
and	O
distention	O
.	O

Her	B-procedure
HCT	I-procedure
dropped	O
and	O
she	O
recieved	O
1	B-procedure
unit	I-procedure
PRBCs	I-procedure
.	O

Geriatric	O
consult	O
was	O
obtained	O
to	O
assist	O
with	O
management	O
.	O

On	O
POD#8	O
a	B-procedure
CT	I-procedure
scan	I-procedure
was	O
obtained	O
which	O
revealed	O
an	O
abcess	O
with	O
a	O
colovesicular	O
fistula	O
.	O

She	O
was	O
taken	O
to	O
the	O
OR	O
for	O
exploration	B-procedure
and	O
drainage	B-procedure
.	O

She	O
recieved	O
further	B-procedure
resection	I-procedure
of	I-procedure
remaining	I-procedure
colon	I-procedure
,	O
repair	B-procedure
of	O
a	O
leak	O
from	O
Relaford	O
pouch	O
and	O
repair	B-procedure
of	O
colovesicular	O
fistula	O
.	O

After	O
her	B-procedure
2nd	I-procedure
surgery	I-procedure
she	O
returned	O
to	O
the	O
ICU	O
and	O
improved	O
steadily	O
.	O

Abdomen	O
remained	O
soft	O
and	O
nontender	O
.	O

She	O
remained	O
on	O
IV	B-procedure
antibiotics	I-procedure
x	O
14	O
days	O
and	O
required	O
pressors	B-procedure
for	O
the	O
first	O
few	O
days	O
post-op	O
.	O

Her	O
incision	O
has	O
remained	O
clean	O
,	O
dry	O
,	O
intact	O
,	O
with	O
staples	B-procedure
removed	O
on	O
POD#	O
27/18	O
.	O

Genitourinary	O
:	O
She	O
had	O
a	B-procedure
foley	I-procedure
catheter	I-procedure
from	O
the	O
time	O
of	O
admission	O
.	O

POD#	O
23/14	O
she	O
recieved	O
a	B-procedure
cystoscopy	I-procedure
which	O
revealed	O
no	O
leak	O
.	O

Her	B-procedure
foley	I-procedure
was	O
subsequently	O
dc	O
'd	O
.	O

Musculoskeletal	O
:	O
Has	O
suffered	O
significant	O
deconditioning	O
since	O
admission	O
,	O
but	O
has	O
consisitently	O
recieved	O
PT	B-procedure
.	O

See	O
PT	O
note	O
for	O
further	B-procedure
assessment	I-procedure
and	O
discussion	O
.	O

Nutrition	O
:	O
She	O
was	O
held	O
NPO	B-procedure
at	O
admission	O
,	O
and	O
initiated	O
on	O
TPN	B-procedure
by	O
HD#3	O
.	O

Post-operatively	O
she	O
began	O
on	O
TF	B-procedure
s,	I-procedure
and	O
the	B-procedure
TPN	I-procedure
was	O
weaned	O
down	O
.	O

By	O
POD#	O
05-29	O
she	O
was	O
having	O
high	O
residuals	O
on	O
TF	B-procedure
s,	I-procedure
so	O
TPN	B-procedure
was	O
reinitiated	O
.	O

Tf	B-procedure
's	I-procedure
were	O
dc	O
'ed	O
prior	O
to	O
second	B-procedure
surgery	I-procedure
.	O

POD#	O
15/6	O
,	O
she	O
resumed	O
TF	B-procedure
's	I-procedure
and	O
TPN	B-procedure
was	O
tapered	O
again	O
.	O

TF	O
goals	O
were	O
achieved	O
and	O
TPN	B-procedure
dc	O
'ed.	O

A	O
diet	O
by	O
mouth	O
was	O
initiated	O
.	O

At	O
time	O
of	O
discharge	O
she	O
is	O
tolerating	O
a	O
regular	O
diet	O
with	O
TF	B-procedure
's	I-procedure
at	O
goal	O
.	O

Patient	O
is	O
an	O
insulin	O
dependent	O
diabetic	O
.	O

She	O
was	O
followed	O
by	O
Cape	O
Cod	O
Hospital	O
Clinic	O
for	O
treatment	B-procedure
of	O
persistent	O
hyperglycemia	O
.	O

Pain	O
:	O
Her	O
pain	O
was	O
controlled	O
with	O
IV	B-procedure
pain	I-procedure
medicines	I-procedure
while	O
in	O
ICU	O
.	O

She	O
has	O
been	O
adequately	O
controlled	O
with	O
Tylenol	B-procedure
,	O
Motrin	B-procedure
&	O
Oxycodone	B-procedure
by	O
mouth	O
,	O
per	O
recommendations	O
by	O
Geriatrics	O
.	O

POD#	O
22/15	O
Ms	O
Crossman	O
was	O
transferred	O
to	O
3	O
North	O
where	O
she	O
continued	O
to	O
progress	O
well	O
with	O
PT	B-procedure
,	O
increasing	O
PO	O
intake	O
,	O
tolerating	O
TF	B-procedure
s,	I-procedure
and	O
weaning	O
from	O
nasal	B-procedure
cannula	I-procedure
oxygen	I-procedure
.	O

She	O
has	O
remained	O
stable	O
with	O
no	O
acute	O
events	O
.	O

She	O
is	O
discharged	O
to	O
rehab	O
on	O
POD#	O
27/18	O
.	O

Medications	O
on	O
Admission	O
:	O

Norvasc	B-procedure

Atenolol	B-procedure

Isosorbide	B-procedure

Lasix	B-procedure

Insulin	B-procedure

Discharge	O
Medications	O
:	O

1.	O
Heparin	B-procedure
(	I-procedure
Porcine	I-procedure
)	I-procedure
5,000	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
mL	O
Injection	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

2.	O
Acetaminophen	B-procedure
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

3.	O
Polyvinyl	B-procedure
Alcohol	I-procedure
-	O
Povidone	B-procedure
1.4-0.6	O
%	O
Dropperette	O
Sig	O
:	O
02-25	O
Drops	O
Ophthalmic	O
PRN	O
(	O
as	O
needed	O
).	O

4.	O
Metoprolol	B-procedure
Tartrate	I-procedure
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

5.	O
Aspirin	B-procedure
81	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
DAILY	O
(	O
Daily	O
).	O

6.	O
Atorvastatin	B-procedure
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

7.	O
Lisinopril	B-procedure
5	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

8.	O
Furosemide	B-procedure
40	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

9.	O
Ipratropium	B-procedure
Bromide	I-procedure
17	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Puff	O
Inhalation	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

10.	O
Albuterol	B-procedure
90	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
1-2	O
Puffs	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

11.	O
Oxycodone	B-procedure
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
pain	O
.	O

12.	O
Docusate	B-procedure
Sodium	I-procedure
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

13.	O
Potassium	B-procedure
Chloride	I-procedure
20	O
mEq	O
Tab	O
Sust	O
.	O
Rel	O
.	O
Particle	O
/	O
Crystal	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tab	O
Sust	O
.	O
Rel	O
.	O
Particle	O
/	O
Crystal	O
PO	O
once	O
a	O
day	O
.	O

14.	O
Glargine	B-procedure
Sig	O
:	O
Twenty	O
Two	O
(	O
22	O
)	O
units	O
at	O
bedtime	O
.	O

15.	O
Miconazole	B-procedure
Nitrate	I-procedure
2	O
%	O
Powder	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

16.	O
Miconazole	B-procedure
Nitrate	I-procedure
2	O
%	O
Cream	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

17.	O
Ibuprofen	B-procedure
100	O
mg/5	O
mL	O
Suspension	O
Sig	O
:	O
Twenty	O
(	O
20	O
)	O
mL	O
PO	O
Q8H	O
(	O
every	O
8	O
hours	O
)	O
as	O
needed	O
.	O

18.	O
Debrox	B-procedure
6.5	O
%	O
Drops	O
Sig	O
:	O
Five	O
(	O
5	O
)	O
Drop	O
Otic	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
5	O
days	O
:	O
both	O
ears	O
.	O

19.	O
Trazodone	B-procedure
50	O
mg	O
Tablet	O
Sig	O
:	O
1	O
/	O
2-1	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

Hurtado	O
Colon	O

Diverticulitis	O

S/P	O
Subtotal	B-procedure
Colectomy	I-procedure
,	O
Ileostomy	B-procedure
,	O
Gastrostomy	B-procedure
tube	I-procedure

S/P	O
Exploratory	B-procedure
laparotomy	I-procedure
,	O
resection	B-procedure
of	I-procedure
small	I-procedure
intestine	I-procedure
with	O
primary	B-procedure
anastomosis	I-procedure
,	O
Sigmoid	B-procedure
colectomy	I-procedure
,	O
repair	B-procedure
of	O
colovesicular	O
fistula	O

Unstable	O
Angina	O

Discharge	O
Condition	O
:	O

stable	O

Discharge	O
Instructions	O
:	O

Please	O
call	O
the	O
surgeon	O
or	O
return	O
to	O
the	O
Emergency	O
Department	O
if	O
you	O
develop	O
chest	O
pain	O
,	O
shortness	O
of	O
breath	O
,	O
fever	O
greater	O
than	O
101.5	O
,	O
foul	O
smelling	O
or	O
colorful	O
drainage	O
from	O
your	O
incisions	O
,	O
redness	O
or	O
swelling	O
,	O
severe	O
abdominal	O
pain	O
or	O
distention	O
,	O
persistent	O
nausea	O
or	O
vomiting	O
,	O
inability	O
to	O
eat	O
or	O
drink	O
,	O
or	O
any	O

other	O
symptoms	O
which	O
are	O
concerning	O
to	O
you	O
.	O

No	O
tub	O
baths	O
or	O
swimming	O
.	O

You	O
may	O
shower	O
.	O

If	O
there	O
is	O
clear	O
drainage	O
from	O
your	O
incisions	O
,	O
cover	O
with	O
a	B-procedure
dry	I-procedure
dressing	I-procedure
.	O

Leave	O
white	B-procedure
strips	I-procedure
above	O
your	O
incisions	O
in	O
place	O
,	O
allow	O
them	O
to	O
fall	O
off	O
on	O
their	O
own	O
.	O

Activity	O
:	O
No	O
heavy	O
lifting	O
of	O
items	O
12-08	O
pounds	O
until	O
the	O
follow	O
up	O
appointment	O
with	O
your	O
doctor	O
.	O

Medications	O
:	O
Resume	O
your	O
home	B-procedure
medications	I-procedure
.	O

You	O
should	O
take	O
a	B-procedure
stool	I-procedure
softener	I-procedure
,	O
Colace	B-procedure
100	O
mg	O
twice	O
daily	O
as	O
needed	O
for	O
constipation	O
.	O

You	O
will	O
be	O
given	O
pain	B-procedure
medication	I-procedure
which	O
may	O
make	O
you	O
drowsy	O
.	O

Followup	O
Instructions	O
:	O

Provider	O
:	O
Joe	O
Kari	O
,	O
MD	O
Phone	O
:(	O
625	O
)	O
747-8259	O

Date	O
/	O
Time	O
:	O
2014-04-11	O
1:15	O

Joe	O
Kari	O
MD	O
09-697	O

Completed	O
by	O
:	O
Carol	O
Robert	O
NP	O
80-CIY	O
2014-03-25	O
@	O
0837	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Marion	O
SCHNEIDER	O
on	O
:	O
Sandra	O
2014-03-25	O
12:56	O
PM	O

(	O
End	O
of	O
Report	O
)	O

598403789	O
DH	O

8993683	O

816711	O

963035	O

02/25/2001	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

GLYN	O
,	O
AEA	O

MRN	O
:	O

8993683	O

Age	O
:	O

67y	O

REGISTRATION	O
DATE	O
:	O

02/25/2001	O
12:20	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
GLYN	O
,	O
AEA	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Daughtersvillshamen&apos;s	O
Hospital	O
on	O
02/25/2001	O
12:20	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
HEMATURIA	O
.	O

Following	O
evaluation	B-procedure
and	O
treatment	B-procedure
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
DAUGHTERSVILLSHAMEN&apos;S	O
HOSPITAL	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
LINKETHORE	O
,	O
HANSVERLLEN	O
G	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
HEMATURIA	O
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
613-870-0699	O
.	O

PCP	O
Name	O
:	O

SWANKEMANDESSKIAIS	O
,	O
SANTCINET	O
E	O

Provider	O
Number	O
:	O

42283	O

869436718	O
SC	O

64806295	O

6613471	O

10/1/2003	O
12:00:00	O
AM	O

post	O
partum	O

DIS	O

Admission	O
Date	O
:	O

10/01/2003	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

10/04/2003	O

******	O
DISCHARGE	O
ORDERS	O
******	O

KULRINNE	O
,	O
RYYELEGE	O
N	O

386-85-38-0	O
X32	O

Room	O
:	O

JQL5-545	O

Service	O
:	O

OBS	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

10/04/03	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

TYLENOL	B-procedure
(	I-procedure
ACETAMINOPHEN	I-procedure
)	I-procedure
650	O
MG	O
PO	O
Q4H	O
PRN	O
PAIN	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
10/01/03	O
by	O
KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

ACETAMINOPHEN	B-procedure
and	O
ACETAMINOPHEN	B-procedure

Reason	O
for	O
override	O
:	O

ok	O

COLACE	B-procedure
(	I-procedure
DOCUSATE	I-procedure
SODIUM	I-procedure
)	I-procedure
100	O
MG	O
PO	O
BID	O
IBUPROFEN	B-procedure
600	O
MG	O
PO	O
Q4H	O
PRN	O
PAIN	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
with	O
food	O
MILK	B-procedure
OF	I-procedure
MAGNESIA	I-procedure
(	I-procedure
MAGNESIUM	I-procedure
HYDROXIDE	I-procedure
)	I-procedure
30	O
MILLILITERS	O
PO	O
BID	O
PRN	O
Constipation	O
PERCOCET	B-procedure
1-2	O
TAB	O
PO	O
Q4H	O
PRN	O
PAIN	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
10/01/03	O
by	O
KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O
on	O
order	O
for	O
TYLENOL	B-procedure
PO	O
650	O
MG	O
Q4H	O
(	O
ref	O
#	O
85225311	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

ACETAMINOPHEN	B-procedure
and	O
ACETAMINOPHEN	B-procedure

Reason	O
for	O
override	O
:	O

ok	O

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

kotejoasthoreuphkays	O
6	O
weeks	O
,	O

ALLERGY	O
:	O

Sulfa	B-procedure
,	O
Bactrim	B-procedure

ADMIT	O
DIAGNOSIS	O
:	O

Pregnancy	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O

post	O
partum	O

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

twins	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Primary	O
Anesthesia	O
:	O

Spinal	O

Vaginal	O
delivery	O
:	O

Undelivered	O

Cesarean	O
Status	O
:	O

Primary	O

Urgency	O
:	O

Scheduled	O

Indications	O
:	O

Breech	O
,	O
Multiple	O
gestation	O
,	O

Uterine	O
incision	O
type	O
:	O

Transverse	O

Placenta	O
:	O

Delivery	O
:	O

Spontaneous	O

Condition	O
:	O

Normal	O

Staff	O
Obstetrician	O
(	O
supervising	O
)	O
:	O

KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O
Delivery	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

none	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G3	O
T1	O
P0	O
A1	O
L1	O

Estimated	O
EDC	O
:	O

10/14/03	O

Maternal	O
transfer	O
:	O

No	O

Initial	O
newborn	O
exam	O
:	O

No	O
observed	O
abnormalities	O

Baby	O
1	O

MRN	O
:	O

76306248	O

Delivery	O
date	O
:	O

10/01/03	O
09:06	O
AM	O

Apgars	B-procedure
8,9	O

Weight	B-procedure
:	O

7lb	O
1	O
oz	O
3204	O
grams	O

Sex	O
:	O

Male	O

Baby	O
2	O

MRN	O
:	O

62685780	O

Delivery	O
date	O
:	O

10/01/03	O
09:08	O
AM	O

Apgars	B-procedure
8,8	O

Weight	B-procedure
:	O

7lb	O
0	O
oz	O
3175	O
grams	O

Sex	O
:	O

Female	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O
(	O
CT17	O
)	O
10/04/03	O
07:11	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2017-09-22	O

Discharge	O
Date	O
:	O

2017-09-27	O

Date	O
of	O
Birth	O
:	O

2017-09-22	O

Sex	O
:	O

M	O

Service	O
:	O

CMED	O
CSRU	O

HISTORY	O
:	O

Peggy	O
Hammock	O
is	O
a	O
full	O
term	O
baby	O
boy	O
born	O
at	O
38	O
1/7	O
weeks	O
by	O
repeat	B-procedure
cesarean	I-procedure
section	I-procedure
to	O
a	O
34	O
year	O
old	O
gravida	O
III	O
,	O
now	O
para	O
II	O
mother	O
.	O

Serologies	B-procedure
include	O
blood	B-procedure
type	I-procedure
O	O
negative	O
,	O
antibody	B-procedure
negative	O
,	O
RPR	B-procedure
nonreactive	O
.	O

Hepatitis	B-procedure
B	I-procedure
surface	I-procedure
antigen	I-procedure
negative	O
,	O
rubella	B-procedure
immune	O
.	O

Group	B-procedure
B	I-procedure
strep	I-procedure
screening	I-procedure
was	O
negative	O
.	O

Pregnancy	O
was	O
uncomplicated	O
until	O
an	O
occurrence	O
of	O
HSV	O
outbreak	O
occurred	O
on	O
2017-09-13	O
approximately	O
one	O
week	O
prior	O
to	O
delivery	B-procedure
.	O

Pregnancy	O
was	O
also	O
complicated	O
by	O
maternal	O
history	O
of	O
depression	O
for	O
which	O
mother	O
received	O
Zoloft	B-procedure
.	O

On	O
day	O
of	O
delivery	B-procedure
mother	O
presented	O
in	O
spontaneous	O
labor	O
.	O

There	O
were	O
no	O
sepsis	O
risk	O
factors	O
.	O

GBS	B-procedure
negative	O
.	O

No	O
maternal	O
fever	O
.	O

Rupture	O
of	O
membranes	O
at	O
time	O
of	O
delivery	B-procedure
.	O

Delivery	B-procedure
was	O
by	O
repeat	B-procedure
cesarean	I-procedure
section	I-procedure
and	O
Apgars	B-procedure
of	O
8	O
and	O
9	O
were	O
given	O
at	O
one	O
and	O
five	O
minutes	O
respectively	O
.	O

Baby	O
appeared	O
well	O
and	O
went	O
to	O
the	O
newborn	O
nursery	O
and	O
was	O
breast	O
feeding	O
and	O
undergoing	O
routine	B-procedure
newborn	I-procedure
care	I-procedure
.	O

On	O
the	O
newborn	O
nursery	O
the	O
mother	O
called	O
the	O
nurse	O
for	O
concern	O
of	O
baby	O
turning	O
dusky	O
while	O
feeding	O
.	O

She	O
called	O
the	O
nurses	O
and	O
patted	O
the	O
infant	O
on	O
the	O
back	O
.	O

This	O
episode	O
was	O
also	O
accompanied	O
by	O
gagging	O
motions	O
noted	O
of	O
the	O
infant	O
.	O

A	O
second	O
episode	O
occurred	O
where	O
the	O
baby	O
turned	O
pale	O
.	O

Mother	O
thought	O
the	O
baby	O
just	O
did	O
not	O
look	O
right	O
.	O

The	O
baby	O
did	O
not	O
turn	O
blue	O
at	O
that	O
time	O
.	O

The	O
Neonatal	O
Intensive	O
Care	O
Unit	O
was	O
notified	O
and	O
the	O
baby	O
was	O
transferred	O
to	O
the	O
Newborn	O
Intensive	O
Care	O
Unit	O
for	O
further	B-procedure
evaluation	I-procedure
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
to	O
the	O
Neonatal	O
Intensive	O
Care	O
Unit	O
:	O

Full	O
term	O
well	O
appearing	O
infant	O
with	O
some	O
facial	O
jaundice	O
,	O
overall	O
pink	O
,	O
warm	O
and	O
well	O
perfused	O
,	O
alert	O
and	O
responsive	O
.	O

Anterior	O
fontanelle	O
is	O
soft	O
,	O
open	O
and	O
flat	O
.	O

Ears	O
are	O
normally	O
set	O
.	O

Red	B-procedure
reflexes	I-procedure
noted	O
bilaterally	O
.	O

He	O
had	O
a	O
left	O
pupil	O
that	O
was	O
in	O
unequal	O
in	O
size	O
with	O
a	O
keyhole	O
appearance	O
consistent	O
with	O
a	O
coloboma	O
.	O

The	O
nares	O
were	O
patent	O
.	O

Palate	O
was	O
intact	O
.	O

Mucous	O
membranes	O
were	O
moist	O
and	O
pink	O
.	O

His	O
neck	O
was	O
supple	O
without	O
masses	O
or	O
bruits	O
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	B-procedure
and	O
equal	O
.	O

Comfortable	O
respiratory	O
pattern	O
.	O

Cardiovascular	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmur	O
.	O

2	O
plus	O
femoral	B-procedure
pulses	I-procedure
were	O
noted	O
.	O

Abdomens	O
oft	O
with	O
positive	O
bowel	O
sounds	O
.	O

Genitourinary	O
:	O

Infant	O
was	O
circumcised	B-procedure
in	O
the	O
newborn	O
nursery	O
which	O
was	O
healing	O
well	O
.	O

Testes	O
were	O
descended	O
bilaterally	O
.	O

Extremities	O
were	O
pink	O
and	O
well	O
perfused	O
.	O

Neurologic	O
:	O

Tone	B-procedure
was	O
appropriate	O
for	O
gestational	O
age	O
with	O
equal	O
strength	B-procedure
,	O
symmetric	O
reflexes	B-procedure
.	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEMS	O
:	O

Respiratory	O
:	O

The	O
infant	O
was	O
placed	O
on	O
a	B-procedure
cardiopulmonary	I-procedure
monitor	I-procedure
upon	O
admission	O
to	O
the	O
Newborn	O
Intensive	O
Care	O
Unit	O
with	O
pulse	B-procedure
oximetry	I-procedure
.	O

He	O
was	O
noted	O
to	O
have	O
an	O
episode	O
of	O
desaturation	O
related	O
to	O
feeding	O
with	O
desaturations	O
in	O
the	O
70	O
percent	O
.	O

This	O
resolved	O
spontaneously	O
when	O
the	O
bottle	O
was	O
pulled	O
from	O
the	O
baby	O
's	O
mouth	O
.	O

Jule	O
remained	O
in	O
room	O
air	O
without	O
any	O
evidence	O
of	O
respiratory	O
distress	O
and	O
was	O
without	O
any	O
further	O
dusky	O
spells	O
or	O
pale	O
episodes	O
in	O
the	O
48	O
hours	O
prior	O
to	O
discharge	O
.	O

Cardiovascular	O
:	O

Renee	O
remained	O
cardiovascularly	O
stable	O
with	O
AP	B-procedure
s	I-procedure
noted	O
to	O
be	O
120	O
to	O
130	O
s.	O

Blood	B-procedure
pressure	I-procedure
84/43	O
with	O
a	B-procedure
mean	I-procedure
of	O
59	O
.	O

Fluid	O
,	O
electrolytes	O
and	O
nutritions	O
:	O

The	O
baby	O
had	O
been	O
breast	O
feeding	O
ad	O
lib	O
in	O
the	O
Newborn	O
Nursery	O
.	O

He	O
continued	O
to	O
feed	O
ad	O
lib	O
while	O
a	O
patient	O
in	O
the	O
Newborn	O
Intensive	O
Care	O
Unit	O
.	O

He	O
was	O
fed	O
with	O
a	O
bottle	O
occasionally	O
by	O
his	O
dad	O
and	O
had	O
a	O
vigorous	O
suck	O
and	O
was	O
noted	O
to	O
have	O
some	O
discoordination	O
of	O
his	O
suck	O
while	O
breathing	O
at	O
the	O
initial	O
onset	O
of	O
feeding	O
time	O
.	O

This	O
resolved	O
with	O
removal	O
of	O
the	O
bottle	O
from	O
the	O
baby	O
's	O
mouth	O
.	O

Breast	O
feeding	O
was	O
limited	O
to	O
four	O
to	O
five	O
minutes	O
on	O
each	O
side	O
per	O
recommendation	O
of	O
neurology	O
after	O
their	B-procedure
evaluation	I-procedure
to	O
try	O
and	O
minimize	O
incidence	O
of	O
gastroesophageal	O
reflux	O
.	O

Weight	B-procedure
at	O
time	O
of	O
discharge	O
is	O
3.13	O
kilograms	O
.	O

Birth	B-procedure
weight	I-procedure
was	O
3.29	O
kilograms	O
in	O
the	O
75th	O
percentile	O
.	O

Head	B-procedure
circumference	I-procedure
was	O
34.5	O
cm	O
,	O
75th	O
percentile	O
,	O
and	O
length	B-procedure
was	O
50.7	O
cm	O
,	O
also	O
the	O
75th	O
percentile	O
.	O

Gastrointestinal	O
:	O

Baby	O
was	O
noted	O
to	O
have	O
frequent	O
spitting	O
episodes	O
.	O

This	O
was	O
minimized	O
with	O
limitation	B-procedure
of	I-procedure
volume	I-procedure
at	I-procedure
each	I-procedure
feed	I-procedure
with	O
frequent	B-procedure
feeding	I-procedure
.	O

He	O
had	O
normal	O
voiding	O
and	O
stooling	O
patterns	O
.	O

The	O
baby	O
demonstrated	O
mild	O
physiologic	O
jaundice	O
with	O
a	B-procedure
serum	I-procedure
bilirubin	I-procedure
obtained	O
on	O
day	O
of	O
life	O
three	O
which	O
was	O
6.7	O
with	O
a	O
direct	O
of	O
0.2	O
.	O

Mother	B-procedure
's	I-procedure
blood	I-procedure
type	I-procedure
is	O
O	O
negative	O
.	O

Infant	B-procedure
's	I-procedure
blood	I-procedure
type	I-procedure
was	O
O	O
positive	O
and	O
Coombs	B-procedure
was	O
noted	O
to	O
be	O
negative	O
.	O

Hematologic	O
:	O

In	O
addition	O
a	B-procedure
complete	I-procedure
blood	I-procedure
count	I-procedure
was	O
obtained	O
on	O
admission	O
with	O
a	B-procedure
white	I-procedure
count	I-procedure
of	O
10.1	O
with	O
43	O
polys	B-procedure
and	O
0	O
bands	B-procedure
.	I-procedure

Hematocrit	B-procedure
was	O
noted	O
to	O
47.5	O
with	O
platelets	B-procedure
of	O
257,000	O
.	O

There	O
were	O
no	O
blood	B-procedure
products	I-procedure
received	O
during	O
hospitalization	O
.	O

Infectious	O
disease	O
:	O

A	B-procedure
blood	I-procedure
culture	I-procedure
was	O
obtained	O
upon	O
admission	O
and	O
Ampicillin	B-procedure
and	O
Gentamicin	B-procedure
were	O
given	O
for	O
48	O
hours	O
with	O
blood	B-procedure
cultures	I-procedure
remaining	O
sterile	O
.	O

Antibiotics	B-procedure
were	O
discontinued	O
on	O
day	O
of	O
life	O
three	O
and	O
infant	O
has	O
remained	O
clinically	O
well	O
off	O
antibiotics	B-procedure
.	O

Neurology	O
:	O

Neurology	O
was	O
consulted	O
due	O
to	O
the	O
concern	O
for	O
seizures	O
in	O
the	O
setting	O
of	O
dusky	O
episodes	O
.	O

Neurology	O
evaluated	O
the	O
baby	O
and	O
found	O
the	O
baby	O
to	O
have	O
a	O
normal	O
neurological	O
examination	O
.	O

An	B-procedure
EEG	I-procedure
was	O
performed	O
.	O

The	B-procedure
EEG	I-procedure
showed	O
transient	O
sharp	O
waves	O
in	O
the	O
left	O
front	O
,	O
left	O
occipital	O
and	O
right	O
parietal	O
regions	O
.	O

There	O
was	O
no	O
electrographic	B-procedure
evidence	I-procedure
of	O
seizure	O
activity	O
noted	O
.	O

Sensory	O
:	O

Hearing	B-procedure
screening	I-procedure
was	O
performed	O
with	O
automated	O
auditory	O
brain	O
stem	O
responses	O
.	O

Baby	O
passed	O
in	O
both	O
ears	O
on	O
09-23	O
.	O

Ophthalmology	O
:	O

Ophthalmology	O
was	O
consulted	O
due	O
to	O
the	O
presence	O
of	O
a	O
coloboma	O
into	O
the	O
left	O
CMED	O
.	O

Ophthalmology	O
noted	O
that	O
this	O
left	O
Martha	O
coloboma	O
was	O
likely	O
an	O
isolated	O
anomaly	O
in	O
the	O
absence	O
of	O
other	O
pathology	O
.	O

Follow	O
up	O
as	O
below	O
.	O

Psychosocial	O
:	O

Cambridge	O
Health	O
Alliance	O
social	O
worker	O
was	O
involved	O
with	O
this	O
family	O
.	O

She	O
may	O
be	O
reached	O
at	O
(	O
756	O
)	O
599-4849	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

To	O
home	O
with	O
parents	O
.	O

Primary	O
pediatrician	O
is	O
Dr.	O
Satterlund	O
of	O
Westborough	O
Pediatrics	O
.	O

Telephone	O
number	O
is	O
(	O
739	O
)	O
520-0347	O
.	O

Fax	O
number	O
is	O
(	O
617	O
)	O
455-4585	O
.	O

Appointment	O
is	O
on	O
Lyon	O
,	O
10-30	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
:	O

Feeds	O
are	O
breast	O
feeding	O
P.O.	O
ad	O
lib	O
.	O

Medications	B-procedure
are	O
Tri-Vi-Michael	B-procedure
1	O
cc	O
by	O
mouth	O
each	O
day	O
.	O

Newborn	B-procedure
state	I-procedure
screen	I-procedure
was	O
sent	O
on	O
day	O
of	O
life	O
three	O
.	O

Results	O
are	O
pending	O
.	O

Immunizations	B-procedure
received	O
are	O
hepatitis	B-procedure
B	I-procedure
vaccine	I-procedure
given	O
on	O
09-26	O
.	O

Follow	O
up	O
appointments	O
scheduled	O
:	O

Neurology	O
follow	O
up	O
with	O
Dr.	O
Workman	O
is	O
scheduled	O
for	O
2017-10-20	O
at	O
12:30	O
pm	O
at	O
the	O
Addison	O
Gilbert	O
Hospital	O
of	O
Oak	O
Bluffs	O
,	O
Ison	O
11	O
.	O

Phone	O
number	O
is	O
209-604-1402	O
.	O

Follow	O
up	O
ophthalmology	O
appointment	O
is	O
with	O
Dr.	O
Jundt	O
on	O
Ison	O
4	O
at	O
the	O
Addison	O
Gilbert	O
Hospital	O
of	O
Oak	O
Bluffs	O
in	O
three	O
months	O
.	O

Appointment	O
to	O
be	O
scheduled	O
by	O
mom	O
.	O

Telephone	O
number	O
is	O
444	O
7700	O
.	O

Boston	O
Regional	O
Medical	O
Centerr	O
Visiting	O
Nurse	O
Association	O
has	O
been	O
asked	O
to	O
visit	O
this	O
family	O
at	O
home	O
to	O
follow	O
up	O
on	O
feeding	O
and	O

parenting	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Full	O
term	O
male	O
infant	O
with	O
cyanosis	O
episodes	O
.	O

Rule	O
out	O
sepsis	O
.	O

Left	O
coloboma	O
.	O

Rule	O
out	O
seizures	O
.	O

Lucile	O
Virgina	O
,	O
MD	O
50AAD	O

Dictated	O
By	O
:	O
Sherry	O
G	O
Christie	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2017-09-27	O
17:51:44	O

T	O
:	O
2017-09-27	O
18:26:21	O

Job	O
#:	O
75510	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Marcus	O
N	O
Schartz	O
on	O
:	O
Maxine	O
2017-09-28	O
9:34	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2011-12-26	O

Discharge	O
Date	O
:	O

2012-01-26	O

Date	O
of	O
Birth	O
:	O

1958-04-03	O

Sex	O
:	O

F	O

Service	O
:	O

NOTE	O
:	O

This	O
is	O
an	O
addendum	O
to	O
the	O
discharge	O
summary	O
for	O
the	O
admission	O
starting	O
2012-01-05	O
.	O

The	O
patient	O
was	O
discharged	O
on	O
2012-01-26	O
.	O

ADDENDUM	O
HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
had	O
stage	O
1	O
sacral	O
decubitus	O
on	O
her	O
buttocks	O
.	O

This	O
was	O
treated	O
with	O
wound	B-procedure
care	I-procedure
using	O
Eucerin	B-procedure
cream	I-procedure
and	O
also	O
patient	O
was	O
treated	O
with	O
lidocaine	B-procedure
jelly	I-procedure
for	O
pain	B-procedure
control	I-procedure
.	O

The	O
patient	O
was	O
seen	O
by	O
the	O
wound	O
care	O
nurse	O
and	O
the	O
decubitus	O
ulcer	O
was	O
felt	O
to	O
be	O
mild	O
,	O
but	O
was	O
causing	O
the	O
patient	O
a	O
lot	O
of	O
discomfort	O
and	O
the	O
wound	O
care	O
nurse	O
Ivy	O
Rose	O
lidocaine	B-procedure
jelly	I-procedure
.	O

With	O
regard	O
to	O
the	O
patient	O
's	O
chronic	O
obstructive	O
pulmonary	O
disease	O
,	O
the	O
patient	O
's	O
respiratory	O
status	O
improved	O
throughout	O
the	O
remainder	O
of	O
her	O
hospital	O
course	O
.	O

The	O
patient	O
had	O
no	O
shortness	O
of	O
breath	O
or	O
cough	O
on	O
discharge	O
.	O

The	O
patient	O
was	O
oxygenating	O
well	O
on	O
her	B-procedure
home	I-procedure
O2	I-procedure
dose	I-procedure
of	O
2	O
liters	O
per	O
minute	O
.	O

The	O
patient	O
overall	O
continued	O
to	O
improve	O
,	O
but	O
remained	O
physically	O
decompensated	O
and	O
the	O
patient	O
was	O
transferred	O
to	O
Waltham/Weston	O
Hospital	O
Rehabilitation	O
Hospital	O
for	O
intensive	B-procedure
physical	I-procedure
therapy	I-procedure
.	O

DISCHARGE	B-procedure
MEDICATIONS	I-procedure
are	O
the	O
same	O
with	O
the	O
addition	O
of	O
viscous	B-procedure
lidocaine	I-procedure
jelly	I-procedure
to	O
be	O
applied	O
to	O
buttock	O
prn	O
and	O
viscous	B-procedure
lidocaine	I-procedure
swish	I-procedure
and	I-procedure
swallow	I-procedure
tid	O
prn	O
before	O
meals	O
.	O

Timothy	O
E	O
Woolfolk	O
,	O
M.D.	O

18-858	O

Dictated	O
By	O
:	O
Robert	O
C.	O
Warren	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-01-26	O
09:56	O

T	O
:	O
2012-01-26	O
09:58	O

JOB	O
#:	O

48146	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kevin	O
Arthur	O
on	O
:	O
Tony	O
2012-01-27	O
6:52	O
AM	O

(	O
End	O
of	O
Report	O
)	O

351853846	O
WGH	O

8921553	O

92855	O

715722	O

3/24/1997	O
12:00:00	O
AM	O

GAIT	O
DISORDER	O
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

PREHEPRIOR	O
,	O
NIENEMILEISELE	O

UNIT	O
NUMBER	O
:	O

372-41-54	O

ADMISSION	O
DATE	O
:	O

03/24/97	O

DISCHARGE	O
DATE	O
:	O

03/28/97	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Gait	O
disorder	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
31-year-old	O
right-handed	O
female	O
with	O
right-sided	O
greater	O
than	O
left-sided	O
weakness	O
and	O
difficulty	O
walking	O
for	O
several	O
days	O
.	O

She	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
3/20/97	O
when	O
she	O
experienced	O
the	O
fairly	O
sudden	O
onset	O
of	O
predominantly	O
right-sided	O
arm	O
and	O
leg	O
weakness	O
and	O
ataxia	O
.	O

She	O
was	O
standing	O
and	O
walking	O
with	O
her	O
friend	O
,	O
who	O
&quot;	O
had	O
to	O
catch	O
her	O
from	O
falling	O
down	O
&quot;	O
as	O
she	O
toppled	O
towards	O
the	O
right	O
.	O

She	O
evidently	O
recovered	O
from	O
the	O
episode	O
after	O
a	O
number	O
of	O
minutes	O
.	O

The	O
following	O
day	O
,	O
she	O
remained	O
in	O
bed	O
through	O
essentially	O
all	O
of	O
the	O
day	O
due	O
to	O
malaise	O
with	O
no	O
specific	O
deficits	O
being	O
noted	O
.	O

In	O
the	O
subsequent	O
two	O
days	O
,	O
she	O
had	O
several	O
small	O
spells	O
of	O
&quot;	O
imbalance	O
&quot;	O
,	O
particularly	O
towards	O
the	O
right	O
,	O
and	O
other	O
symptoms	O
included	O
diffuse	O
and	O
mainly	O
frontal	O
headaches	O
and	O
mild	O
neck	O
soreness	O
.	O

There	O
was	O
no	O
diplopia	O
,	O
visual	O
loss	O
,	O
speech	O
abnormality	O
or	O
sensory	O
change	O
in	O
her	O
history	O
.	O

She	O
was	O
initially	O
evaluated	O
at	O
an	O
outside	O
hospital	O
emergency	O
room	O
,	O
and	O
then	O
transferred	O
to	O
Well	O
General	O
Hospital	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Is	O
notable	O
for	O
depression	O
,	O
and	O
she	O
has	O
been	O
followed	O
regularly	O
by	O
Dr.	O
Freiermchird	O
of	O
Nash	O
Health	O
for	O
several	O
months	O
with	O
pharmacologic	B-procedure
treatment	I-procedure
,	O
which	O
is	O
apparently	O
working	O
well	O
.	O

Her	B-procedure
Doxepin	I-procedure
has	O
recently	O
been	O
increased	O
.	O

She	O
is	O
status	O
post	O
appendectomy	B-procedure
and	O
otherwise	O
has	O
no	O
remarkable	O
past	O
medical	O
history	O
.	O

ALLERGIES	O
:	O

Quinine	B-procedure
gives	O
her	O
a	O
rash	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

The	O
only	O
medications	B-procedure
she	O
is	O
on	O
are	O
Paxil	B-procedure
30	O
mg	O
p.o.	O
q.day	O
,	O
Doxepin	B-procedure
25	O
mg	O
p.o.	O
q.day	O
,	O
and	O
Klonopin	B-procedure
2	O
mg	O
p.o.	O
q.h.s.	O

SOCIAL	O
HISTORY	O
:	O

She	O
is	O
currently	O
unemployed	O
,	O
but	O
until	O
recently	O
,	O
she	O
was	O
employed	O
at	O
a	O
bank	O
.	O

She	O
was	O
born	O
and	O
raised	O
in	O
Atonlaremont	O
Rockpo	O
.	O

There	O
is	O
a	O
history	O
of	O
childhood	O
abuse	O
.	O

She	O
does	O
not	O
drink	O
.	O

She	O
is	O
a	O
former	O
tobacco	O
user	O
and	O
takes	O
no	O
illicit	O
drugs	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

She	O
was	O
pleasant	O
,	O
in	O
no	O
acute	O
distress	O
;	O
blood	B-procedure
pressure	I-procedure
130/60	O
;	O
heart	B-procedure
rate	I-procedure
66	O
;	O
respirations	B-procedure
18	O
;	O
temperature	B-procedure
98	O
.	O

Her	O
thyroid	O
was	O
within	O
normal	O
limits	O
.	O

There	O
were	O
no	O
carotid	O
or	O
cervical	O
bruits	O
.	O

She	O
had	O
a	O
normal	O
S1	O
and	O
S2	O
and	O
regular	O
rate	O
and	O
rhythm	O
with	O
no	O
murmurs	O
.	O

Her	O
lungs	O
were	O
clear	O
to	O
auscultation	B-procedure
bilaterally	O
.	O

Her	O
abdomen	O
was	O
benign	O
.	O

Her	O
extremities	O
were	O
without	O
clubbing	O
,	O
cyanosis	O
,	O
edema	O
,	O
or	O
rash	O
;	O
there	O
were	O
some	O
older	O
hematomas	O
in	O
the	O
bilaterally	O
shins	O
.	O

Mental	O
status	O
-	O
her	O
speech	O
was	O
fluent	O
without	O
errors	O
.	O

Her	O
affect	O
was	O
slightly	O
inappropriate	O
at	O
times	O
;	O
for	O
example	O
,	O
singing	O
or	O
humming	O
along	O
while	O
performing	O
some	O
of	O
the	B-procedure
motor	I-procedure
tasks	I-procedure
and	O
giving	O
the	O
impression	O
of	O
indifference	O
to	O
the	O
deficits	O
that	O
were	O
demonstrated	O
on	O
the	B-procedure
examination	I-procedure
.	O

Her	O
memory	O
was	O
fully	O
intact	O
for	O
short-term	O
recollection	O
of	O
three	O
out	O
of	O
three	O
objects	O
at	O
five	O
minutes	O
with	O
excellent	O
naming	O
,	O
repetition	O
,	O
proverb	O
interpretation	O
,	O
and	O
ability	O
to	O
follow	O
commands	O
.	O

Visual	O
fields	O
were	O
full	O
to	O
confrontation	O
.	O

Her	O
left	O
pupil	O
was	O
7	O
mm	O
reacting	O
to	O
5	O
mm	O
.	O

Her	O
right	O
pupil	O
was	O
5.5	O
mm	O
reacting	O
to	O
4	O
mm	O
.	O

Her	O
extraocular	O
movements	O
were	O
intact	O
for	O
horizontal	O
and	O
vertical	O
pursuits	O
.	O

There	O
was	O
no	O
nystagmus	O
and	O
no	O
ptosis	O
.	O

Her	O
saccades	O
were	O
normal	O
.	O

Facial	O
strength	O
and	O
sensation	O
were	O
full	O
and	O
symmetric	O
.	O

Her	O
tongue	O
,	O
uvula	O
and	O
palate	O
were	O
midline	O
.	O

Shoulder	O
shrug	O
was	O
5/5	O
power	O
.	O

Motor	B-procedure
examination	I-procedure
revealed	O
5/5	O
power	O
in	O
all	O
groups	O
in	O
the	O
proximal	O
and	O
distal	O
upper	O
and	O
lower	O
extremities	O
.	O

There	O
was	O
no	O
drift	O
.	O

There	O
was	O
normal	O
bulk	O
and	O
tone	O
.	O

She	O
had	O
slightly	O
slow	O
fine	O
finger	O
motility	O
approximately	O
equal	O
bilaterally	O
,	O
although	O
this	O
was	O
extremely	O
difficult	O
to	O
reproduce	O
.	O

Sensory	O
-	O
intact	O
light	O
touch	O
,	O
temperature	O
,	O
and	O
vibration	O
overall	O
.	O

Reflexes	B-procedure
were	O
2+	O
throughout	O
in	O
the	O
upper	O
and	O
lower	O
extremities	O
,	O
and	O
toes	O
were	O
downgoing	O
.	O

There	O
was	O
no	O
jaw	O
jerk	O
and	O
no	O
Hoffman	O
&apos;s	O
sign	O
.	O

Coordination	O
-	O
toe	B-procedure
tap	I-procedure
was	O
slow	O
bilaterally	O
,	O
although	O
difficult	O
to	O
reproduce	O
,	O
and	O
at	O
best	O
,	O
was	O
essentially	O
within	O
normal	O
limits	O
.	O

On	O
standing	O
,	O
she	O
tended	O
to	O
fall	O
to	O
the	O
front	O
,	O
back	O
or	O
sides	O
without	O
trying	O
to	O
stop	O
her	O
fall	O
initially	O
,	O
and	O
extensive	B-procedure
gait	I-procedure
testing	I-procedure
was	O
deferred	O
due	O
to	O
concerns	O
for	O
safety	O
.	O

Her	B-procedure
heel-to-shin	I-procedure
and	I-procedure
finger-to-nose	I-procedure
testing	I-procedure
was	O
fully	O
intact	O
bilaterally	O
without	O
ataxia	O
or	O
tremor	O
.	O

LABORATORY	O
DATA	O
:	O

Were	O
unremarkable	O
with	O
normal	O
electrolytes	B-procedure
and	O
complete	B-procedure
blood	I-procedure
count	I-procedure
parameters	I-procedure
.	O

Her	B-procedure
erythrocyte	I-procedure
sedimentation	I-procedure
rate	I-procedure
was	O
12	O
.	O

Her	B-procedure
coagulation	I-procedure
parameters	I-procedure
were	O
normal	O
.	O

Head	B-procedure
CT	I-procedure
scan	I-procedure
without	I-procedure
contrast	I-procedure
showed	O
normal	O
brain	O
parenchyma	O
and	O
no	O
intracranial	O
process	O
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
her	O
gait	O
disorder	O
with	O
other	O
notable	O
findings	O
on	O
examination	B-procedure
including	O
anisocoria	O
,	O
which	O
,	O
by	O
the	O
patient	O
&apos;s	O
report	O
,	O
had	O
been	O
noted	O
several	O
months	O
earlier	O
.	O

A	B-procedure
magnetic	I-procedure
resonance	I-procedure
imaging	I-procedure
and	O
magnetic	B-procedure
resonance	I-procedure
angiogram	I-procedure
study	I-procedure
was	O
obtained	O
,	O
which	O
showed	O
no	O
clear	O
evidence	O
of	O
arterial	O
dissections	O
or	O
infarction	O
or	O
other	O
pathologic	O
processes	O
.	O

She	O
had	O
been	O
placed	O
on	O
heparin	B-procedure
initially	O
,	O
but	O
this	O
was	O
discontinued	O
after	O
the	B-procedure
magnetic	I-procedure
resonance	I-procedure
imaging	I-procedure
results	O
were	O
obtained	O
.	O

Posterior	B-procedure
transcranial	I-procedure
Doppler	I-procedure
studies	I-procedure
showed	O
normal	O
studies	O
of	O
both	O
vertebral	O
arteries	O
,	O
and	O
carotid	B-procedure
non-invasive	I-procedure
studies	I-procedure
showed	O
normal	O
right	O
and	O
left	O
carotid	O
bifurcations	O
.	O

On	O
the	O
second	O
hospital	O
day	O
,	O
her	O
gait	O
continued	O
to	O
be	O
markedly	O
unstable	O
,	O
although	O
with	O
no	O
consistent	O
pattern	O
in	O
terms	O
of	O
weakness	O
or	O
directionality	O
of	O
falling	O
,	O
and	O
she	O
continued	O
to	O
have	O
no	O
reproducible	O
upper	O
extremity	O
or	O
lower	O
extremity	O
ataxia	O
or	O
dysmetria	O
.	O

She	O
was	O
seen	O
by	O
the	O
Psychiatry	B-procedure
Service	I-procedure
.	O

She	O
was	O
not	O
felt	O
to	O
be	O
acutely	O
suicidal	O
or	O
otherwise	O
in	O
need	O
of	O
acute	B-procedure
psychiatric	I-procedure
treatment	I-procedure
.	O

The	O
psychiatrist	O
also	O
noted	O
the	O
indifference	O
the	O
patient	O
evinced	O
regarding	O
her	O
own	O
symptomatology	O
.	O

The	O
patient	O
was	O
evaluated	O
in	O
one	O
of	O
the	O
neurology	O
conferences	O
for	O
several	O
hours	O
,	O
and	O
during	O
this	O
time	O
,	O
showed	O
significant	O
improvement	O
while	O
receiving	O
gait	B-procedure
training	I-procedure
as	O
well	O
as	O
evaluation	B-procedure
;	O
in	O
particular	O
,	O
she	O
became	O
more	O
stable	O
with	O
counter-balancing	B-procedure
methods	I-procedure
.	O

This	O
trend	O
of	O
improvement	O
continued	O
,	O
and	O
she	O
was	O
discharged	O
in	O
stable	O
condition	O
.	O

She	O
will	O
follow	O
up	O
with	O
her	O
psychiatrist	O
,	O
Dr.	O
Freiermchird	O
(	O
Sone	O
Memorial	O
Hospital	O
)	O
on	O
a	O
regular	O
basis	O
,	O
and	O
she	O
can	O
follow	O
up	O
with	O
the	O
Neurology	O
Service	O
on	O
a	O
p.r.n.	O
basis	O
if	O
needed	O
.	O

She	O
will	O
continue	O
on	O
her	B-procedure
previous	I-procedure
outpatient	I-procedure
medical	I-procedure
regimen	I-procedure
.	O

NIREGE	O
MEMORY	O
,	O
M.D.	O

TR	O
:	O

bzo	O

DD	O
:	O

03/29/97	O

TD	O
:	O

03/31/97	O
12:36	O
P	O

cc	O
:	O

NYRI	O
A	O
MEMORY	O
,	O
M.D.	O

ASHELLRIETTE	O
NESSASU	O
THREATSVOT	O
,	O
M.D.	O

EJEAN	O
NADARC	O
FREIERMCHIRD	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2011-02-06	O

Discharge	O
Date	O
:	O

2011-02-08	O

Date	O
of	O
Birth	O
:	O

Sex	O
:	O

M	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Pohl	O
is	O
a	O
53	O
-	O
year-old	O
male	O
with	O
history	O
of	O
alcohol	O
use	O
and	O
hypertension	O
.	O

He	O
was	O
found	O
in	O
his	O
apartment	O
lobby	O
"	O
shouting	O
"	O
and	O
very	O
agitated	O
.	O

The	O
patient	O
states	O
that	O
he	O
recalls	O
going	O
out	O
alone	O
to	O
a	O
cafe	O
the	O
evening	O
prior	O
to	O
admission	O
.	O

There	O
he	O
recalls	O
having	O
pizza	O
and	O
two	O
glasses	O
of	O
red	O
wine	O
.	O

The	O
patient	O
told	O
other	O
staff	O
that	O
he	O
had	O
a	O
few	O
cocktails	O
and	O
drinking	O
a	O
few	O
more	O
glasses	O
of	O
wine	O
when	O
he	O
ran	O
into	O
some	O
friends	O
at	O
a	O
bar	O
.	O

He	O
denies	O
any	O
other	O
drug	O
or	O
toxin	O
ingestion	O
.	O

He	O
does	O
not	O
recall	O
walking	O
home	O
,	O
but	O
he	O
states	O
that	O
the	O
way	O
is	O
well	O
known	O
to	O
him	O
.	O

He	O
has	O
no	O
further	O
recollection	O
,	O
until	O
he	O
presented	O
to	O
the	O
emergency	O
room	O
.	O

He	O
by	O
emergency	O
room	O
report	O
,	O
was	O
found	O
in	O
his	O
apartment	O
lobby	O
agitated	O
.	O

EMS	O
was	O
called	O
and	O
the	O
patient	O
was	O
taken	O
to	O
the	O
emergency	O
room	O
.	O

Blood	B-procedure
alcohol	I-procedure
level	I-procedure
was	O
383	O
.	O

Agitated	O
in	O
emergency	O
room	O
requiring	O
4	B-procedure
leather	I-procedure
restraints	I-procedure
,	O
received	O
5	O
mg	O
of	O
Haldol	B-procedure
,	O
2	O
mg	O
of	O
Ativan	B-procedure
.	O

He	O
became	O
hypotensive	O
in	O
the	O
emergency	O
room	O
with	O
a	B-procedure
systolic	I-procedure
blood	I-procedure
pressure	I-procedure
in	O
the	O
80	O
's	O
and	O
had	O
decreased	O
respiratory	O
rate	O
.	O

He	O
received	O
a	B-procedure
normal	I-procedure
saline	I-procedure
bolus	I-procedure
of	O
2	O
liters	O
of	O
good	O
blood	O
pressure	O
response	O
.	O

The	O
patient	O
was	O
then	O
admitted	O
to	O
the	O
medical	O
Intensive	O
Care	O
Unit	O
for	O
observation	O
of	O
his	B-procedure
blood	I-procedure
pressure	I-procedure
and	O
then	O
transferred	O
to	O
our	O
service	O
on	O
medicine	O
when	O
the	B-procedure
blood	I-procedure
pressures	I-procedure
remained	O
stable	O
overnight	O
.	O

The	O
patient	O
denies	O
any	O
chest	O
pain	O
,	O
shortness	O
of	O
breath	O
,	O
dysuria	O
,	O
diarrhea	O
,	O
bright	O
red	O
blood	O
per	O
rectum	O
.	O

He	O
does	O
complain	O
of	O
cold	O
symptoms	O
times	O
one	O
week	O
.	O

The	O
patient	O
states	O
in	O
the	O
past	O
that	O
he	O
has	O
participated	O
in	O
several	O
alcohol	B-procedure
treatment	I-procedure
programs	I-procedure
,	O
most	O
recently	O
Star	O
which	O
is	O
similar	O
Alcoholics	O
Anonymous	O
.	O

The	O
patient	O
admits	O
that	O
he	O
has	O
had	O
many	O
stressors	O
in	O
his	O
life	O
lately	O
.	O

His	O
job	O
as	O
a	O
computer	O
programmer	O
is	O
unstable	O
.	O

His	O
brother	O
is	O
mentally	O
handicapped	O
and	O
might	O
be	O
sent	O
away	O
from	O
his	O
instate	O
institution	O
.	O

He	O
is	O
also	O
concerned	O
about	O
the	O
threat	O
of	O
war	O
and	O
is	O
ready	O
to	O
"	O
move	O
to	O
Madagascar	O
".	O

He	O
states	O
that	O
he	O
primarily	O
relies	O
on	O
friends	O
.	O

In	O
the	O
past	O
,	O
he	O
has	O
been	O
very	O
depressed	O
and	O
has	O
seen	O
a	B-procedure
counselor	I-procedure
at	O
Greenfield	O
Community	O
College	O
Community	O
Health	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hypertension	O
.	O

2.	O
History	O
of	O
colonic	O
polyps	O
times	O
3	O
,	O
benign	O
in	O
2007	O
,	O
repeat	B-procedure
colonoscopy	I-procedure
due	O
to	O
in	O
2010	O
.	O

3.	O
History	O
of	O
right	O
inguinal	O
hernia	O
in	O
2002	O
.	O

FAMILY	O
HISTORY	O
:	O

Noncontributory	O
.	O

SOCIAL	O
HISTORY	O
:	O

Positive	O
tobacco	O
,	O
10	O
pack	O
year	O
history	O
,	O
quit	O
for	O
8	O
years	O
in	O
his	O
40	O
's	O
and	O
now	O
no	O
cigarettes	O
for	O
one	O
week	O
using	O
no	O
pharmacal	B-procedure
therapy	I-procedure
.	O

Positive	O
for	O
ETOH	O
(	O
10	O
glasses	O
a	O
week	O
),	O
positive	O
for	O
drugs	O
,	O
marijuana	O
in	O
college	O
.	O

He	O
denies	O
any	O
IV	O
drug	O
use	O
.	O

The	O
patient	O
currently	O
lives	O
lone	O
in	O
Malden	O
.	O

He	O
came	O
out	O
here	O
for	O
college	O
at	O
BU	O
and	O
works	O
as	O
a	O
computer	O
programmer	O
.	O

Primarily	O
the	O
family	O
lives	O
in	O
Wisconsin	O
.	O

The	O
patient	O
has	O
only	O
male	O
sexual	O
partners	O
and	O
in	O
the	O
last	O
six	O
months	O
has	O
two	O
regular	O
partners	O
who	O
reportedly	O
are	O
human	O
immunodeficiency	O
virus	O
negative	O
and	O
no	O
IV	O
drug	O
use	O
.	O

He	O
uses	O
condoms	B-procedure
consistently	O
.	O

Major	O
stressors	O
in	O
his	O
life	O
include	O
unstable	O
job	O
,	O
brother	O
is	O
mentally	O
handicapped	O
,	O
war	O
.	O

ALLERGIES	O
:	O
No	O
known	O
drug	O
allergies	O
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

1.	O
Lisinopril	B-procedure
5	O
mg	O
p.o.	O
q.d.	O

2.	O
Mavik	B-procedure
question	O
of	O
dosage	O
.	O

3.	O
Hydrochlorothiazide	B-procedure
question	O
of	O
dosage	O
.	O

MEDICATIONS	O
ON	O
TRANSFER	O
:	O

1.	O
Ranitidine	B-procedure
150	O
mg	O
b.i.d.	O

2.	O
Thiamine	B-procedure
100	O
mg	O
q.d.	O

3.	O
Folic	B-procedure
acid	I-procedure
1	O
mg	O
q.	O
d.	O

4.	O
Multivitamin	B-procedure

PHYSICAL	O
EXAMINATION	O
:	O

Vitals	B-procedure
on	I-procedure
admission	I-procedure
:	O
Please	O
refer	O
to	O
addendum	O
.	O

Vital	B-procedure
signs	I-procedure
were	O
stable	O
.	O

Systolic	B-procedure
blood	I-procedure
pressure	I-procedure
in	O
the	O
120	O
's	O
to	O
130	O
's.	O

Pulse	B-procedure
in	O
the	O
60	O
's	O
to	O
70	O
's.	O

The	O
patient	O
was	O
a	O
thin	O
well-appearing	O
man	O
who	O
was	O
visibly	O
restless	O
in	O
bed	O
.	O

Neurological	O
:	O

He	O
was	O
alert	O
and	O
oriented	O
times	O
3	O
and	O
with	O
slightly	O
pressured	O
speech	O
.	O

He	O
states	O
that	O
mood	O
is	O
depressed	O
.	O

He	O
denies	O
auditory	O
,	O
visual	O
or	O
tactile	O
hallucinations	O
.	O

Cranial	B-procedure
nerves	I-procedure
II-XII	I-procedure
are	O
grossly	O
intact	O
,	O
5/5	O
strength	B-procedure
in	I-procedure
all	I-procedure
extremities	I-procedure
,	O
sensation	B-procedure
is	O
intact	O
in	O
all	O
extremities	O
.	O

Head	B-procedure
,	I-procedure
ears	I-procedure
,	I-procedure
eyes	I-procedure
,	I-procedure
nose	I-procedure
and	I-procedure
throat	I-procedure
:	O
Atraumatic	O
and	O
normocephalic	O
.	O

Sclerae	O
were	O
anicteric	O
.	O

Oropharynx	O
was	O
benign	O
without	O
exudate	O
.	O

Neck	O
:	O

Supple	O
.	O

Cardiovascular	O
:	O

Regular	O
rate	O
and	O
rhythm	O
with	O
normal	O
S1	O
and	O
S2	O
.	O

NO	O
murmurs	O
,	O
rubs	O
or	O
gallops	O
.	O

Chest	O
:	O

Rare	O
crackles	O
on	O
the	O
right	O
base	O
,	O
otherwise	O
clear	O
to	O
auscultation	B-procedure
bilaterally	I-procedure
.	O

Abdomen	O
:	O

Positive	O
bowel	O
sounds	O
,	O
nontender	O
and	O
nondistended	O
.	O

No	O
hepatosplenomegaly	O
.	O

Extremities	O
:	O

He	O
had	O
Dorsalis	B-procedure
pedis	I-procedure
in	O
radial	B-procedure
pulses	I-procedure
,	O
hands	O
and	O
feet	O
notably	O
tremulous	O
without	O
asterixis	O
.	O

No	O
stigmata	O
of	O
IV	O
drug	O
use	O
.	O

LABORATORY	O
DATA	O
:	O

CBC	B-procedure
:	O
White	B-procedure
blood	I-procedure
cell	I-procedure
count	I-procedure
is	O
8.8	O
,	O
hematocrit	B-procedure
35.5	O
platelets	B-procedure
266	O
,	O
PT	B-procedure
13	O
,	O
PT-T	B-procedure
23.3	O
,	O
INR	B-procedure
was	O
1.1	O
.	O

Chem-7	B-procedure
:	O
Sodium	B-procedure
145	O
,	O
potassium	B-procedure
3.4	O
,	O
chloride	B-procedure
116	O
,	O
bicarb	B-procedure
21	O
,	O
BUN	B-procedure
12	O
,	O
creatinine	B-procedure
0.6	O
,	O
glucose	B-procedure
96	O
,	O
calcium	B-procedure
7.2	O
,	O
phos	B-procedure
3.6	O
,	O
magnesium	B-procedure
1.7	O
.	O

Liver	B-procedure
function	I-procedure
tests	I-procedure
:	O
ALT	B-procedure
38	O
,	O
AST	B-procedure
34	O
,	O
alk	B-procedure
phos	I-procedure
is	I-procedure
107	O
,	O
albumin	B-procedure
is	O
3.2	O
,	O
peak	B-procedure
bili	I-procedure
is	I-procedure
0.3	O
,	O
amylase	B-procedure
31	O
,	O
and	O
lipase	B-procedure
is	O
32	O
.	O

UA	B-procedure
was	O
negative	O
.	O

Urine	B-procedure
tox	I-procedure
was	O
negative	O
.	O

Serum	B-procedure
tox	I-procedure
was	O
positive	O
for	O
ETOH	B-procedure
at	O
383	O
,	O
otherwise	O
negative	O
.	O

Serum	B-procedure
osmolality	I-procedure
was	O
38397	O
,	O
calculated	B-procedure
osmolality	I-procedure
gap	I-procedure
was	O
21	O
.	O

Radiology	O
:	O

chest	B-procedure
x-ray	I-procedure
from	O
02-07	O
had	O
linear	O
atelectasis	O
in	O
right	O
lower	O
lobe	O
with	O
no	O
evidence	O
of	O
a	O
band-like	O
opacity	O
in	O
the	O
left	O
lower	O
lobe	O
which	O
was	O
evident	O
on	O
the	B-procedure
chest	I-procedure
x-ray	I-procedure
on	O
02-06	O
.	O

CT	B-procedure
of	I-procedure
the	I-procedure
head	I-procedure
on	O
02-06	O
was	O
negative	O
for	O
hemorrhage	O
.	O

There	O
was	O
bran	O
atrophy	O
and	O
right	O
temporal	O
encephalomalacia	O
.	O

ASSESSMENT	O
AND	O
PLAN	O
:	O

Mr.	O
Pohl	O
is	O
a	O
53	O
-	O
year-old	O
male	O
with	O
a	O
history	O
of	O
ETOH	O
,	O
hypertension	O
who	O
presented	O
int	O
he	O
emergency	O
room	O
with	O
increased	O
agitation	O
,	O
like	O
secondary	O
to	O
ETOH	O
intoxication	O
and	O
developed	O
subsequent	O
hypotension	O
,	O
systolic	B-procedure
blood	I-procedure
pressures	I-procedure
in	O
the	O
80	O
's,	O
status	O
post	O
Ativan	B-procedure
and	O
Haldol	B-procedure
,	O
but	O
was	O
responsive	O

to	O
fluid	B-procedure
resuscitation	I-procedure
at	O
4	O
liters	O
and	O
was	O
admitted	O
to	O
the	O
CMED	O
CCU	O
for	O
hemodynamic	B-procedure
monitoring	I-procedure
.	O

On	O
hospital	O
day	O
#2	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
Medicine	O
Ludlow	O
Team	O
.	O

Plan	O
for	O
patient	O
regarding	O
cardiac	O
,	O
unlike	O
hypotension	O
of	O
cardiac	O
origin	O
.	O

The	O
patient	O
responded	O
well	O
to	O
fluid	B-procedure
resuscitation	I-procedure
.	O

Elevated	O
CK	O
on	O
02-07	O
is	O
likely	O
secondary	O
to	O
mild	O
rhabdomyolysis	O
.	O

The	O
patient	O
was	O
hemodynamically	O
stable	O
overnight	O
in	O
the	O
CMED	O
CCU	O
.	O

We	O
decided	O
to	O
discontinue	O
telemetry	B-procedure
and	O
held	O
all	B-procedure
hypertension	I-procedure
medications	I-procedure
including	O
Lisinopril	B-procedure
,	O
Mavik	B-procedure
,	O
hydrochlorothiazide	B-procedure
.	O

2.	O
For	O
pulmonary	O
,	O
the	O
patient	O
had	O
a	O
good	O
O2	B-procedure
saturations	I-procedure
on	O
room	O
air	O
.	O

He	O
had	O
atelectasis	O
in	O
the	O
right	O
lower	O
lobe	O
by	O
chest	B-procedure
x-ray	I-procedure
.	O

We	O
encouraged	O
activity	O
and	O
patient	O
out	O
of	O
bed	O
.	O

3.	O
Gastrointestinal	O
:	O

The	O
patient	O
on	O
ranitidine	B-procedure
150	O
mg	O
p.o.	O
b.i.d.	O
for	O
gastrointestinal	B-procedure
prophylaxis	I-procedure
.	O

4.	O
Urology	O
:	O
Foley	B-procedure
was	O
discontinued	O
in	O
the	O
CMED	O
CCU	O
at	O
12	O
p.m.	O

The	O
patient	O
was	O
urinating	O
without	O
difficulty	O
.	O

We	O
gave	O
the	O
patient	O
bathroom	O
privileges	O
.	O

5.	O
FEN	O
:	O

We	O
continued	O
IV	B-procedure
fluids	I-procedure
at	O
100	O
cc	O
per	O
hour	O
for	O
one	O
liter	O
secondary	O
to	O
a	O
concern	O
for	O
rhabdomyolysis	O
plus	O
kidney	B-procedure
protective	I-procedure
effects	I-procedure
.	O

K	B-procedure
was	O
3.4	O
,	O
repleted	O
,	O
potassium	B-procedure
chloride	I-procedure
40	O
mEq	O
times	O
1	O
dose	O
p.o.	O

Calcium	B-procedure
with	O
7.2	O
corrected	O
to	O
less	O
than	O
8.0,	O
completed	O
calcium	B-procedure
carbonate	I-procedure
at	O
500	O
mg	O
blood	B-procedure
pressure.o.	I-procedure
t.i.d.	O
while	O
in	O
the	O
hospital	O
.	O

Mag	B-procedure
was	O
1.7	O
,	O
repleted	O
with	O
magnesium	B-procedure
oxide	I-procedure
with	O
400	O
mg	O
p.o.	O
times	O
one	O
dose	O
.	O

Diet	O
as	O
tolerated	O
.	O

6.	O
Substance	O
use	O
and	O
psychiatry	O
:	O

The	O
patient	O
states	O
that	O
he	O
was	O
willing	O
to	O
speak	O
with	O
someone	O
from	O
addiction	O
services	O
.	O

We	O
were	O
concerned	O
regarding	O
possibly	O
binge	O
drinking	O
or	O
ETOH	O
abuse	O
.	O

The	O
patient	O
seemed	O
notably	O
anxious	O
and	O
depressed	O
.	O

It	O
is	O
possible	O
that	O
the	O
patient	O
is	O
self	O
medicating	O
for	O
underlying	O
psychiatric	O
disorder	O
.	O

We	O
will	O
monitor	B-procedure
for	O
signs	O
of	O
alcohol	O
withdrawal	O
according	O
to	O
the	B-procedure
CIWA	I-procedure
scale	I-procedure
.	O

We	O
will	O
given	O
valium	B-procedure
5	O
mg	O
p.o.	O
q.	O
3	O
hours	O
for	O
withdrawal	O
.	O

We	O
will	O
consult	O
addiction	O
service	O
in	O
the	O
a.m.	O

We	O
will	O
consider	O
psychiatry	O
consult	O
in	O
the	O
future	O
to	O
assess	O
for	O
underlying	O
anxiety	O
disorder	O
or	O
depression	O
.	O

DISPOSITION	O
:	O

The	O
patient	O
may	O
be	O
discharge	O
Harry	O
02-08	O
pending	O
observations	B-procedure
for	O
delirium	O
tremens	O
after	O
discussion	O
with	O
primary	O
care	O
physician	O
,	O
Dr.	O
Blue	O
who	O
knows	O
the	O
patient	O
well	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
transferred	O
to	O
medicine	O
service	O
on	O
hospital	O
day	O
#2	O
after	O
remaining	O
hemodynamically	O
stable	O
in	O
the	O
CMED	O
CCU	O
overnight	O
.	O

1.	O
Blood	B-procedure
pressure	I-procedure
:	O

The	B-procedure
patient	I-procedure
's	I-procedure
blood	I-procedure
pressure	I-procedure
remained	O
stable	O
on	O
hospital	O
day	O
#2	O
through	O
hospital	O
day	O
#3	O
status	O
post	O
IV	B-procedure
hydration	I-procedure
with	O
systolic	B-procedure
blood	I-procedure
pressures	I-procedure
in	O
the	O
120	O
's	O
to	O
130	O
's.	O

We	O
continued	O
to	O
hold	O
the	O
patient	O
's	O
home	B-procedure
blood	I-procedure
pressure	I-procedure
medications	I-procedure
.	O

The	O
patient	O
was	O
asymptomatic	O
without	O
chest	O
pain	O
,	O
shortness	O
of	O
breath	O
and	O
no	O
mental	O
status	O
changes	O
.	O

2.	O
Substance	O
abuse	O
:	O

On	O
Hospital	O
day	O
#2	O
through	O
hospital	O
day	O
#3	O
,	O
the	O
patient	O
had	O
mild	O
tremor	O
on	O
hands	O
,	O
but	O
improved	O
over	O
hospital	O
course	O
.	O

The	O
patient	O
became	O
notably	O
less	O
anxious	O
throughout	O
hospital	O
stay	O
.	O

CIWA	B-procedure
scale	I-procedure
over	O
night	O
was	O
1	O
for	O
tremor	O
and	O
the	O
patient	O
did	O
not	O
require	O
any	O
Valium	B-procedure
for	O
alcohol	O
withdrawal	O
.	O

We	O
believe	O
that	O
the	O
patient	O
is	O
able	O
to	O
be	O
discharged	O
and	O
to	O
follow	O
up	O
with	O
Dr.	O
Sandra	O
Rose	O
,	O
addiction	O
services	O
as	O
an	O
outpatient	O
.	O

Call	O
for	O
further	O
referral	O
.	O

3.	O
FEN	O
:	O

Calcium	B-procedure
carbonate	I-procedure
500	O
mg	O
p.o.	O
t.i.d.	O
,	O
Mag	B-procedure
oxide	I-procedure
400	O
mg	O
p.o.	O
times	O
one	O
dose	O
,	O
potassium	B-procedure
chloride	I-procedure
repleted	O
40	O
mEq	O
times	O
one	O
dose	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
ETOH	O
intoxication	O
.	O

2.	O
Hypertension	O
.	O

3.	O
History	O
of	O
colonic	O
polyp	O
times	O
3	O
,	O
benign	O
in	O
2007	O
,	O
repeat	B-procedure
colonoscopy	I-procedure
due	O
in	O
2010	O
.	O

4.	O
History	O
of	O
right	O
inguinal	O
hernia	O
in	O
2002	O
.	O

DISCHARGE	O
STATUS	O
:	O

Home	O
.	O

FOLLOW	O
UP	O
:	O

Follow	O
up	O
with	O
Dr.	O
Marcia	O
Bender	O
to	O
be	O
arranged	O
by	O
the	O
patient	O
.	O

The	O
patient	O
will	O
also	O
call	O
clinical	O
nurse	O
specialist	O
,	O
Sandra	O
Rose	O
at	O
(	O
968	O
)	O
347-9868	O
for	O
further	O
referral	O
to	O
addiction	O
services	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Return	O
to	O
home	B-procedure
medications	I-procedure
:	O

1.	O
Lisinopril	B-procedure
5	O
mg	O
p.o.q.d.	O

2.	O
Mavik	B-procedure
unknown	O
dosage	O
.	O

3.	O
Hydrochlorothiazide	B-procedure
unknown	O
dosage	O
.	O

MARK	O
T	O
Ragin	O
,	O
M.D.	O
34-329	O

Dictated	O
By	O
:	O
Alice	O
T.	O
Mahoney	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2011-02-08	O
12:05	O

T	O
:	O
2011-02-08	O
12:15	O

JOB	O
#:	O
77892	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Richard	O
Carlson	O
on	O
:	O
SUN	O
2011-02-20	O
1:40	O
PM	O

(	O
End	O
of	O
Report	O
)	O

